Diastereoselective intramolecular carbolithiation and acylation reactions by Simon, Meike
  
DISSERTATION ZUR ERLANGUNG DES DOKTORGRADES 
DER FAKULTÄT FÜR CHEMIE UND PHARMAZIE 
DER LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN 
 
 
 
 
 
DiastereoseleĐtiǀe IŶtraŵoleĐular 
CarďolithiatioŶ aŶd AĐǇlatioŶ ReaĐtioŶs 
 
 
 
 
 
von 
Meike Simon 
Aus Darmstadt, Deutschland 
 
 
2018 
  
  
  
Erklärung 
Diese Dissertation wurde im Sinne von § 7 der Promotionsordnung vom 28. November 2011 von Herrn 
Prof. Dr. Paul Knochel betreut. 
 
Eidesstattliche Versicherung 
Diese Dissertation wurde eigenständig und ohne unerlaubte Hilfsmittel erarbeitet. 
 
München, den 28.02.2018 
 
_________________________ 
Meike Simon 
 
 
 
 
 
 
 
Dissertation eingereicht am:  01. März 2018 
1. Gutachter:    Prof. Dr. Paul Knochel  
2. Gutachter:    Prof. Dr. Konstantin Karaghiosoff 
Mündliche Prüfung am:  12. April 2018 
  
  
 
  
  
This work was carried out from March 2015 to February 2018 under the guidance of Prof. Dr. Paul 
Knochel at the Department of Chemistry of the Ludwig-Maximilians-Universität, Munich. 
 
Foremost, I would like to express my appreciation for Prof. Dr. Paul Knochel, who gave me the 
exceptional opportunity to do my Ph.D. in his group, and for his invaluable guidance over the course of 
my scientific research. 
I am also very grateful to Prof. Dr. Konstantin Karaghiosoff for being my second referee for this thesis, 
and for all the discussions we had. I also would like to thank Prof. Dr. Manfred Heuschmann, Prof. Dr. 
Rasmus Linser, Prof. Dr. Oliver Trapp, and Prof. Dr. Franz Bracher for their interest shown in this 
manuscript by accepting to be referees. 
For funding, I would like to thank the Verband der Chemischen Industrie e.V. for providing me a 
Chemiefonds-Stipendium (Ph.D. Scholarship). 
I really would like to thank Peter Dowling, Ferdinand Lutter, Varvara Morozova, Juri Skotnitzki, Lucie 
Thomas, and Dorothée Ziegler for the careful correction of this manuscript. 
A special thanks to my lab mates of F2.017 Zhi-Bing Dong, Jeffrey M. Hammann, Ilya Makarov, 
Varvara Morozova, Kohei Moriya, Juri Skotnitzki, Eric Tan and Dorothée S. Ziegler. It was a pleasure 
to work with you, discuss with you and share lots of happy moments. I will always keep Juri’s music 
in my ears. Thank you, that there were always special songs for special moments. I thank all past and 
present members whom I have met in the Knochel group, for their kindness and their help. A special 
thank also to our “Bachelor” team for having a lot of fun also outside the lab. 
I thank my former students Stefanie Beck, Daniel Graf, Lukas Wein and Christian Steinborn for their 
excellent contributions in the course of their internships. 
I would also like to thank Peter Dowling, Sophie Hansen, Lena Hauser, Dr. Vladimir Malakov and 
Yulia Tsvik for their help in organising everyday life in the lab and in the office. My research would 
not have been possible without the help of the whole analytical department. Dr. Werner Spahl and Sonja 
Kosak are thanked for their work in high resolution mass spectrometry. Dr. David Stevenson, Claudia 
Dubler and Petra Keilholz are thanked for their help in the NMR facility. Finally, Prof. Dr. Konstantin 
Karaghiosoff’s work in single crystal X-ray analysis and NMR measurements is an irreplaceable asset 
to the department. 
  
 
Last but not least, I would like to thank my family and friends for their support throughout my studies 
and my PhD and their continuous encouragement. Finally, I would truly like to thank Mitch for his love 
and patience with me. 
. 
  
 
Parts of this Ph.D. Thesis have been published 
A) Communications and Full Papers 
1) “Diastereoselective Intramolecular Carbolithiations of Stereodefined Secondary Alkyllithiums 
Bearing a Remote Alkynylsilane” 
M. Simon, K. Karaghiosoff, P. Knochel, manuscript submitted. 
B) Patents 
1) “Kohlenwasserstoff-Lösliche Halogen- und Thiolat- /Magnesium-Austauschreagenzien” 
P. Knochel, D. S. Ziegler, M. Simon, DE 2018200805.1, a patent application has been filed. 
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“Ever tried. Ever failed. No matter. Try again. Fail again. Fail better.” 
Samuel Beckett (in Worstward Ho, 1983) 
 
 
  
  
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
To my family 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Abstract  
 
I 
 
Abstract 
This Ph.D. thesis describes the formation of unstabilised secondary alkyllithium reagents, and their 
highly diastereolective behaviour in carbolithiation and acylation reactions, and additionally details a 
new sulfur/metal-exchange on piperidyl thioethers. 
Part I: The first part of this work focuses on the diastereoselective preparation of secondary, 
unstabilised Li-compounds via an iodine/lithium-exchange at −100 °C using t-BuLi (inverse addition, 
2.5 equiv.) and their application in intramolecular carbolithiation and acylation reactions. 
The first topic describes the synthesis of various stereodefined cyclopentane derivatives. Performing a 
stereospecific iodine/lithium-exchange of secondary iodides, each bearing an internal alkynylsilane-
moiety, generated the stereodefined Li-species. Various exo-alkylidene cyclopentane, related cis-
bicyclo[3.3.0]octane, and cis-bicyclo[4.3.0]nonane derivatives were afforded in excellent 
diastereoselectivity by an intramolecular carbolithiation reaction. Carrying out the iodine/lithium-
exchange in an enantioselective fashion, demonstrated a high potential for enantiomeric syntheses. The 
remaining silane-moiety was successfully transformed into an iodide, which was further modified, 
giving an opportunity to construct up to four contiguous stereocentres in cyclopentanes, as well as in 
bicyclic ring structures (Scheme A). 
 
Scheme A: Example for the preparation of an exo-alkylidene cyclopentane bearing four contiguous stereocentres. 
Also, an approach toward the stereoselective synthesis of ketones via an intramolecular acylation 
reaction was developed. Thus, various stereodefined organolithiums were prepared from stereodefined 
secondary iodoesters. The iodine/lithium-exchange was triggered by the inverse addition of t-BuLi 
(2.5 equiv.) at −100 °C in diethyl ether. The Li-reagents formed undergo a fast transfer of the acyl 
group, and a range of ketones were obtained, which were isolated after protection of the remaining 
alcohol group (Scheme B). 
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Scheme B: Diastereoselective acyl-transfer after an I/Li-exchange with t-BuLi. 
Part II: The second part of this work focused on the development of a new sulfur/metal-exchange on 
piperidyl thioethers. The desired magnesium reagents A7 were produced by treating piperidyl thioethers 
with s-BuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu in toluene at room temperature. Reaction with various 
electrophiles afforded the desired products. When a second residue is present in the piperidyl ring, only 
the thermodynamic product is formed after quenching with electrophiles (Scheme C). 
 
Scheme C: Reaction of thioethers with s-BuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu in the presence of TMEDA and reaction 
with various electrophiles. 
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1 Introduction 
Lots of organic compounds, especially natural products, contain chiral centres in their molecular 
structure, e.g. perfumes, cosmetics, nutrients, pesticides and pharmaceuticals. Historically, those chiral 
compounds were isolated from natural products. Nowadays, different ways for the preparation of 
enantiomerically pure compounds are known: 1) synthesising the compound in its racemic form and 
subsequent resolution; 2) using plants or bacteria producing the desired compound; 3) synthesis starting 
with a natural product or 4) an asymmetric synthesis.[1] Obtaining stereoisomerically pure compounds 
is important for example for pharmaceuticals in terms of their mode of action. In most cases, only one 
of the enantiomers has the desired biological activity, while the other one is inactive or even has an 
inverse effect.[2] Marckwald defined the expression “asymmetric synthesis” in 1904 as follows:[3] 
“Asymmetrische Synthesen sind solche, welche aus symmetrisch constituirten Verbindungen unter 
intermediärer Benutzung optisch-activer Stoffe, aber unter Vermeidung jedes analytischen Vorganges, 
optisch-active Substanzen erzeugen.” 
To define a transformation as asymmetric, the following criteria are useful: 1) the reaction is 
stereoselective; 2) if a chiral catalyst is involved, a low loading should be possible, and the catalyst 
should be easily separable; 3) if a chiral auxiliary is used, it should be removable without compromising 
the newly formed stereocentre, and recoverable in good yield without racemisation, and 4) the chiral 
auxiliary or catalyst should be readily and inexpensively available.[1] 
1.1 Organolithium Compounds 
In 1996, Beak described organolithium reagents as the “most used organometallics in contemporary 
organic chemistry”.[4] Lithium is the smallest of the metals and the structures of the organolithium 
compounds are complex due to their high tendency to aggregate.[5,6] The degree of covalence varies with 
temperature, solvent and structure. The C-Li bond might be best described as ionic, even if a covalent 
character cannot be neglected.[7] 
Organolithium compounds were first prepared by Schlenk and Holtz by the reaction of lithium with a 
diorganomercury compound.[8] Later, Ziegler et al. showed that this reaction is reversible.[9] 
Organolithium derivatives can be prepared by deprotonation, reductive lithiation, transmetalation from 
Hg, Sn, Se, Te, S and P, as well as by halogen/lithium-exchange.[10] 
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1.2 Stereoselective Preparation of Organolithium Reagents 
Letsinger[11] and Curtin[12] described the first chiral lithium reagents in the 1λ50’s. Letsinger obtained 
acid 3 after iodine/lithium-exchange of (−)-2-iodooctane 1 using s-BuLi at −70 °C in petroleum ether 
and subsequent trapping with CO2 in low yield and with approximately 80% racemisation (Scheme 1).[11] 
 
Scheme 1: I/Li-exchange of (−)-2-iodooctane 1. 
To obtain Li-compounds, which are relatively stable toward racemisation, an external stabilisation is 
needed. This can be achieved either by an intramolecular coordination of the Li-atom by a heteroatom 
or by stabilising the electron-rich C-Li bond via a nearby empty orbital or an electron-withdrawing 
group.[10] 
In 1980, Still discovered the stereospecific transmetalation from Sn to Li of chiral α-alkoxystannanes. 
Not only was the organolithium formed stereospecifically, but also the resulting Li-species 5 were found 
to be configurationally stable, at least for 15 min at −30 °C. Quenching with acetone as electrophile 
afforded the desired product 6 (Scheme 2).[13] 
 
Scheme 2: Preparation of O-stabilised organolithiums 5 via Sn/Li-exchange. 
Alternatively, chiral ligands, such as (−)-sparteine, were used to achieve an enantioselective 
deprotonation reaction. (−)-Sparteine was first reported in 1968 for the reaction of ethylmagnesium 
bromide with benzaldehyde.[14,15] The active conformation of (−)-sparteine, which is able to act as a 
bidentate ligand, is slightly higher in energy compared to its ground state.[16] Treating N-methyl-
3-phenylpropionic acid 7 with s-BuLi in the presence of (−)-sparteine, the desired product 9 was isolated 
after trapping with TMSCl in 78% yield and with high enantioselectivity.[17] 
 Introduction 
 
4 
 
 
Scheme 3: Enantioselective deprotonation of N-methyl-3-phenylpropionic acid amide 7 using (−)-sparteine. 
About five years ago, Knochel et al. developed a stereoretentive iodine/lithium-exchange for the 
preparation of cis- and trans-cycloalkyllithiums 11 from the corresponding iodides 10. Addition of 
t-BuLi to a solution of the iodide 10 mainly resulted in hydrolysis and elimination products. Thus, 
inversion of the addition order supressed the undesired hydrolysis and elimination, and the desired 
unstabilised secondary organolithium 11 was obtained. Reaction of the lithium reagent 11 with various 
electrophiles yielded the corresponding products in 23–92% yield (Scheme 4).[18] 
 
Scheme 4: Stereoretentive I/Li-exchange and trapping with an electrophile. 
This concept was later extended to secondary open-chain alkyllithium compounds functionalised at 2, 3 
and 4-position (Figure 1).[19–21] 
 
Figure 1: 1,4-, 1,3- and 1,2-functionalised secondary alkyllithiums. 
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1.3 Carbolithiations 
Carbolithiation reactions are defined as the addition of an organolithium reagent across an unactivated 
C-C π-bond, forming a new C-C and a C-Li σ-bond.[22] For these reactions the carbometalation ability 
of organolithium compound 13 must be higher than that of the newly formed organolithium 15 to prevent 
the formation of polymers. Lithium species 15 can be, for example, stabilised by conjugation or 
coordination.[10,23–25] 
 
Scheme 5: General scheme of a carbolithiation reaction. 
The origin of intermolecular carbolithiation reactions lies in anionic polymerisation. Ziegler[26] did 
pioneer work with the controlled addition of anionic initiators to nonpolar carbon-electrophiles. 
Theoretical calculations have shown, that the first step in the reaction of methyllithium with ethylene is 
the formation of a Li-π-complex with an activation energy of 18–24 kcal/mol, followed by syn-
addition.[27] 
The first asymmetric intermolecular carbolithiation was developed by Marek and Normant,[28] preparing 
lithium species 18 under the influence of the chiral ligand (−)-sparteine (Scheme 6). This method is 
taking advantage of the complex-induced proximity effect (CIPE). Also, because of the chelation of Li 
with the oxygen, no polymerisation was observed. Furthermore, it was possible to maintain a good 
enantiomeric excess in the presence of only 5 mol% of (−)-sparteine. The use of a (+)-sparteine surrogate 
was successfully applied to the synthesis of R-19 in similar yield and enantioselectivity.[29] 
 
Scheme 6: Enantioselective carbolithiations using chiral ligands. 
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Intramolecular carbolithiations to alkynes can be used to prepare oligosubstituted alkenes.[30] A 
drawback of this reaction is that the lithium reagent can deprotonate terminal acetylenic or propargylic 
protons, and in some cases isomerisation products of the vinyllithium, formed during the reaction, were 
observed.[10] 
In the 1λ60’s, Drozd et al. reported the isomerisation of 5-hexenyllithium (20) to cyclopentylmethyl-
lithium (21) after reductive lithiation of 1-bromo-5-hexene (22) with lithium metal in ether (Scheme 
7).[23] 
 
Scheme 7: Isomerisation of 5-hexenyllithium (21) to cyclopentylmethyllithium (22). 
In 1985, Bailey et al. carried out mechanistic studies on the cyclisation of 5-hexenyllithium (20) to 
cyclopentylmethyllithium (21) preparing Li-species 20 by treating 6-iodo-1-hexene with t-BuLi. The 
cyclisation can be described as a first-order process, that is therefore highly dependent on temperature. 
The reaction of the anionic species 21 also proceeds much slower[31] than the cyclisation of the 5-hexenyl 
radical.[32] 
Intramolecular carbolithiations, such as 5-exo-trig cyclisations, proceed highly stereoselective. The 
entropy factor favours a monoaddition, even if the initial organolithium reagent has a higher reactivity 
than the carbometalated one. The cyclisation proceeds via a highly organised cyclic transition state. To 
ensure minimal steric hindrance, all moieties in the chair-like transition state are in a pseudo-equatorial 
position (Scheme 8).[31] The interaction of the lithium with the C-C double bond, calculated by Bailey 
et al.,[33] was later confirmed by Hofmann and Rölle by NMR.[34] However, this mechanism is not 
accurate enough to predict the outcome of cyclisations of secondary unsaturated organolithiums.[25] 
 
Scheme 8: Intramolecular addition of a C-Li bond across an unactivated double bond. 
Intramolecular carbolithiations to alkynes allow an access to four- to six-membered carbo- and 
heterocycles,[25] usually with a high level of stereo- and regioselectivity, since the addition of 
organolithium reagent over the C-C triple bond proceeds stereospecifically.[23] Introducing an activation 
group at the acetylene, such as a phenyl- or a silyl-group, allows the carbolithiation to proceed faster 
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than with a butyl-group.[35–37] Notably Bailey,[38] Coldham,[39] and Negishi[40] generalised this kind of 
cyclisation.[23] 
Hoppe et al.[41,42] used an intramolecular trans-cyclocarbolithiation for the preparation of four- to six-
membered rings. Lithiodestannylation of (1R,5RS)-23 with n-BuLi in THF at −100 °C and in the 
presence of LiCl yielded, after anti-selective 6-exo-dig cyclisation, the desired product 24. The 
secondary Li-species 25, that is formed, can be coordinated by the carbamate. It is presumed, that a 
1,3,5-triaxial interaction between the TBSO-, the CbO-group, and one methyl group prevents the 
formation of transition state (1S,5R)- 25 (Scheme 9).[42] 
 
Scheme 9: Synthesis of 2-alkylidene-cyclohexane-1,3-diol 24. CbO: (i-Pr)2NCO2. R = TBS. 
1.4 Intramolecular Barbier-Type Reaction 
A Barbier reaction[43] describes the reaction between an alkyl halide and a carbonyl group in the presence 
of a metal. Molle and Bauer showed, that an in situ formation of an organometallic is not necessarily 
involved in a Barbier reaction.[44] 
In 1985, Cooke studied the iodine/lithium-exchange of primary iodides, such as 27 and the following, 
intramolecular attack to an amide group, producing the cyclic ketone 28 (Scheme 10).[45] 
 
Scheme 10: I/Li-exchange of iodoamide 27 and Barbier-type cyclisation to cyclopentanone (28). 
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Such a reaction can be also performed with esters. The reaction taking place can be named as an 
intramolecular nucleophilic acyl substitution (INAS) reaction. INAS can be classified into two groups: 
1) forming cyclic ketones, while OR or NR2 acts as a leaving group or 2) transferring a carbon fragment 
from oxygen to carbon affording a hydroxyketone (Scheme 11).[46] 
 
Scheme 11: Intramolecular nucleophilic acyl substitution. 
INAS reactions have also been used in natural product synthesis for targets bearing an ester group. In 
some cases, ketone 29, formed during the reaction, was in fact an undesired side product beside the 
desired hemiacetal 30 (Scheme 12, eq. 1).[47,48] In the synthesis of (+)-Sundiversifolide, the 
cycloheptanone 33 formed during the reaction sequence was an important building block (Scheme 12, 
eq. 2).[49] 
 
Scheme 12: Intramolecular nucleophilic acyl substitution in natural product synthesis. 
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2 Project Outline 
Knochel and co-workers have already demonstrated that the iodine/lithium-exchange of secondary 
stereodefined iodides proceeds with retention of the configuration, if no coordinating group is present 
in the molecule.[18,19] 
 
Scheme 13: Stereoretentive I/Li-exchange of secondary alkyl iodides. 
With those results in mind, the first goal of this thesis was the development of a synthetic route toward 
the preparation of cyclopentane derivatives via a stereoselective iodine/lithium-exchange and 
intramolecular carbolithiation. The α-anion stabilising TMS-group should be transformed, allowing to 
synthesise cyclic systems with up to four contiguous stereocentres (Scheme 14). 
 
Scheme 14: I/Li-exchange followed by an intramolecular carbolithiation to create structures with up to four stereocentres. 
The second goal of this Ph.D. thesis was the preparation of stereodefined ketones starting from the 
corresponding iodoesters. An iodine/lithium-exchange, followed by an intramolecular acylation 
reaction, should afford the desired ketones (Scheme 15). 
 
Scheme 15: I/Li-exchange and subsequent intramolecular transfer of the acyl group. 
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3 Results: Intramolecular Carbolithiation Reactions 
3.1 Introduction 
Intramolecular carbometalations of organolithiums bearing a remote alkene or alkyne have been used to 
prepare various carbocycles.[23–25,50–52] Pionier work from Bailey[37,38,53–55] and Negishi[56] has shown that 
primary alkyllithiums add intramolecularly to internal alkynes and alkynylsilanes. Hoppe[41,42] showed 
that optically enriched O-stabilized organolithium derivatives undergo trans-selective carbolithiations 
to ynol carbamates with high enantioselectivity. Recently, Knochel et al. have shown that non-stabilised, 
secondary alkyllithiums can be prepared from secondary alkyl iodides with retention of 
configuration.[18–20] Also, it was shown that intramolecular carbolithiations provide stereoselective 
access to alkylidene cyclobutanes 37 (Scheme 16).[57] 
 
Scheme 16: Stereoselective synthesis of alkylidenecyclobutane derivatives 37. 
3.2 Synthesis of the Iodides 
First, the secondary iodoalkynes rac-(2R,3R)-40a and rac-(2R,3S)-40a had been prepared. Copper(I)-
catalysed addition of alkylmagnesium bromide 41 to trans- and cis-2,3-epoxybutane, respectively, 
provided the two alcohols rac-(2S,3R)-42a and rac-(2S,3S)-42a diastereoselectively in 86–89% 
(d.r.>99:1).[58–61] Conversion with inversion of the configuration of alcohols rac-(2S,3R)-42a and 
rac-(2S,3S)-42a to the corresponding iodides rac-(2R,3R)-40a and rac-(2R,3S)-40a was performed 
under Appel-conditions[62,63] in 51–63% (d.r.>99:1) using iodine, triphenylphosphine and 
N-methylimidazole (NMI) (Scheme 17). 
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Scheme 17: Stereoselective preparation of iodides rac-(2R,3R)-40a and rac-(2R,3S)-40a via Cu(I)-catalysed epoxide opening 
with Grignard reagent 41. The diastereomeric ratio was determined by NMR-analysis. 
The trimethylsilane moiety attached to the alkyne is known to stabilise an occurring α-anion during the 
cyclisation procedure.[64] Nevertheless, it is easily removable and transformable into various functional 
groups.[65–67] 
Iodides rac-(2R,4S)-40b and rac-(2R,4R)-40b were prepared stereoselectively after separation of the 
two diastereoisomers of intermediate 43 by column chromatography (Scheme 18). First, the alcohol 
group of pent-4-en-2-ol 44 was protected with PMBCl (78% yield). After epoxidation with meta-
chloroperbenzoic acid (mCBPA) (78% yield), epoxide 46 was opened with ((triphenylsilyl)ethynyl)-
lithium and the product 47 was isolated in 69% yield. After protection of the secondary alcohol with 
TBSOTf and 2,6-lutidine, the diastereoisomers of the protected diol 43 were separated by column 
chromatography affording rac-(2S,4S)-43 in 30% yield and rac-(2S,4R)-43 in 17% yield (d.r.>99:1). 
After PMB-deprotection of rac-(2S,4S)-43 and rac-(2S,4R)-43 with DDQ the corresponding alcohols 
rac-(2S,4S)-42b and rac-(2S,4R)-42b were obtained in 83–88% yield. Following iodination using 
Appel-conditions afforded iodides rac-(2R,4S)-40b and rac-(2R,4R)-40b in 78–82% yield and with 
excellent diastereoselectivity. 
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Scheme 18: Preparation of iodides rac-(2R,4S)-40b and rac-(2S,4R)-40b starting from pent-4-en-2-ol 44. 
TBAI = tetrabutylammonium iodide. 
Bicyclic iodides syn-40c–e were also prepared by copper(I)-catalysed epoxide-opening using the 
corresponding Grignard-reagent 41. Synthesis of the anti-isomers was mostly not possible. Iodination 
under Apple-conditions lead to the elimination product, as did the use of DCC·MeI. Conversion of a 
mesylate into an iodide using TMSI and FeBr3 or Fe(acac)3 respectively was not successful. Only 
iodide anti-40c could be obtained in 43% yield (d.r.<1:99) using iodine, triphenylphosphine and NMI 
(Figure 2). 
 
Figure 2: Iodides prepared for the synthesis of bi- and tricyclic structures. 
3.3 Intramolecular Carbolithiation 
The alkyl iodides rac-(2R,3R)-40a and rac-(2R,3S)-40a were stereoselectively converted to the Li-
derivatives syn-48a and anti-48a using an iodine/lithium-exchange triggered by the inverse addition of 
t-BuLi (2.5 equiv., Et2O, −100 °C). Quenching with iodine gave the corresponding syn- and anti-iodides 
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syn-49a and anti-49a in 71–77% yield (d.r.>99:1), indicating a high retention of configuration. 
Interestingly, the reaction of iodide anti-49a with Bu(PhS)CuLi[68] allowed the substitution of the iodide 
by a butyl moiety to afford anti-50 (Scheme 19).[69] 
 
Scheme 19: Stereoselective synthesis of alkenyl iodides (syn-49a and anti-49a) from the corresponding iodides 
rac-(2R,3R)-40a and rac-(2R,3S)-40a via I/Li-exchange, intramolecular carbolithiation and trapping with iodine. The iodide 
of anti-49a was converted into a butyl group using Bu(PhS)CuLi. 
This reaction sequence was extended to other electrophiles, such as ethyl chloroformate leading to the 
esters syn-49b and anti-49b in 65–77% with complete retention of the configuration (Table 1, entries 
1–2). Quenching of syn-48a and anti-48a with benzophenone gave the tertiary alcohols syn-49c (65%, 
d.r.>99:1) and anti-49c (76%, d.r.>99:1; entries 3–4). X-ray crystallographic analysis of syn-49c 
confirmed the syn-relative stereochemistry (Figure 3). Next, 3-oxygenated substrates were examined for 
the intramolecular carbolithiation. Since Knochel et al. reported that such iodides undergo a fast 
equilibration after iodine/lithium-exchange providing an alkyllithium reagent in a stereoconvergent 
manner,[20,57] SiMe3 was replaced by SiPh3, which is known to facilitate carbolithiations and may 
therefore avoid subsequent equilibration.[70–73] To our delight, the stereoselective performance of an 
iodine/lithium-exchange on rac-(2R,4R)-40b and rac-(2R,4S)-40b respectively produced syn-49d (99% 
yield, d.r.>99:1) and anti-49d (55% yield, d.r. >99:1) after aqueous workup (entries 5–6) The anti-
relative stereochemistry of anti-49d was confirmed by X-ray crystallographic analysis (Figure 3). 
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Table 1: Intramolecular diastereoselective carbolithiation leading to exo-alkylidene cyclopentane derivatives. 
 
Entry Substrate Electrophile Product [a] 
 
 
 
 
1 rac-(2R,3R)-40a ClCO2Et syn-49b 
   65%; d.r.>99:1 
 
 
 
 
2 rac-(2R,3S)-40a ClCO2Et anti-49b 
   77%; d.r. >99:1 
 
  
 
3 rac-(2R,3R)-40a Ph2CO syn-49c 
   65%; d.r.>99:1 
 
  
 
4 rac-(2R,3S)-40a Ph2CO anti-49c 
   76%; d.r. >99:1 
 
 
 
 
5 rac-(2R,4R)-40b NH4Cl syn-49d 
   99%; d.r.>99:1 
 
 
 
 
6 rac-(2R,4S)-40b NH4Cl anti-49d 
   55%; d.r. >99:1 
[a]
 Yields refer to analytically pure products. 
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Figure 3: X-ray crystallographic structure of cyclopentane derivatives syn-49c and anti-49d. 
Using the conditions described above, it was possible to prepare bicyclic and tricyclic ring systems.[54,74] 
Thus, the reaction of the cyclopentane iodide syn-40c with t-BuLi (−100 °C, 15 min) provided after 
iodolysis the bicyclic iodide syn-51a (63% yield, d.r.>99:1; Table 2, entry 1). Subjecting 
trans-cyclopentane iodide anti-40c to the same reaction conditions, only a negligible amount of the Li-
species cyclised to the desired product anti-51a. Uncyclised iodide (28%), hydrolysis (42%) and 
elimination product (23%) were observed as main products during the reaction. 
Alternatively, after quenching the Li-species of syn-40c with ClCO2Et, ester syn-51b was obtained in 
56% yield, d.r.>99:1 (entry 2). Similarly, the iodocyclohexane syn-40d, after treatment with t-BuLi, 
undergoes the expected carbolithiation leading to the bicyclic products syn-51c and syn-51d in 65–77% 
yield, d.r.>99:1 after iodination or quenching with methyl triflate (entry 3–4). Finally, the syn-phenyl-
substituted cyclohexyl iodide syn-40e undergoes a carbolithiation after iodine/lithium-exchange. 
Iodination at −100 °C gave syn-51e in 63% yield, d.r.>99:1 (entry 6). 
Table 2: Diastereoselective synthesis of polycyclic alkenylsilanes. 
Entry Substrate Electrophile Product [a] 
 
 
 
 
1 syn-40c I2 syn-51a 
   63%; d.r.>99:1 
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2 syn-40c ClCO2Et syn-51b 
   56%; d.r.>99:1 
 
 
 
 
3 syn-40d I2 syn-51c 
   65%; d.r.>99:1 
   
 
4 syn-40d MeOSO2CF3 syn-51d 
   77%; d.r.>99:1 
 
 
 
 
5 syn-40e I2 syn-51e 
   92%; d.r.>99:1 
[a]
 Yields refer to analytically pure products. 
 
Also, cross-coupling reactions were performed (Scheme 20). Standard carbolithiation, starting from 
rac-(2R,3R)-40a followed by a transmetalation with ZnCl2, gave the zinc reagent syn-52a, which was 
cross-coupled according to Negishi[75,76] with ethyl 4-iodobenzoate using 5 mol% Pd(OAc)2, 10 mol% 
SPhos,[77] in dimethylacetamide (DMA), affording stereoselectively the tetrasubstituted alkenylsilane 
syn-49e (84% yield, d.r.>99:1). Subjecting syn-40d to the same reaction conditions and a cross-coupling 
with 2-bromonaphthalene furnished the tetrasubstituted alkenylsilane syn-51f diastereoselectively in 
99% yield, d.r.>99:1. 
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Scheme 20: Diastereoselective cyclisation and Negishi cross-coupling. 
Carbolithiation products of type 49 were used to construct cyclopentanes bearing four fully controlled 
contiguous stereocentres. Thus, further iodination of syn-49e with N-iodosuccinimide (NIS) in 
acetonitrile provided the alkenyl iodide syn-53 (87% yield, d.r.>99:1) and subsequent Negishi cross-
coupling with MeZnCl lead to the tetrasubstituted olefin syn-54 (77% yield, d.r.>99:1). This sequence 
demonstrates that the carbolithiation products can be stereoselectively converted to silyl-free tetra-
substituted olefins. Pd-catalysed hydrogenation of syn-54 gave the syn-ester syn-55 (100% yield, 
d.r.>99:1). The structure of syn-55 was confirmed by X-ray analysis of the corresponding carboxylic 
acid syn-56, obtained after saponification (Scheme 21). 
 
Scheme 21: Diastereoselective preparation of cyclopentane syn-55 bearing four contiguous tertiary stereocentres. 
This intramolecular carbolithiation was also applied to an enantioselective synthesis (Scheme 22). After 
standard iodine/lithium-exchange on R-40f (e.r. = 98:2), transmetalation with ZnCl2 and Negishi cross-
coupling with ethyl 4-iodobenzoate, the tetrasubstituted styrene derivative R-49f was obtained in 74% 
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yield (e.r. = 95:5). Enantiomer S-40f (e.r. = 97:3) was exposed to the same reaction conditions, affording 
S-49f in 70% yield (e.r. = 96:4). 
 
Scheme 22: Enantioselective synthesis of cyclopentane derivatives R-49f and S-49f. 
Bicyclic ring systems can be build up with full stereocontrol of four contiguous centres using the 
described intramolecular carbolithiation (Scheme 23). Thus, the two alkenylsilanes syn-51f and syn-51d 
were converted with retention of configuration to the corresponding alkenyl iodides 57a and 57b using 
NIS in acetonitrile/dichloromethane at 25 °C for 2–23 h to obtain the alkenyl iodides 57a and 57b in 
75–80% yield. The relative configuration was verified by NOESY experiments. Stereoselective Negishi 
cross-coupling with methylzinc chloride and 2-naphthylzinc chloride respectively (5 mol% Pd(OAc)2, 
10 mol% SPhos, 0 °C, 2.5–4 h) provides Z-58a and E-58a in 79–88% yield (d.r.>99:1).a
I/Li-exchange of the alkenyl iodide 57b with t-BuLi at −78 °C and quenching with ethyl chloroformate 
gave ester 58b in 91% (d.r.>99:1).II Exo-hydrogenation of Z-58a and E-58a using H2 (1 atm) in the 
presence of 10 mol% Pd/C in MeOH (25 °C, 2–2.5 h) furnished the two epimeric cis-
bicyclo[4.3.0]nonanes 59 and 60 in 76–92%. The relative configuration of 59 was established by X-ray 
analysis (Figure 4). The relative configuration of 60 was verified by NOESY experiments. 
                                                     
a The relative configuration of Z-58a and E-58a was verified by NOESY experiments. 
II The relative configuration of 58b was verified by NOESY experiments. 
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Scheme 23: Preparation of cis-bicyclic[4.3.0]nonanes bearing four contiguous stereocentres. 
 Results: Intramolecular Carbolithiation Reactions 
 
20 
 
 
Figure 4: X-ray crystallographic structure of 59. 
3.4 Synthesis of Cyclohexane Derivatives 
In a next step, we tried to apply the method to the construction of six-membered ring systems. Both, 
Bailey and Negishi describe an iodine/lithium-exchange reaction of 7-iodohept-1-yne with t-BuLi in a 
mixture of hexane and Et2O at −78 °C, and a subsequent intramolecular carbolithiation, affording the 
cyclohexane derivatives at room temperature. The product was obtained in 48–50% yield. Bailey 
identified an allene formation as competitive process.[37,56] 
Applying the reaction conditions described in the literature to the secondary iodide 61a, it was not 
possible to detect the desired cyclisation product 62a (Scheme 24). Therefore, gem-dimethyl groups 
were introduced at the propargylic position of the 6-heptynyl iodide to prevent an allene formation as 
side-product, and to benefit from the Thorpe-Ingold effect.[78] In fact, it was possible to obtain 62b after 
iodine/lithium-exchange of 61b with t-BuLi (2.5 equiv., −78 °C), 6-exo-cyclisation at room temperature 
and iodination. 
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Scheme 24: Different conditions for the I/Li-exchange of secondary iodides and the intramolecular carbolithiation. 
The reaction was carried out at −100 °C for 15 min, so that an iodine/lithium-exchange could be 
performed in a diastereoselective fashion, but no cyclisation product was observed. For this reason, new 
reaction conditions need to be developed to prepared cyclic compounds diastereoselectively, which 
contain more than five carbon atoms in the ring. 
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4 Results: Intramolecular Acylation Reactions 
4.1 Introduction 
Nowadays, lots of different methods for the preparation of ketones are known. In Scheme 25, some 
synthetic pathways are shown.  
 
Scheme 25: Different methods for the preparation of aliphatic ketones. 
Ketones can be prepared by: a) oxidation of secondary alcohols,[79] b) hydrolysis of gem-dihalides,[80] c) 
hydration of alkynes,[81] d) ozonolysis of alkenes,[82] e) Brown hydroboration, followed by oxidation,[83] 
f) reaction of Grignard reagents with nitriles, followed by hydrolysis,[84] g) acylation of organocadmium 
or organocopper with acid chlorides,[85,86] h) organolithiums or Grignard reagents with Weinreb 
amides[87] and i) a Fukuyama coupling.[88] 
Ketones are present in different drugs, such as Unoprostone,[89] Megestrol acetate[90] and Oxycodone,[91] 
and are important intermediates in natural product synthesis because they can be further transformed 
into different functional groups. 
Recently, a method for the preparation of unstabilised, secondary alkyllithiums was developed by 
Knochel et al. Unfortunately, acylation reactions afforded, even after transmetalation to copper, the 
desired ketones only in moderate yields and with a significant loss of diastereoselectivity.[18–20,57,92] 
Therefore, we developed a method for the stereoselective synthesis of ketones based on Barbier-type 
conditions starting from easily accessible diols. To the best of our knowledge, only primary halides have 
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been used so far. The method was applied to stereodefined, secondary alkyl iodides, so two stereocentres 
could be controlled at once. 
4.2 Intramolecular Acylation Reactions of Unstabilised Secondary Alkyllithiums 
For the synthesis of the starting material, the two diastereoisomers of hexane-2,5-diol 63 were separated 
using the method described by Kazlauskas.[93] Afterwards, the secondary iodoesters of type 64 were 
prepared by esterification of alcohol 63 with different acyl chlorides to form esters of type 65 (70–97% 
yield, >99% retention).III Performing an iodination under Appel-type conditions[62,63] gave the desired 
iodides 64a–e with inversion of the configuration (50–98% yield, >88% retention). 
 
Scheme 26: Preparation of iodoesters 64 from the corresponding alcohols 63. 
                                                     
III The percentage of the racemisation was calculated in the following way: 
[d.r.(starting ŵaterialͿ−d.r.;productͿ]/[d.r.;startiŶg ŵaterialͿ]. 
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In the next step, iodide syn-64a was subjected to t-BuLi (2.5 equiv., inverse addition) in hexane:diethyl 
ether (3:1) at –100 °C for 15 min and then stirred at −50 °C for 45 min. As expected, an iodine/lithium-
exchange occurred and the t-BuLi did not directly attack the ester group of the molecule, indicating the 
high speed of the exchange reaction of the iodide by t-BuLi.[94] After formation of the lithium 
species syn-66a, a [1,5]-migration of the acyl-group was observed, and the resulting ketone syn-67a was 
obtained after an aqueous quench in 39% yield and d.r. = 96:4 (Scheme 27). 
 
Scheme 27: I/Li-exchange of iodide syn-64a and subsequent intramolecular transfer of the acyl group gave ketone syn-67a. 
After 15 d, lactol syn-68a was observed by NMR. 
However, after 15 d in the fridge, ketone syn-67a was partly converted to lactol syn-68a by an 
intramolecular nucleophilic addition of the remaining hydroxyl group to the carbonyl group. This 
transformation was detected by NMR-analysis. The carbonyl signal of the keto-group was shifted in the 
13C-spectrum from 204.4 ppm to 104.9 ppm, where hemiacetals can be found. For that reason, all 
alcohols of type 67 were directly protected with a TBS-group after the reaction sequence. 
Changing the solvent system from hexane:diethyl ether (3:1) to pure diethyl ether allowed the 
completion of the reaction at −100 °C within 5 min and a full retention of the configuration. Thus, TBS-
protected ketone anti-69a was obtained in 81% yield and d.r.>99:1. Subjecting syn-64a (d.r. >99:1) to 
the same reaction condition afforded syn-69a in 42% yield, d.r.>99:1 (Scheme 28). 
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Scheme 28: Preparation of ketones anti-69a and syn-69a via I/Li-exchange. 
The reaction sequence was extended to other starting materials as shown in Table 3. The cyclohexyl-
derivatives syn-64b (d.r. = 87:13) and anti-64b (d.r.>99:1) gave, after iodine/lithium-exchange and 
TBS-protection, syn-69b (d.r. = 90:10) and anti-69b (d.r. = 92:8) in 34–64% yield. i-Propyliodoesters 
syn-64c (d.r.>99:1) and anti-64c (d.r. = 92:8) gave under standard conditions syn-69c (d.r.>99:1) and 
anti-69c (d.r. = 90:10) in 47–50% yield. The stereoselective performance of an iodine/lithium-exchange 
and subsequent intramolecular acylation on syn-64d (d.r. = 93:7) and anti-64d (d.r.>99:1), respectively, 
produced syn-69d (d.r. = 91:9) and anti-69d in 20–39% yield (d.r. = 98:2). Also, the heterocyclic 
iodoesters syn-64e (d.r.>99:1) and anti-64e (d.r.>99:1) were used under standard conditions to afford 
ketones syn-69e (d.r>99:1) and anti-69e in 21–38% yield (d.r.>99:1). 
Table 3: Products obtained after I/Li-exchange and intramolecular transfer of the acyl group. 
 
Entry Starting Material Product [a] 
 
 
 
1 syn-64b syn-69b 
 d.r. = 87:13 34%, d.r. = 90:10 
 
 
 
2 anti-64b anti-69b 
 d.r.>99:1 64%, d.r. = 92:8 
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3 syn-64c syn-69c 
 d.r.>99:1 50%, d.r.>99:1 
 
 
 
4 anti-64c anti-69c 
 d.r. = 92:8 47%, d.r. = 90:10 
 
 
 
5 syn-64d syn-69d 
 d.r. = 93:7 20%, d.r. = 91:9 
 
 
 
6 anti-64d anti-69d 
 d.r.>99:1 39%, d.r. = 98:2 
 
 
 
7 syn-64e syn-69e 
 d.r.>99:1 38%, d.r.>99:1 
 
 
 
8 anti-64e anti-69e 
 d.r.>99:1 21%, d.r.>99:1 
[a]
 Yields refer to analytically pure products. 
 
Overall, a higher yield was observed for the anti-diastereomers of type 69 compared to the syn-
diastereomers. Therefore, a cyclic transition state, as shown in Scheme 29, is proposed for the 
mechanism of this reaction. Considering the structure of the anti-diastereomer anti-70, all substituents 
are in an equatorial position, while in the transition state of the syn-diastereomer syn-70, only one methyl 
group is equatorial, the other is pointing axial. 
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Scheme 29: Proposed mechanism including a cyclic transition state. 
In summary, a useful method for the preparation of stereodefined alkyl ketones is described starting 
from diols that are easily accessible. After an iodine/lithium-exchange, and following transfer of the 
acyl group via a cyclic transition state, ketones 69a–e were obtained in 21–81% yield and with high 
stereoretention >93%. 
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5 Summary and Outlook 
Part I of this work focused on the diastereoselective preparation of secondary, unstabilised Li-
compounds via an iodine/lithium-exchange at −100 °C using t-BuLi (inverse addition, 2.5 equiv.) and 
their application in intramolecular carbolithiation and acylation reactions. 
The first topic dealt with the synthesis of various stereodefined cyclopentane derivatives. First, the 
stereodefined Li-species were generated by iodine/lithium-exchange of secondary iodides bearing an 
internal alkylidynesilane-moiety. An intramolecular carbolithiation afforded the exo-alkylidene 
cyclopentane, related cis-bicyclo[3.3.0]octane and cis-bicyclo[4.3.0]nonane derivatives in excellent 
diastereoselectivity. The iodine/lithium-exchange was also carried out in an enantioselective fashion, 
demonstrating a high potential for enantiomeric syntheses. The remaining silane-moiety was 
successfully transformed into an alkyl group or an iodide, which was further modified. This gave the 
opportunity to construct up to four contiguous stereocentres in cyclopentanes, as well as in bicyclic ring 
structures (Scheme 30). 
 
Scheme 30: Example for the preparation of an exo-alkylidene cyclopentane bearing four contiguous stereocentres. 
Further applications of these intramolecular carbolithiations in natural product synthesis need to be 
investigated. 
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An approach toward the stereoselective synthesis of ketones via an intramolecular acylation reaction 
was developed. Thus, various stereodefined organolithiums were prepared from stereodefined 
secondary iodoesters. The inverse addition of t-BuLi (2.5 equiv.) at −100 °C in diethyl ether triggered 
the iodine/lithium-exchange. The formed Li-reagents undergo a fast transfer of the acyl group, and 
different ketones were obtained, which were isolated after protection of the remaining alcohol group 
(Scheme 31). 
 
Scheme 31: Diastereoselective acyl-transfer after an I/Li-exchange with t-BuLi. 
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6 Introduction 
6.1 Organomagnesium Reagents 
Organomagnesium compounds play an important role in organic syntheses and organometallic 
chemistry.[95] In 1900, Victor Grignard did pioneering work on their synthesis and their broad range of 
applications. His discovery was honoured with the Nobel Prize in 1912.[96,97] Grignard reagents are 
sensitive towards air and moisture, requiring careful handling. A common method for the preparation of 
these reactive magnesium species is the oxidative addition of magnesium into an organohalide bond. 
This direct insertion can be performed with magnesium turnings, with activated metals, such as Rieke 
magnesium[98–102] or in the presence of lithium chloride.[103] Another possibility are metalation reactions 
with magnesium amides such as TMPMg·LiCl and (TMP)2Mg, as reported by Knochel[104] and 
Eaton.[105] Alternatively, a halogen/magnesium-exchange can be performed. The first example of a 
bromine/magnesium-exchange reaction was reported in 1931 by Prévost.[106] The exchange reaction is 
an equilibrium process, in which the more stable organomagnesium compound is formed.[95] A 
commonly used exchange reagent is i-PrMgCl·LiCl (Turbo-Grignard) developed by Knochel et al.[107] 
It turned out that the lithium salt significantly accelerates the bromine/magnesium-exchange.  
Only few methods have been reported, in which other than ethereal solvents, such as diethyl ether or 
THF, have been used. The preparation of dialkylmagnesium species with long alkyl chains has been 
described in hydrocarbon solvents.[108] Hevia et al.[109] reported potassium-alkylmagnesiates 
(KMg(CH2SiMe3)3), which were prepared in hexane and benzene. They can act as a new base for the 
synthesis of potassium arylmagnesiates in hexane.  
Knochel et al.[110] developed the new magnesium reagents s-BuMgOCH2CH(Et)Bu· 
LiOCH2CH(Et)Bu (71a) and s-Bu2Mg·2LiOCH2CH(Et)Bu (71b). Those reagents are prepared in 
toluene and can be used for bromine/magnesium- and chlorine/magnesium-exchanges using TMEDA 
(N,N,N′,N′-tetramethylethylenediamine) or PMDTA (N,N,N′,N′′,N′′-pentamethyldiethylenetriamine) as 
an additive. Treating bromide 72 with s-BuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (71a) in the presence 
of TMEDA and reaction of the Mg-species with morpholino(phenyl)methanone furnished the desired 
product 73 in 75% yield. After a chlorine/magnesium-exchange of 74 with 
s-Bu2Mg·2LiOCH2CH(Et)Bu (71b) and PMDTA and allylation with allyl bromide in the presence of 
copper(I)iodide, the allylated product 75 was isolated in 75% yield (Scheme 32).[110–112] 
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Scheme 32: Br/Mg- and Cl/Mg-exchange with the new Mg-reagents 71a and 71b in toluene. R = CH2CH(Et)Bu. 
6.2 Arylthio/Metal-Exchange 
6.2.1 Lithiation with Butyllithium 
Already in 1967, Arens[113] and Seebach[114] described the carbanion formation 76, while treating 
tetrakis(phenylthio)methane (77) with n-butyllithium. Such a sulfur-exchange was also described later 
by Cohen,[115] who converted cyclopropanone dithioketals (79) into 1-lithio-1-(phenylthio)cyclo-
propanes (80) using t-BuLi (Scheme 33). 
 
 Scheme 33: ArS/Li-exchange using butyllithium.  
Knochel et al.[116] used s-BuLi for the stereoselective synthesis of tetrasubstituted alkene via a 
sulfur/lithium-exchange. Bromothioether 81 was treated with s-BuLi forming Li-species 82. The 
alkenyllithium 83 was then reacted with various electrophiles (Scheme 34).  
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Scheme 34: Preparation of the alkenyllithium 83 by an intramolecular S/Li-exchange. 
This methodology was originally developed for the synthesis of functionalised benzylic magnesium 
reagents. In this case, an iodothioether 84 was used instead of the bromothioether 81. Therefore, it was 
possible to perform an iodine/magnesium-exchange at −50 to −15 °C first, followed by the 
intramolecular sulfur/magnesium-exchange, triggered by t-BuOLi at −20 °C, affording the desired 
benzylic magnesium species 85.[117] 
 
Scheme 35: Preparation of benzylic magnesium derivatives 85 by an intramolecular S/Mg-exchange. 
6.2.2 Reductive Lithiation and Magnesiation 
Besides sulfur-exchanges using BuLi, reductive metalation can be used. A single-electron transfer (SET) 
with Li-metal or arene radical anions such as LiDTBB, LDMAN and lithium naphthalenide can trigger 
the reductive cleavage of the C-S bond. These radical anions are highly reactive and can react as 
reductant or as base. Considering the mechanism (Scheme 36), the arene radical anion transfers an 
electron to the phenyl thioether I generating a highly reactive radical anion II and the arene, which 
regenerated the arene radical anion in the presence of an excess of lithium. II dissociates to the alkyl 
radical III and lithium phenylthiolate. After a second electron transfer the desired lithium compound IV 
can be obtained and used in further reactions.[51] 
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Scheme 36: Mechanism for the S/Li-exchange via reductive lithiation. 
The first preparation of an α-functionalised organolithium by reductive lithiation was carried out by 
Cohen et al.[118] in 1978 on cyclopropane dithioketal of type 88 (Scheme 37, eq. 1). Treating 88 with 
lithium naphthalenide (2.0 equiv.)  in THF at −70 °C afforded the sulfur-stabilised cyclopropyl-
lithium 89, which could be trapped with various electrophiles. At the same time Screttas and Micha-
Screttas performed a comparable cleavage on n-BuCH(SPh)2 (91) (Scheme 37, eq. 2).[119,120] 
 
Scheme 37: Reductive lithiation by Cohen (eq. 1), and Screttas and Micha-Screttas (eq. 2). 
Furthermore, α-lithio cyclic ethers and amines can be prepared by reductive lithiation. Beak[121] reported 
that N-Boc 3-hydroxypiperidine does not undergo lithiation at C-2 or C-6. Later, Gallagher et al.[122] 
were able to achieve the Li-species by reductive lithiation. First, they generated the corresponding 
alkoxide 93 by adding n-BuLi to thioether 94, followed by the addition of lithium naphthalenide 
(4.0 equiv.). After allylation, the desired product 95 was obtained in 60% yield, cis:trans = 1:3.3 
(Scheme 38). 
 
Scheme 38: C(6)-allylation of 3-hydroxypiperidine by reductive lithiation. 
The large excess of lithium naphthalenide limits the variety of electrophiles.[122] In 2009, Zheng et al.[123] 
extended this procedure to the synthesis of 3-piperidinol N-α-carbanions.  
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Pioneer work on reductive magnesiation was carried out by Maercker.[124] He reported that 
allylmagnesiums can be generated by refluxing allyl phenyl sulfides in THF with magnesium powder, 
which was activated by treating it with 1,2-dibromoethane or iodine. Cheng et al.,[125] used a mixture of 
magnesium powder with 10 mol% of 1,2-dibromoethane and 1.0 equiv. of anthracene in THF and 
sonicated the mixture for 4 h. Afterwards, the allyl phenyl sulfide 96 was added, the reaction mixture 
was heated to 65 °C for 16 h, and subsequent addition of the electrophile yielded product 97 in 87% 
yield (Scheme 39). 
 
Scheme 39: Preparation of an allylmagnesium compound by reductive magnesiation of allyl phenyl sulfide 96 and 
subsequent carbomagnesiation. 
6.2.3 Arylthio/Metal-Exchange Alpha to a Nitrile 
Metalated nitriles are readily prepared by an arylthio/metal-exchange. Compared with a sulfoxide/metal-
exchange, a sulfide/metal-exchange requires more reactive organometallics.[126] α-Metalated nitriles are 
powerful nucleophiles due to the small cylindric diameter of the cyano-group and the high charge 
density at the formally anionic carbon. The generated metalated alkyl nitriles are largely stabilised by 
inductive electron withdrawal rather than through resonance.[126–129] The arylthio/metal-exchange can be 
achieved by the addition of n-BuLi, i-PrMgCl, Bu3MgLi, Et2ZnBuLi or Me2CuLi. Reaction with various 
electrophiles afforded the desired quaternary nitriles (e.g. 98, 99, 100) (Scheme 40).[129] The use of 
i-PrMgCl, Bu3MgLi, Et2ZnBuLi or Me2CuLi was only possible using a 2-pyridylthioalkanenitrile (e.g. 
102) or a 2-methoxyphenylthioalkannitrile.[126,129,130] 
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Scheme 40: Sequential ArS/M-exchange and trapping with electrophiles. 
Performing an exchange of cyclohexane derivative 103 with n-BuLi or Bu3MgLi affords a three-
coordinated sulfidate 104 as the predominant solution species. Mechanistic studies identified an 
equilibrium with 105 as reactive species, which is consistent with the loss of the stereochemically 
defined arylthio nitriles (Scheme 41).[126,129] 
 
Scheme 41: Mechanism of the ArS/Li-exchange. 
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7 Project Outline 
Arylthio/metal-exchanges are less represented in literature than the corresponding halogen/metal-
exchanges. Thioethers are stable compounds, but it is therefore a more challenging task to replace them 
with a metal. 
However, a method should be developed to perform an arylthio/metal-exchange (Scheme 42). 
 
Scheme 42: S/M-exchange on Boc-protected piperidine. 
N-Boc-Piperidine was chosen as a model compound because the Boc-group might coordinate the metal 
and would therefore stabilise the metal species. Quenching with different electrophiles would allow us 
to explore the scope of this methodology. 
Furthermore, the use of thioethers containing a second substituent at the piperidine ring should allow us 
to study the stereochemical behaviour during this reaction (Scheme 43). 
 
Scheme 43: Stereochemical behaviour during the reaction. 
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8 Results: A New Arylthio/Magnesium-Exchange 
8.1 Introduction 
Thioethers are stable compounds, making them a more challenging task in exchange reactions. 
Reductive lithiation is a common method used in the literature to prepare lithiated species of 
arylthioethers.[51,119,120,122,123,131] 
8.2 Optimisation of the Reaction Conditions 
Taking up this challenge, thioether 106a has been prepared starting from piperidine 107a. First, the 
amine was protected using Boc2O (quant.). In a second step, the thiophenyl group was introduced by 
deprotonation of the α-position of 108a using s-BuLi and TMEDA in diethyl ether. After deprotonation 
at −78 °C for 3 h, the lithiated species was reacted with diphenyl disulfide (73% yield). 
 
Scheme 44: Preparation of thioether 106a from piperidine 107a. 
First, various reaction conditions were tested to find out which organometallic reagent would allow a 
smooth thiophenol/metal-exchange on thioether 106a (Table 4). The reactions were monitored by GC 
using undecane as internal standard. Adding n-BuLi in THF at −78 °C to 106a afforded piperidine 110a 
(R = n-Bu) in 58% (entry 1). Changing the metal reagent to s-BuLi reduced the amount of 110a 
(R = s-Bu) to 4%, but other unidentified products appeared in 22% (entry 2). t-BuLi in Et2O at −78 °C 
showed besides starting material 106a, piperidine 110a (R = t-Bu) and other side products in 57%, 35% 
and 4% respectively, also 4% of the desired hydrolysis product 108a (entry 3). No reaction could be 
observed using Mg-based metal reagents such as Turbo-Grignard (i-PrMgCl·LiCl), n-BuMgCl·LiCl or 
n-Bu2Mg in THF at room temperature (entries 4–6). Using the more reactive magnesiate n-Bu3Mg·2LiCl 
afforded 110a (R = n-Bu) in 68%, but no hydrolysis product 108a was observed (entry 7). Also using 
the lanthanum species Bu2LaMe only afforded 110a (R = n-Bu 53%; R = Me 17%; entry 8). Using the 
exchange reagent s-BuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (71a, 1.2 equiv.) and TMEDA 
(1.2 equiv.) in the apolar solvent toluene at room temperature gave the desired product 108a in 36%, 
remaining starting material 106a in 49%, and 10% of 110a (R = s-Bu) (entry 9). 
Table 4: Screening of different organometallic reagents to perform a SPh/M-exchange on thioether 106a. 
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Entry Reagent Solvent Temperature Observation after 1 h[a] 
1 n-BuLi (1.2 equiv.) THF −78 °C 106a (62%), 110a (58%) 
2 s-BuLi (1.2 equiv.) THF −78 °C 106a (74%), 110a (4%), others (22%) 
3 t-BuLi (1.2 equiv.) Et2O −78 °C 108a (4%), 106a (57%), 110a (35%), 
    others (4%) 
4 i-PrMgCl·LiCl (1.2 equiv.) THF rt no reaction 
5 n-BuMgCl·LiCl (1.2 equiv.) THF rt no reaction 
6 n-Bu2Mg (1.2 equiv.) THF rt no reaction 
7 n-Bu3MgLi·LiCl (1.2 equiv.) THF rt 106a (32%), 110a (68%) 
8 Bu2LaMe (0.7 equiv.) THF −30 °C 106a (30%), 110a (Me: 17%; n-Bu 53%) 
9 s-BuMgOR·LiOR 71a (1.2 equiv.), toluene rt 108a (36%), 106a (49%), 110a (10%),  
 TMEDA (1.2 equiv.)   others (5%) 
R = CH2CH(Et)Bu; [a] Yields were obtained by GC-analysis. 
 
Knochel et al. recently developed the preparation of Grignard reagents of type 
s-BuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (71a) and s-Bu2Mg·2LiOCH2CH(Et)Bu (71b) in toluene. 
These Grignard reagents are of high interest to industry due to new reactivities in apolar solvents, as 
well as for ecological reasons and improved water extraction processes during the work-up.[110–112] 
To determine the optimum reaction conditions for performing a thiophenol/magnesium-exchange using 
the magnesium reagent s-BuMgOR·LiOR 71a (R = CH2CH(Et)Bu) in toluene, the exchange rate of 
thioether 106a was examined, which goes on to provide the corresponding Grignard reagent 109a under 
various conditions (Table 5). First, magnesium alkoxide MgOCH2CH(Et)Bu (1.2 equiv.) and TMEDA 
(1.2 equiv.) were used, but no reaction was observed even after 6 h (entry 1). However, using 
s-BuMgOR·LiOR (71a, 1.2 equiv.) and TMEDA (1.2 equiv.) led to a conversion of 60%, and the 
desired product 108a was observed in 45% yield (entry 2). In the absence of TMEDA, no product 
formation was detected. Only the alkylated piperidine derivative was observed in 36% yield (entry 3). 
Increasing the equivalents of exchange reagent 71a and TMEDA to 3.0 equiv., a higher conversion 
(82%) of the starting material 106a was observed, however the desired product was afforded in only 
41% yield (entry 5). Adding s-BuMgOR·LiOR (71a, 3.0 equiv.) via a syringe pump (0.05 mL/min) to 
106a was shown to be crucial leading to 108a in 71% (entry 6). 
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Table 5: Screening of different conditions to perform a SPh/M-exchange in thioether 106a using 
s-BuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu. 
 
Entry Reagent TMEDA (equiv.) Observation after 6 h[a] 
1 MgOR (1.2 equiv.) 1.2 no reaction 
2 s-BuMgOR·LiOR (1.2 equiv) 1.2 108a (45%), 106a (40%), others (15%) 
3 s-BuMgOR·LiOR (1.2 equiv.) – 106a (64%), others (36%) 
4 s-BuMgOR·LiOR (3.0 equiv.) 3.0 108a (41%), 106a (18%), others (41%) 
5 s-BuMgOR·LiOR (3.0 equiv.)[b] 3.0 108a (71%), 106a (18%), others (11%) 
[a]
 Yields were obtained by GC-analysis. [b] Addition of s-BuMgOR·LiOR via syringe pump (0.05 mL/min). 
 
Also, the behaviour of different thioethers has been studied. Thioethers 106b–d have been prepared by 
deprotonation of Boc-protected piperidine (108a) with s-BuLi at –78 °C, and quenching with the 
appropriate disulfide or thiosulfonate. Thioethers 106b–d were treated with the two exchange reagents 
s-BuMgOR·LiOR (71a) and s-Bu2Mg·2LiOR (71b) to find the optimal thiolate-residue for this 
exchange reaction (Table 6). Subjecting the Me-thiolate 106b to s-BuMgOR·LiOR (71a, 3.0 equiv.), 
the reaction showed a lower conversion compared to the Ph-thiolate derivative 106a (Table 6, entry 1). 
Introduction of an electron-donating group, like OMe, to the phenyl ring leads to 57% of the desired 
hydrolysis product 108a with s-BuMgOR·LiOR (71a, 3.0 equiv.) (entry 2). Using s-Bu2Mg· 
2LiOR (71b, 1.5 equiv.) as exchange reagent in combination with TMEDA (3.0 equiv.) afforded 44% 
of the desired product 108a and 30% of side products (entry 3). PMDTA (1.5 equiv.) as additive 
favoured the formation of side products (62%) in comparison to 108a (6%, entry 4). Changing the 
thiolate residue to 4-fluorobenzene, lowered the yield of the desired product 108a to 38% using 
s-BuMgOR·LiOR (71a) and TMEDA (entry 5). Surprisingly, the reaction with s-Bu2Mg· 
2LiOCH2CH(Et)Bu (71b, 1.5 equiv.) and TMEDA (3.0 equiv.) furnished 70% of the hydrolysis 
product 108a and only 8% of side products were detected (entry 6). Using PMDTA (1.5 equiv.) as 
additive again favoured the formation of side products (65%) compared to 108a (5%, entry 7). 
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Table 6: Screening of different thioethers to perform a SR/Mg-exchange in toluene and subsequent hydrolysis. 
 
Entry R =  Reagent[a] Additive Observation after 6 h 
1 Me s-BuMgOR·LiOR 71a TMEDA 108a (49%), 106a (51%) 
 
106b (3.0 equiv.) (3.0 equiv.)  
2 
 
s-BuMgOR·LiOR 71a TMEDA 108a (57%), 106a (43%) 
 
106c (3.0 equiv.) (3.0 equiv.)  
3  s-Bu2Mg·2LiOR 71b TMEDA 108a (44%), 106a (26%), others (30%) 
  (1.5 equiv.) (3.0 equiv.)  
4  s-Bu2Mg·2LiOR 71b PMDTA 108a (6%), 106a (32%), others (62%) 
  (1.5 equiv.) (1.5 equiv.)  
5 
 
s-BuMgOR·LiOR 71a TMEDA 108a (38%), 106a (62%) 
 
106d (3.0 equiv.) (3.0 equiv.)  
6  s-Bu2Mg·2LiOR 71b TMEDA 108a (70%), 106a (22%), others (8%) 
  (1.5 equiv.) (3.0 equiv.)  
7  s-Bu2Mg·2LiOR 71b PMDTA 108a (5%), 106a (30%), others (65%) 
  (1.5 equiv.) (1.5 equiv.)  
[a]
 Addition of exchange reagent via syringe pump (0.05 mL/min). 
 
8.3 Reaction with Electrophiles 
With optimised conditions in hand (s-BuMgOR·LiOR (71a, 3.0 equiv.) and TMEDA (3.0 equiv.), rt, 
6 h), magnesium species 109a was reacted with various electrophiles. After hydrolysis, N-Boc 
piperidine (108a) was isolated in 79% yield. Deuterolysis afforded the desired product 110b in 70% 
yield. The deuterated amount of the material, determined by 1H-NMR, was >97%. Direct quenching of 
the magnesium species 109a with S-methyl phenylthiosulfonate gave thioether 106b in 85% yield. Also, 
an allylation reaction with allyl bromide in the presence of CuCN·2LiCl[132] was performed, and the 
allylated product 110c was obtained in 52%. Reducing the metalation time to 2 h, afforded product 110c 
only in 34%. 
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After exchange of the phenyl thiolate of 106a, transmetalation of the magnesium species 109a with 
ZnCl2 and Negishi cross-coupling with 4-iodoanisole, Pd(dba)2 (5 mol%) and SPhos (10 mol%) 
afforded the cross-coupling product 110d in 25% yield. 
Table 7: Products obtained after SPh/Mg-exchange of thioether 106a. 
 
Entry Electrophile Product [a] 
  
 
1 H2O 108a; 79% 
  
 
2 AcOD/D2O 110b; 70% 
  
 
3 MeSSO2Ph 106b; 85% 
  
 
4 allyl bromide 110c; 52%[b] 
  
 
5 4-iodoanisole 110d; 25%[c] 
[a]
 Yields refer to analytically pure products. [b] In the
presence of CuCN·2LiCl (0.30 equiv.). [c] After trans-
metalation with ZnCl2 and with Pd(dba)2 (5 mol%), SPhos
(10 mol%). 
 
In the next step, t-butyl syn-4-methyl-2-(phenylthio)piperidine-1-carboxylate (111) was used as starting 
material to perform the developed thiophenol/magnesium-exchange reaction. The synthesis of 
thioether  111 was carried out in a similar way as for the other thioethers before in 72% yield (d.r.>99:1) 
over two steps. The optimal exchange reaction time with s-BuMgOR·LiOR (71a, 3.0 equiv.) and 
TMEDA (3.0 equiv.) was discovered to be 4 h at room temperature (82% conversion). 
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Scheme 45: SPh/Mg-exchange reaction of thioether 111 using s-BuMgOR·LiOR (71a) and TMEDA. 
To our delight, subjecting this thioether 111 to standard thiophenol/magnesium-exchange conditions 
with s-BuMgOR·LiOR (71a) in combination with TMEDA and subsequent copper-catalysed allylation 
reaction with allyl bromide, only the syn-isomer of the allylated product 112a was obtained in 83% yield 
(Scheme 45). Performing an allylation reaction of magnesium species 109b with 3-bromocyclohexene 
and CuCN·2LiCl provided the allylated product 112b in 78% yield and d.r. = 74:26. After reaction of 
109b with 4-fluorobenzoyl chloride in the presence of CuCN·2LiCl (0.3 equiv.), the acylated 
product 112c was obtained in 46% (d.r.>99:1). X-ray crystallographic analysis confirmed the syn-
relative stereochemistry (Figure 5). 
 
Figure 5: X-ray crystallographic structure of the acyl compound 112c. 
Transmetalation of 109b with ZnCl2 and following Negishi cross-coupling with 4-iodoanisole, Pd(dba)2 
(5 mol%) and SPhos (10 mol%) furnished cross-coupling product 112d in 32% yield and d.r.>99:1 
(Scheme 45). 
Further studies of the thiophenol/magnesium-exchange on different heteroatom-substituted alkanes and 
the extension of the electrophile scope are under investigation in our laboratories.  
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9 Summary and Outlook 
The second part of this work focused on the development of a new sulfur/metal-exchange on piperidyl 
thioethers. Treating piperidyl thioether 106a and 111 with s-BuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu 
(71a) in toluene at room temperature produced the desired magnesium species 109. After reaction with 
different electrophiles the desired products were obtained. If a second residue is present in the piperidyl 
ring only the thermodynamic product is formed after quenching with electrophiles (Scheme 46). 
 
Scheme 46: Treatment of thioethers with s-BuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu 71a in the presence of TMEDA and 
reaction with different electrophiles. 
In further studies, the mechanism of this reaction should be examined. The scope of various electrophiles 
need to be extended and a thorough screening of reaction conditions will be required for the realization 
of such an exchange on other hetero-substituted cycloalkanes such as pyrrolidine and tetrahydropyranes. 
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10 General Information 
All air-sensitive experiments were carried out under an argon atmosphere sealed with rubber septa. All 
glassware was flame-dried prior to use. Air and moisture-sensitive liquids were transferred via syringe 
which were purged with argon prior to use. Low temperature reactions were carried out in Dewar vessel 
filled with cooling agentsμ methanol/liquid nitrogen (−100 °C), acetone/dry ice (−78 °C), water/ice 
(0 °C) or using a HUBER T100 cryostat. Reaction temperatures above 23 °C were carried out in an oil 
bath. The reactions were monitored by GC, NMR spectroscopy or analytical thin-layer chromatography 
(TLC), using aluminium plates precoated with silica gel (Merck 60, F-254). The TLC-plates were 
visualised by exposure to ultraviolet light (UV) and/or stained with one of the solutions given below 
followed by heating with a heat gun: 
Phosphomolybdic Acid (PMA): phosphomolybdic acid (10 g) in 100 mL absolute ethanol 
Potassium Permanganate: KMnO4 (3 g), K2CO3 (20 g), KOH (1.3 g) in 300 mL water 
Ninhydrin: ninhydrin (750 mg) in 250 mL absolute ethanol and 25 mL acetic acid 
Flash-column chromatography was performed using silica gel 60 SiO2, 0.040–0.063 mm, 230–400 
mesh ASTM) from Merck. Yields refer to chromatographically and spectroscopically (1H and 13C 
NMR) pure material. 
Solvents and Reagents 
Solvents were dried according to standard procedures by distillation over drying agents and stored under 
argon. Dichloromethane was predried over calcium chloride and distilled from calcium hydride. Diethyl 
ether was predried over calcium chloride and passed through activated aluminium oxide (solvent 
purification system SPS-400-2 from Innovative Technologies Inc.). Tetrahydrofuran (THF) was 
continuously refluxed and freshly distilled from sodium benzophenone ketyl under nitrogen and stored 
over molecular sieves. All other reagents and solvents were purchased from chemical suppliers (Sigma‐
Aldrich, Acros Organics, Alfa Aesar, ABCR, FluoroChem, TCI Europe) and used without further 
purification. Solvents for crystallisation and flash-column chromatography were purchased in technical 
grade and distilled under reduced pressure prior to use. Organomagnesium reagents were titrated against 
iodine in THF.[133] Organolithium reagents were titrated against isopropanol using 1,10-phenanthroline 
as indicator in THF or Et2O.[134] 
ZnCl2 solution (1.0 M in THF) was prepared by drying ZnCl2 (27.3 g, 200 mmol) in a Schlenk-flask 
under vacuum at 150 °C for 5 h. After cooling to 25 °C, dry THF (200 mL) was added and the solution 
was stirred until the salts were dissolved. 
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CuCN∙2LiCl[132] solution (1.0 M in THF) was prepared by drying CuCN (8.96 g, 100 mmol) and LiCl 
(8.48 g, 200 mmol) in a Schlenk-flask under vacuum for 5 h at 150 °C. After cooling to 25 °C, dry THF 
(100 mL) was added and the solution was stirred until the salts were dissolved. 
Analytics 
NMR spectra were recorded on a Bruker Avance III HD 800 MHz spectrometer equipped with a 
CryoProbeTM, Bruker Avance III HD 400 MHz spectrometer equipped with a CryoProbeTM, Bruker 
AXR300, Varian VXR400 S and Bruker AMX600 spectrometers operating at 800 MHz, 400 MHz, 
300 MHz, 400 MHz and 600 MHz for proton nuclei (200 MHz, 100 MHz, 75 MHz, 100 MHz, 
150 MHz for carbon nuclei), respectively. Proton chemical shifts were reported as δ values in ppm and 
are referenced to residual protium in the NMR solvent (CHCl3: δ 7.26, C6HD5 7.16). Carbon chemical 
shifts were reported as δ values in ppm and are referenced to the carbon resonance of the NMR solvent 
(CDCl3: δ 77.16, C6D6 128.06). Abbreviations for signal coupling are as follows: s singlet, d doublet, t 
triplet, q quartet, quint quintet, h hextet, hept heptet, m multiplet as well as br broad. The specified 
multiplicities of the signals correspond to the observed ones and not the theoretical ones. In addition to 
1H and 13C NMR measurements, 2D NMR techniques such as homonuclear correlation spectroscopy 
(COSY), heteronuclear single quantum coherence (HSQC) and heteronuclear multiple bond coherence 
(HMBC) were used to assist signal assignment. For further elucidation of 3D structures of the product, 
nuclear Overhauser enhancement spectroscopy (NOESY) was conducted. 
All high-resolution mass spectra (HR-MS) were measured by the analytic section of the Department of 
Chemistry, Ludwig-Maximilians-Universität München. High resolution electron impact ionization (EI) 
and low resolution (MS) spectra were recorded on a Finnigan MAT 95Q or Finnigan MAT 90 
instrument. EI was conducted with an electron energy of 70 eV. Electrospray ionization (ESI) spectra 
were recorded on a Finnigan LTQ FTICR instrument. 
Gas chromatography (GC) was performed on machines of the types Hewlett-Packard 6890 or 5890 
Series II, and Agilent Technologies 7890A (Hewlett Packard, 5% phenylmethylpolysiloxane; length: 15 
m, diameterμ 0.25 mm; film thicknessμ 0.25 ȝm). 
Infrared spectra (IR) were recorded from 4500 cm−1 to 650 cm−1 on a PERKIN ELMER Spectrum BX 
II FT-IR instrument. For detection a Smiths Detection DuraSample IR II Diamond ATR sensor was 
used. The absorption bands are reported in wavenumbers (cm−1). 
Enantiomeric ratios (e.r.) of the compounds were measured on chiral GC using a Supelco-ߚ-DEX 120 
column. Optical rotation values were recorded on an Anton Paar MCP 200 polarimeter. The specific 
rotation is calculated as follows: 
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[ߙ]�� = ߙߚ ∙ � ߙ: recorded optical rotation ߚ: concentration of the analyte in 10 mg/mL �: length of the cuvette in dm �: measuring temperature in °C �: wave length in nm 
The respective concentration and the solvent are given in the analytical part of the experimental 
description. 
Melting points (m.p.) were determined on a BÜCHI B-540 apparatus and are uncorrected. 
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11 Experimental Section Part I: Intramolecular Carbolithiation 
Reactions 
Typical Procedure (TP1) for the Epoxide Opening Using Grignard Reagents 
A dry and argon-flushed Schlenk-flask was charged with CuI (10 mol%) and dry diethyl ether (0.1 M), 
followed by the dropwise addition of the respective alkyl Grignard reagent (1.1 equiv.) at 0 °C. Then, 
the appropriate epoxide (1.0 equiv.) was added dropwise at 0 °C. After warming to room temperature, 
the reaction was stirred for 16 h. Saturated aqueous NH4Cl solution was added, the phases were 
separated and the aqueous phase was extracted with diethyl ether. The combined organic layers were 
dried over MgSO4. The solvents were evaporated and the crude residue was subjected to column 
chromatography purification on silica yielding the respective title compound. 
Typical Procedure (TP2) for the Iodination of Alcohols 
A dry and argon-flushed Schlenk-flask was charged with a solution of PPh3 (1.2 equiv.) and 
N-methylimidazole (1.2 equiv.) in dichloromethane (0.3 M) and was cooled to −10 °C. Iodine 
(1.2 equiv.) was added and the resulting yellow solution was stirred for 15 min at −10 °C. The 
respective alcohol (1.0 equiv.) dissolved in dichloromethane (1.0 M) was added dropwise and the 
resulting reaction mixture was stirred for 2 h at −10 °C. The reaction mixture was quenched with 
saturated aqueous NaHSO3∙Na2S2O5 solutionIV, the phases were separated and the aqueous phase was 
extracted with dichloromethane. The combined organic layers were dried over MgSO4 and the solvents 
were evaporated at 30 °C.V The residue was triturated three times with a mixture of pentane:diethyl 
ether (4:1).VI The residue was filtered off using a plug of silica and all organic phases were combined. 
All solvents were evaporated and the crude residue was subjected to column chromatography 
purification on silica yielding the respective title compound. 
                                                     
IV Quenching with water or unsaturated aqueous NaHSO3∙Na2S2O5 solution sometimes causes epimerisation of 
the product. 
V Evaporation at higher temperatures (>30 °C) sometimes causes epimerisation of the product. 
VI Removal of triphenylphosphine oxide before column chromatography is recommended to get higher yield by 
washing and filtering the crude product with a mixture of n-pentane:ethyl ether. 
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Typical Procedure (TP3) for the I/Li-Exchange and Subsequent Cyclisation 
A dry and argon-flushed Schlenk-tube with diethyl ether (0.23 M based on t-BuLi) was cooled to 
−100 °C and charged with a solution of t-BuLi (in pentane, 2.5 equiv.). The appropriate alkyl iodide 
(1.0 equiv.) in diethyl ether (0.4 M) was added dropwise over 10 min and the reaction mixture was 
stirred for 15 min. After the addition of the electrophile (2.5 equiv.),VII the solution was stirred for 5 min 
at −100 °C and was then allowed to warm to room temperature. Saturated aqueous NH4Cl solution was 
added, the phases were separated and the aqueous phase was extracted with diethyl ether. The combined 
organic layers were dried over MgSO4. The solvents were evaporated and the crude residue was 
subjected to column chromatography purification on silica yielding the respective title compound. 
Typical Procedure (TP4) for I/Li-Exchange, Intramolecular Carbolithiation and Cross-
Coupling Reactions 
A dry and argon-flushed Schlenk-tube with diethyl ether (0.23 M based on t-BuLi) was cooled to 
−100 °C and charged with a solution of t-BuLi (in pentane, 3.38 equiv.). The appropriate alkyl iodide 
(1.35 equiv.) in diethyl ether (0.4 M) was added dropwise over 10 min and the reaction mixture was 
stirred for 15 min. ZnCl2 (1.0 M in THF, 2.0 equiv.) and THF (0.5 M based on ZnCl2) were added and 
the reaction mixture was allowed to warm to 15 °C over 25 min. The reaction was cooled to −80 °C, 
SPhos (10 mol%) and a solution of the appropriate aryl iodide (1.0 equiv.) and Pd(OAc)2 (5 mol%) in 
DMA (0.13 M based on aryl iodide) were added dropwise. The reaction was stirred at room temperature 
for 16 h. After the addition of saturated aqueous NH4Cl solution, the phases were separated and the 
aqueous phase was extracted with diethyl ether. The combined organic layers were dried over MgSO4. 
The solvents were evaporated and the crude residue was subjected to column chromatography 
purification on silica yielding the respective title compound. 
  
                                                     
VII If necessary, the electrophile was dissolved in 1 mL of solvent. 
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11.1 Preparation of the Alcohols 
 
(4-Bromobut-1-yn-1-yl)trimethylsilane S1. PPh3 (12.5 g, 47.6 mmol, 1.2 equiv.) was added to a 
solution of 4-(trimethylsilyl)but-3-yn-1-ol (5.76 g, 39.7 mmol, 1.0 equiv.) in dichloromethane (79 mL) 
at −20 °C. NBS (7.85 g, 43.7 mmol, 1.1 equiv.) was slowly added at this temperature and the reaction 
was allowed to warm to room temperature over 16 h. After the addition of a saturated aqueous NaHCO3 
solution the reaction mixture was extracted with diethyl ether. The combined organic layers were dried 
over MgSO4. The crude product was purified by column chromatography on silica using pentane:diethyl 
ether (1000:1) as an eluent to afford S1 as a colourless liquid (89%, 7.23 g, 35.2 mmol). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 3.43 (t, J = 7.5 Hz, 2H), 2.77 (t, J = 7.5 Hz, 2H), 0.16 (s, 9H). 
13C-NMR (151 MHz, CDCl3, ppm): δ = 103.3, 87.2, 29.3, 24.4, 0.1. 
FT-IR (ATR, cm−1): �̃ = 2960, 2899, 2178, 1418, 1328, 1271, 1250, 1212, 1055, 1044, 998, 982, 902, 
837, 759, 698, 679. 
MS (EI, 70 eV): m/z (%) = 192 (16), 190 (15), 163 (97), 161 (100), 139 (47), 137 (47), 109 (19). 
HR-MS (EI, 70 eV): [C7H13BrSi], calcd.: 203.9970; found: 203.9949 (M+). 
 
Grignard reagent 41. A dry and argon-flushed flask was charged with dry LiCl (562 mg, 13.3 mmol, 
1.1 equiv.) and magnesium turnings (355 mg, 14.5 mmol, 1.2 equiv.) in THF (10 mL). Bromide S1 
(2.47 g, 12.1 mmol, 1.0 equiv.) in THF (2.0 mL) was added slowly at 0 °C. The reaction mixture was 
allowed to stir at room temperature for 2 h. Following titration with iodine at 0 °C gave a concentration 
of 0.56 – 0.81 M. 
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Alcohol rac-(2S,3R)-42a. Following TP1, (4-(trimethylsilyl)but-3-yn-1-yl)magnesium bromide 41 
(0.69 M, 10.0 mL, 6.90 mmol, 1.1 equiv.) reacts with cis-dimethyloxirane (466 mg, 6.27 mmol, 
1.0 equiv.) and CuI (122 mg, 0.627 mmol, 10 mol%) as catalyst at 0 °C. The solution was stirred at this 
temperature for 16 h and was worked-up as usual. The crude product was purified by column 
chromatography on silica using pentane:diethyl ether (2:1) as an eluent to afford rac-(2S,3R)-42a as a 
colourless oil (86%, 1.07 g, 5.40 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 3.75 – 3.64 (m, 1H), 2.33 (ddd, J = 16.9, 8.2, 5.9 Hz, 1H), 
2.20 (ddd, J = 17.0, 8.1, 7.4 Hz, 1H), 1.85 – 1.67 (m, 1H), 1.67 – 1.46 (m, 2H), 1.42 – 1.31 (m, 1H), 
1.15 (d, J = 6.3 Hz, 3H), 0.90 (d, J = 6.8 Hz, 3H), 0.14 (s, 9H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 107.7, 84.7, 71.6, 39.5, 31.5, 19.9, 17.8, 14.7, 0.3. 
FT-IR (ATR, cm−1): �̃ = 3362, 2961, 2175, 1453, 1379, 1321, 1248, 1094, 1051, 1002, 923, 837, 758, 
697. 
MS (EI, 70 eV): m/z (%) = 167 (16), 165 (45), 140 (17), 139 (15), 127 (19), 112 (20), 109 (25), 97 (10), 
96 (18), 83 (12), 75 (100), 73 (92), 72 (11). 
HR-MS (EI, 70 eV): [C10H19OSi], calcd.: 183.1205; found: 183.1202 ([M−Me]+). 
 
Alcohol rac-(2S,3S)-42a. Following TP1, (4-(trimethylsilyl)but-3-yn-1-yl)magnesium bromide 41 
(0.70 M, 13.1 mL, 9.17 mmol, 1.1 equiv.) reacts with trans-dimethyloxirane (620 mg, 8.34 mmol, 
1.0 equiv.) using CuI (162 mg, 0.834 mmol, 10 mol%) as catalyst at 0 °C. The solution was stirred at 
this temperature for 16 h and was worked-up as usual. The crude product was purified by column 
chromatography on silica using pentane:diethyl ether (2:1) as an eluent to afford rac-(2S,3S)-42a as a 
colourless oil (89%, 1.47 g, 7.41 mmol, d.r.>99:1). 
 
1H-NMR (599 MHz, CDCl3, ppm): δ = 3.76 (qd, J = 6.4, 4.2 Hz, 1H), 2.33 (ddd, J = 17.0, 8.0, 
6.1 Hz, 1H), 2.22 (dt, J = 16.9, 7.7 Hz, 1H), 1.70 (dtd, J = 13.1, 7.7, 5.2 Hz, 1H), 1.63 – 1.47 (m, 2H), 
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1.38 (dddd, J = 13.3, 8.5, 7.9, 6.1 Hz, 1H), 1.17 (d, J = 6.4 Hz, 3H), 0.90 (d, J = 6.8 Hz, 3H), 0.14 (s, 
9H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 107.6, 84.8, 70.8, 39.1, 31.8, 20.4, 18.0, 13.9, 0.3. 
FT-IR (ATR, cm−1): �̃ = 3359, 2962, 2900, 2175, 1455, 1430, 1378, 1248, 1146, 1082, 1048, 1017, 
1002, 943, 927, 870, 836, 758, 697. 
MS (EI, 70 eV): m/z (%) = 165 (16), 140 (10), 112 (11), 109 (12), 96 (13), 85 (15), 75 (100), 73 (96), 
72 (14), 57 (12), 45 (14). 
HR-MS (EI, 70 eV): [C10H19OSi], calcd.: 183.1205; found: 183.1197 ([M−Me]+). 
 
1-Methoxy-4-((pent-4-en-2-yloxy)methyl)benzene 45.[135] A dry and argon-flushed Schlenk-flask was 
charged with NaH (217 mg, 5.43 mmol, 1.4 equiv.) and THF (4.5 mL). A solution of pent-4-en-2-ol 44 
(400 µL, 3.88 mmol, 1.0 equiv.) in THF (1.5 mL) was added dropwise at 0 °C. The reaction mixture 
was stirred for 30 min at 0 °C. Then, PMBCl (590 µL, 4.27 mmol, 1.1 equiv.) and tetrabutylammonium 
iodide (143 mg, 0.388 mmol, 0.1 equiv.) were added at 0 °C. After warming to room temperature, the 
reaction mixture was stirred for 16 h. Water and saturated aqueous NaCl solution were added, the phases 
were separated and the aqueous phase was extracted with diethyl ether. The combined organic layers 
were dried over MgSO4. The crude product was purified by column chromatography on silica using 
hexane:diethyl ether (20:1) as an eluent to afford 45 as a colourless oil (63%, 473 mg, 2.46 mmol). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.27 (d, J = 8.8 Hz, 2H), 6.87 (d, J = 8.1 Hz, 2H), 5.83 (ddt, 
J = 17.3, 10.3, 7.1 Hz, 1H), 5.16 – 4.96 (m, 2H), 4.47 (q, J = 11.4 Hz, 2H), 3.80 (s, 3H), 3.56 (dt, 
J = 6.2 Hz, 1H), 2.37 (dt, J = 13.2, 6.2 Hz, 1H), 2.22 (dt, J = 13.7, 6.8 Hz, 1H), 1.18 (d, J = 6.1 Hz, 
3H). 
13C-NMR (101 MHz, CDCl3, ppm):δ = 159.2, 135.3, 131.1, 129.3, 116.9, 113.9, 74.2, 70.1, 55.4, 
41.0, 19.6. 
FT-IR (ATR, cm−1): �̃ = 2971, 2933, 2836, 1612, 1586, 1512, 1464, 1374, 1339, 1301, 1244, 1172, 
1128, 1084, 1034, 1012, 913, 819, 753. 
MS (EI, 70 eV): m/z (%) = 148 (39), 121 (100). 
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HR-MS (EI, 70 eV): [C13H18O2], calcd.: 206.1307; found: 206.1301 (M+). 
 
Epoxide 46. A 500 mL flask was charged with 45 (6.45 g, 31.2 mmol, 1.0 equiv.) in dichloromethane 
(200 mL). mCPBA (6.20 g, 36.0 mmol, 1.15 equiv.) was added over three times at 0 °C and the reaction 
mixture was stirred for 42 h at room temperature. Saturated aqueous NaHCO3 solution was added, the 
phases were separated and the aqueous phase was extracted with dichloromethane. The combined 
organic layers were dried over MgSO4. The crude product was purified by column chromatography on 
silica using hexane:diethyl ether (3.5:1) as an eluent to afford a mixture of diastereomers (60:40) of 46 
as a colourless oil (78%, 5.40 mg, 24.3 mmol). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.31 – 7.23 (m, 2H), 6.91 – 6.84 (m, 2H), 4.58 (d, J = 11.3 Hz, 
0.5H), 4.52 (d, J = 11.8 Hz, 0.6H), 4.43 (d, J = 10.0 Hz, 0.6H), 4.41 (d, J = 10.1 Hz, 0.4H), 3.80 (s, 
3H), 3.79 – 3.74 (m, 0.7H), 3.74 – 3.66 (m, 0.5H), 3.08 (dtd, J = 7.1, 4.2, 2.8 Hz, 0.6H), 3.05 – 3.01 (m, 
0.4H), 2.80 (dd, J = 5.0, 4.0 Hz, 0.6H), 2.77 – 2.73 (m, 0.4H), 2.50 (dd, J = 5.0, 2.7 Hz, 0.6H), 2.48 
(dd, J = 5.1, 2.7 Hz, 0.4H), 1.93 – 1.80 (m, 1H), 1.67 (ddd, J = 14.2, 5.8, 5.2 Hz, 0.4H), 1.51 (ddd, J = 
14.3, 7.3, 4.4 Hz, 0.7H), 1.28 (d, J = 6.2 Hz, 1.3H), 1.25 (d, J = 6.2 Hz, 1.8H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = Major: 159.2, 130.9, 129.3, 113.9, 72.7, 70.5, 55.4, 50.0, 47.6, 
40.4, 20.2; Minor: 159.2, 130.9, 129.3, 113.9, 72.4, 70.1, 55.4, 49.8, 47.0, 39.5, 19.8. 
FT-IR (ATR, cm−1): �̃ = 2969, 2933, 2912, 2865, 2837, 1612, 1586, 1512, 1463, 1443, 1410, 1375, 
1339, 1301, 1244, 1172, 1128, 1100, 1069, 1032, 947, 911, 996, 938, 910, 872, 845, 818, 750. 
MS (EI, 70 eV): m/z (%) = 137 (54), 121 (100). 
HR-MS (EI, 70 eV): [C13H18O3], calcd.: 222.1256; found: 222.1248 (M+). 
 
Silane 47. A dry and argon-flushed Schlenk-flask was charged with triphenylsilyl acetylene (8.8 g, 
30.9 mmol, 1.0 equiv.) and THF (120 mL). n-BuLi (2.1 M in hexane, 14.8 mL, 31.1 mmol, 1.0 equiv.) 
was added dropwise at −78 °C and the reaction mixture was stirred at this temperature for 1 h. 46 
(3.96 mL, 32.1 mmol, 1.0 equiv.) in THF (10 mL) and BF3·Et2O (5.10 g, 22.9 mmol, 0.74 equiv.) were 
added successively at −78 °C. The mixture was stirred at −78 °C for 20 min. After warming to room 
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temperature, the reaction was stirred for 3 h. Saturated aqueous NH4Cl solution was added, the phases 
were separated and the aqueous phase was extracted with diethyl ether. The combined organic layers 
were dried over MgSO4. The crude product was purified by column chromatography on silica using 
hexane:diethyl ether (3:2→5:4) as an eluent to afford a mixture of diastereomers (59:41) of 47 as a pale 
yellow oil (69%, 10.8 g, 21.3 mmol). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.69 – 7.62 (m, 6H), 7.47 – 7.34 (m, 9H), 7.30 – 7.23 (m, 2H), 
6.93 – 6.85 (m, 2H), 4.61 (d, J = 11.1 Hz, 0.4H), 4.56 (d, J = 11.2 Hz, 0.6H), 4.39 (d, J = 11.4 Hz, 
0.6H), 4.37 (d, J = 11.2 Hz, 0.4H), 4.24 – 4.11 (m, 0.6H), 4.04 (dddd, J = 9.8, 7.6, 4.9, 2.4 Hz, 0.4H), 
3.98 – 3.90 (m, 0.6H), 3.90 – 3.86 (m, 0.4H), 3.86 – 3.81 (m, 0.5H), 3.80 (s, 1.2H), 3.80 (s, 1.7H), 3.15 
(d, J = 3.8 Hz, 0.5H), 2.62 (td, J = 16.7, 6.2 Hz, 1.4H), 2.50 (td, J = 16.6, 7.6 Hz, 0.6H), 2.00 – 1.90 
(m, 0.4H), 1.90 – 1.84 (m, 1H), 1.82 – 1.71 (m, 0.5H), 1.26 (d, J = 6.3 Hz, 1.7H), 1.26 (d, J = 6.1 Hz, 
1.3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = Major: 159.3, 135.6, 133.9, 130.4, 130.0, 129.5, 128.1, 114.0, 
108.9, 82.2, 72.4, 70.3, 67.5, 55.4, 41.7, 29.0, 19.3; Minor: 159.4, 135.6, 133.9, 130.1, 130.0, 129.6, 
128.0, 114.1, 109.0, 82.1, 75.5, 70.5, 70.1, 55.4, 42.8, 29.0, 19.8. 
FT-IR (ATR, cm−1): �̃ = 3452, 2966, 2933, 2908, 2869, 2836, 2174, 1612, 1587, 1512, 1484, 1463, 
1455, 1428, 1375, 1336, 1301, 1246, 1174, 1138 , 1111, 1032, 1009, 997, 845, 819, 741, 707, 697. 
MS (EI, 70 eV): m/z (%) = 260 (10), 259 (34), 247 (10), 199 (32), 190 (12), 137 (50), 122 (11), 121 
(100). 
HR-MS (EI, 70 eV): [C33H34O3Si], calcd.: 506.2277; found: 506.2272 (M+). 
 
Silane 43. A dry and argon-flushed Schlenk-flask was charged with 47 (10.8 g, 21.3 mmol, 1.0 equiv.) 
in dichloromethane (180 mL). 2,6-Lutidine (3.7 mL, 31.9 mmol, 1.5 equiv.) and TBSOTf (5.9 mL, 
25.6 mmol, 1.2 equiv.) were added successively at 0 °C. After warming up to room temperature, the 
reaction mixture was stirred for 42 h. Saturated aqueous NH4Cl solution was added, the phases were 
separated and the aqueous phase was extracted with dichloromethane. The combined organic layers 
were dried over MgSO4. The crude product was purified by column chromatography on silica using 
hexane:diethyl ether (30:1) as an eluent and a second time with hexane:toluene (1:3.5) to afford rac-
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(2S,4S)-43 as a pale yellow oil (30%, 3.90 g, 6.28 mmol) and rac-(2S,4R)-43 as a pale yellow oil (17%, 
2.20 g, 3.54 mmol). 
 
rac-(2S,4S)-43: 
1H-NMR (400 MHz, CDCl3, ppm): δ =  7.67 (dd, J = 7.9, 1.4 Hz, 6H), 7.43 – 7.32 (m, 9H), 7.24 (d, 
J = 8.6 Hz, 2H), 6.84 (d, J = 8.6 Hz, 2H), 4.51 (d, J = 11.0 Hz, 1H), 4.31 (d, J = 11.0 Hz, 1H), 4.15 
(ddt, J = 9.3, 6.1, 3.7 Hz, 1H), 3.79 (s, 3H), 3.74 (ddq, J = 12.2, 6.1, 3.1 Hz, 1H), 2.60 (dd, J = 17.0, 
6.2 Hz, 1H), 2.53 (dd, J = 16.9, 4.2 Hz, 1H), 1.95 (ddd, J = 14.1, 9.0, 3.3 Hz, 1H), 1.75 (ddd, J = 14.1, 
8.8, 3.4 Hz, 1H), 1.22 (d, J = 6.1 Hz, 3H), 0.88 (s, 9H), 0.07 (s, 3H), 0.05 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 159.0, 135.7, 134.1, 131.4, 129.8, 129.1, 128.0, 113.8, 109.3, 
81.8, 71.8, 69.7, 67.7, 55.4, 44.9, 30.0, 26.0, 20.3, 18.2, −4.1, −4.5. 
FT-IR (ATR, cm−1): �̃ = 2954, 2929, 2856, 2176, 1614, 1588, 1514, 1484, 1462, 1429, 1373, 1336, 
1302, 1247, 1172, 1144, 1112, 1075, 1034, 1005, 938, 908, 835, 824, 807, 775, 741, 708, 696. 
MS (EI, 70 eV): m/z (%) = 121 (100). 
HR-MS (EI, 70 eV): [C39H48O3Si2], calcd.: 620.3142; found: 620.3136 (M+). 
rac-(2S,4R)-43: 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.65 (dd, J = 8.0, 1.5 Hz, 6H), 7.46 – 7.31 (m, 9H), 7.21 (d, 
J = 8.6 Hz, 2H), 6.82 (d, J = 8.6 Hz, 2H), 4.45 (d, J = 11.4 Hz, 1H), 4.34 (d, J = 11.4 Hz, 1H), 
4.05 – 3.96 (m, 1H), 3.77 (s, 3H), 3.66 (h, J = 6.3 Hz, 1H), 2.56 (dd, J = 16.9, 6.0 Hz, 1H), 2.49 (dd, 
J = 17.0, 4.8 Hz, 1H), 1.99 (dt, J = 13.4, 6.5 Hz, 1H), 1.79 (dt, J = 13.8, 6.1 Hz, 1H), 1.19 (d, 
J = 6.1 Hz, 3H), 0.85 (s, 9H), 0.04 (s, 3H), 0.03 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 159.1, 135.7, 134.1, 131.1, 129.9, 129.3, 128.0, 113.8, 109.3, 
81.6, 71.5, 69.8, 68.2, 55.4, 43.7, 29.2, 25.9, 20.0, 18.1, −4.3, −4.6. 
FT-IR (ATR, cm−1): �̃ = 2954, 2929, 2856, 2176, 1613, 1588, 1513, 1463, 1429, 1374, 1335, 1302, 
1247, 1172, 1139, 1112, 1034, 1005, 937, 908, 835, 807, 775, 741, 708, 697. 
MS (EI, 70 eV): m/z (%) = 121 (100). 
HR-MS (EI, 70 eV): [C39H48O3Si], calcd.: 620.3142; found: 620.3138 (M+). 
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Alcohol rac-(2S,4S)-42b. A dry and argon-flushed Schlenk-flask was charged with rac-(2S,4S)-43 
(3.90 g, 6.30 mmol, 1.0 equiv.), dichloromethane (35 mL) and phosphate buffer (20 mL, pH = 7). DDQ 
(2.86 g, 12.6 mmol, 2.0 equiv.) was added at 0 °C and the reaction was stirred for 1.5 h at this 
temperature. Saturated aqueous NaHCO3 solution was added, the phases were separated and the 
aqueous phase was extracted with diethyl ether. The combined organic layers were dried over MgSO4. 
The crude product was purified by column chromatography on silica using hexane:ethyl acetate (7:1) 
as an eluent and a second time with hexane:ethyl acetate (7:1) to afford rac-(2S,4S)-42b as a colourless 
oil (83%, 2.62 g, 5.25 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.68 – 7.59 (m, 6H), 7.47 – 7.33 (m, 9H), 4.29 – 4.12 (m, 2H), 
2.94 (d, J = 2.6 Hz, 1H), 2.70 (dd, J = 16.9, 8.0 Hz, 1H), 2.64 (dd, J = 16.9, 5.4 Hz, 1H), 1.89 (ddd, 
J = 14.5, 5.3, 2.2 Hz, 1H), 1.73 (ddd, J = 14.2, 10.1, 3.6 Hz, 1H), 1.16 (d, J = 6.2 Hz, 3H), 0.88 (s, 9H), 
0.11 (s, 3H), 0.09 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 135.6, 133.8, 130.0, 128.1, 108.5, 82.3, 70.0, 64.4, 43.3, 28.3, 
25.9, 24.0, 18.0, −4.5, −4.8. 
FT-IR (ATR, cm−1): �̃ = 3458, 2956, 2929, 2856, 2176, 1589, 1514, 1471, 1462, 1428, 1373, 1254, 
1187, 1112, 1028, 1013, 1005, 937, 912, 835, 807, 775, 739, 707, 696. 
MS (EI, 70 eV): m/z (%) = 283 (10), 273 (19), 259 (100), 195 (52), 159 (53), 144 (28), 129 (11), 105 
(14), 75 (33). 
HR-MS (EI, 70 eV): [C27H31O2Si2], calcd.: 443.1863; found: 443.1852 ([M−t-Bu]+). 
 
Alcohol rac-(2S,4R)-42b. A dry and argon-flushed Schlenk-flask was charged with rac-(2S,4R)-43 
(2.20 g, 3.54 mmol, 1.0 equiv.), dichloromethane (20 mL) and phosphate buffer (12 mL, pH = 7). DDQ 
(1.60 g, 7.09 mmol, 2.0 equiv.) was added at 0 °C and the reaction was stirred for 1 h at this 
temperature. Saturated aqueous NaHCO3 solution was added, the phases were separated and the 
aqueous phase was extracted with diethyl ether. The combined organic layers were dried over MgSO4. 
The crude product was purified by column chromatography on silica using hexane:diethyl ether (3:1) 
to afford rac-(2S,4R)-42b with 4-methoxybenzaldehyde as an impurity. To remove this impurity, the 
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resulting mixture was diluted with THF (10 mL) and tosyl hydrazine (830 mg, 4.46 mmol) was added. 
The reaction mixture was stirred at room temperature for 18 h. The solvents were evaporated and the 
crude product was purified by column chromatography on silica using hexane:diethyl ether (3:1) to 
afford rac-(2S,4R)-42b as a pale yellow oil (88%, 1.56 g, 3.11 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.67 – 7.61 (m, 6H), 7.45 – 7.34 (m, 9H), 4.11 (ddt, J = 8.8, 
6.8, 4.3 Hz, 1H), 3.99 (dqd, J = 8.9, 6.1, 2.7 Hz, 1H), 2.90 (s, 1H), 2.67 – 2.53 (m, 2H), 1.91 (ddd, 
J = 14.3, 4.0, 2.9 Hz, 1H), 1.78 (dt, J = 14.3, 9.0 Hz, 1H), 1.17 (d, J = 6.2 Hz, 3H), 0.89 (s, 9H), 0.13 
(s, 3H), 0.12 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm):δ = 135.5, 133.7, 129.9, 127.9, 108.1, 82.5, 71.4, 67.0, 44.8, 29.7, 
25.7, 23.6, 17.9, −4.1, −4.8. 
FT-IR (ATR, cm−1): �̃ = 3430, 2956, 2929, 2856, 2177, 1589, 1484, 1471, 1462, 1428, 1361, 1255, 
1187, 1112, 1082, 1026, 1014, 998, 937, 835, 806, 775, 739, 707, 696. 
MS (EI, 70 eV): m/z (%) = 368 (41), 275 (41), 259 (100), 207 (31), 181 (21), 155 (11). 
HR-MS (EI, 70 eV): [C27H31O2Si2], calcd.: 443.1863; found: 443.1854 ([M−t-Bu]+). 
 
Alcohol anti-42c. Following TP1, (4-(trimethylsilyl)but-3-yn-1-yl)magnesium bromide 41 (0.81 M, 
6.10 mL, 4.94 mmol, 1.1 equiv.) reacts with cyclopentene oxide (390 mg, 4.49 mmol, 1.0 equiv.) using 
CuI (97 mg, 0.494 mmol, 10 mol%) as catalyst at 0 °C. The solution was stirred at this temperature for 
16 h and was worked-up as usual. The crude product was purified by column chromatography on silica 
using pentane:diethyl ether (2:1) as an eluent to afford anti-42c as a colourless oil (69%, 652 mg, 
3.10 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 3.86 (q, J = 5.8 Hz, 1H), 2.40 – 2.20 (m, 2H), 1.99 – 1.86 (m, 
2H), 1.83 – 1.63 (m, 4H), 1.63 – 1.56 (m, 2H), 1.48 (tt, J = 14.2, 6.6 Hz, 1H)1.24 – 1.11 (m, 1H), 0.15 
(s, 9H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 107.7, 84.9, 79.0, 48.0, 34.7, 32.8, 30.3, 21.9, 18.9, 0.3. 
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FT-IR (ATR, cm−1): �̃ = 3346, 2957, 2174, 1452, 1344, 1248, 1168, 1039, 1019, 837, 758, 697. 
MS (EI, 70 eV): m/z (%) = 97 (11), 84 (21), 75 (100), 73 (54). 
HR-MS (EI, 70 eV): [C11H19OSi], calcd.: 195.1205; found: 195.1203 ([M−Me]+). 
 
Ester syn-S2. DEAD (40% in toluene, 2.97 mL, 6.56 mmol, 1.0 equiv.) was added dropwise to a 
solution of anti-42c (1.38 g, 6.56 mmol, 1.0 equiv.) and triphenylphosphine (1.72 g, 6.56 mmol, 
1.0 equiv.) in THF (24.6 mL). Then, benzoic acid (961 mg, 7.87 mmol, 1.2 equiv.) was added over a 
period of 30 min. After stirring at room temperature for 16 h, water (0.08 mL) was added and the 
mixture was concentrated in vacuo. The crude product was purified by column chromatography on 
silica using hexane:diethyl ether (9:1) as an eluent to afford syn-S2 as a colourless oil (54%, 1.12 g, 
3.55 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 8.08 – 7.97 (m, 2H), 7.60 – 7.50 (m, 1H), 7.50 – 7.40 (m, 2H), 
5.43 (td, J = 4.5, 1.2 Hz, 1H), 2.37 – 2.20 (m, 2H), 2.15 – 1.99 (m, 2H), 1.99 – 1.75 (m, 4H), 1.73 – 1.49 
(m, 3H), 0.13 (s, 9H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 166.0, 132.7, 130.8, 129.4, 128.2, 107.0, 84.5, 78.1, 43.8, 
32.6, 29.4, 28.2, 22.0, 18.8, 0.0. 
FT-IR (ATR, cm−1): �̃ = 2957, 2872, 2174, 1715, 1451, 1314, 1271, 1248, 1175, 1111, 1069, 1026, 
838, 759, 709, 688, 670. 
MS (EI, 70 eV): m/z (%) = 180 (12), 179 (76), 177 (39), 118 (11), 105 (100), 77 (34), 73 (36). 
HR-MS (EI, 70 eV): [C19H25O2Si], calcd.: 313.1624; found: 313.1613 ([M−H]+). 
 
Alcohol syn-S3. syn-S2 (970 mg, 3.08 mmol, 1.0 equiv.) was treated with potassium carbonate (1.71 g, 
12.3 mmol, 4.0 equiv.) in MeOH (5.6 mL). The reaction mixture was stirred at 60 °C for 16 h. A 
saturated aqueous solution of NH4Cl was added. The phases were separated and the aqueous phase was 
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extracted with diethyl ether. The combined organic layers were dried over MgSO4. The crude product 
was purified by column chromatography on silica using pentane:diethyl ether (3:1) as an eluent to afford 
syn-S3 as a colourless oil (96%, 408 mg, 2.95 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 4.23 (td, J = 4.3, 1.5 Hz, 1H), 2.38 – 2.16 (m, 2H), 1.96 (t, 
J = 2.7 Hz, 1H), 1.93 – 1.71 (m, 5H), 1.71 – 1.51 (m, 3H), 1.46 – 1.31 (m, 2H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 84.9, 74.1, 68.3, 45.0, 34.9, 28.7, 27.9, 21.7, 17.4. 
FT-IR (ATR, cm−1): �̃ = 3398, 3304, 2940, 2869, 2116, 1450, 1434, 1328, 1297, 1145, 1107, 1040, 
1008, 990, 958, 941, 855. 
MS (EI, 70 eV): m/z (%) = 109 (60), 97 (100), 95 (30), 91 (33), 84 (65), 81 (59), 79 (80), 67 (56), 57 
(73), 55 (52), 54 (36), 53 (31), 41 (83). 
HR-MS (EI, 70 eV): [C9H14O], calcd.: 138.1045; found: 138.1048 (M+). 
 
Alcohol syn-42c. A dry and argon-flushed Schlenk-flask was charged with syn-S3 (389 mg, 2.82 mmol, 
1.0 equiv.) in THF (5.6 mL). n-BuLi (2.49 M, 2.32 mL, 5.77 mmol, 2.05 equiv.) was added dropwise at 
−78 °C. After 1 h at this temperature, TMSCl (753 µL, 5.77 mmol, 2.05 equiv.) was added and the 
reaction mixture was stirred at room temperature for 30 min. HCl (2 N, 2.8 mL, 5.60 mmol, 2.0 equiv.) 
was added. After stirring for 16 h at room temperature, the reaction mixture was neutralised with a 
saturated aqueous solution of NaHCO3. The phases were separated and the aqueous phase was extracted 
with diethyl ether. The combined organic layers were dried over MgSO4. The crude product was 
purified by column chromatography on silica using pentane:diethyl ether (2:1) as an eluent to afford 
syn-42c as a colourless oil (99%, 590 mg, 2.80 mmol, d.r.>99:1). 
 
1H-NMR (599 MHz, CDCl3, ppm): δ = 4.29 – 4.24 (m, 1H), 2.40 – 2.32 (m, 1H), 2.28 – 2.20 (m, 1H), 
1.89 – 1.50 (m, 8H), 1.53 (s, 1H), 1.44 – 1.36 (m, 1H), 0.15 (s, 9H). 
13C-NMR (151 MHz, CDCl3, ppm): δ = 108.3, 84.8, 74.1, 45.9, 34.9, 29.2, 28.4, 22.0, 19.2, 0.2. 
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FT-IR (ATR, cm−1): �̃ = 3377, 2957, 2901, 2870, 2173, 1430, 1328, 1248, 1143, 1104, 1026, 994, 836, 
758, 697. 
MS (EI, 70 eV): m/z (%) = 177 (23), 75 (100), 73 (70). 
HR-MS (EI, 70 eV): [C12H21OSi], calcd.: 209.1362; found: 209.1358 (M+). 
 
Alcohol anti-42d. Following TP1, (4-(trimethylsilyl)but-3-yn-1-yl)magnesium bromide 41 (0.81 M, 
6.35 mL, 5.15 mmol, 1.1 equiv.) reacts with cyclohexene oxide (4.68 mg, 4.68 mmol, 1.0 equiv.) using 
CuI (91 mg, 0.468 mmol, 10 mol%) as catalyst at 0 °C. The solution was stirred at this temperature for 
16 h and was worked-up as usual. The crude product was purified by column chromatography on silica 
using pentane:diethyl ether (2:1) as an eluent to afford anti-42c as a colourless solid (77%, 804 mg, 
3.58 mmol, d.r.>99:1). 
 
m.p.: 48.6 – 50.8 °C. 
1H-NMR (400 MHz, CDCl3, ppm): δ = 3.25 (td, J = 9.7, 4.5 Hz, 1H), 2.34 (ddd, J = 17.0, 8.5, 6.1 Hz, 
1H), 2.22 (ddd, J = 17.0, 8.1, 7.1 Hz, 1H), 2.03 – 1.92 (m, 2H), 1.82 – 1.71 (m, 2H), 1.68 – 1.61 (m, 
1H), 1.42 (dtd, J = 13.3, 8.1, 6.1 Hz, 1H), 1.36 – 1.11 (m, 4H), 1.00 – 0.87 (m, 1H), 0.14 (s, 9H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 108.2, 84.7, 74.5, 44.7, 35.9, 31.7, 30.2, 25.6, 25.0, 17.5, 0.3. 
FT-IR (ATR, cm−1): �̃ = 3273, 2958, 2925, 2858, 2175, 1450, 1426, 1407, 1354, 1342, 1247, 1065, 
1052, 1033, 994, 987, 969, 942, 934, 836, 758, 697, 664. 
MS (EI, 70 eV): m/z (%) = 191 (33), 165 (28). 
HR-MS (EI, 70 eV): [C13H24OSi], calcd.: 224,1596; found: 224.1593 (M+). 
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Alcohol anti-42e. The aromatic alkynol anti-42e was prepared in two steps according to the literature 
in 60% yield.[136] 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.48 (ddd, J = 7.7, 1.4, 0.7 Hz, 1H), 7.35 – 7.27 (m, 2H), 7.16 
(ddd, J = 7.7, 6.8, 1.9 Hz, 1H), 3.94 – 3.80 (m, 1H), 3.13 (d, J = 11.2 Hz, 1H), 2.21 – 2.15 (m, 1H), 
1.98 – 1.84 (m, 2H), 1.84 – 1.74 (m, 1H), 1.60 – 1.52 (m, 1H), 1.49 – 1.30 (m, 4H), 0.27 (s, 9H). 
 
Alcohol R-42f. Following TP1, (4-(trimethylsilyl)but-3-yn-1-yl)magnesium bromide 41 (0.56 M, 
10.6 mL, 5.94 mmol, 1.1 equiv.) reacts with R-(+)-propylene oxide (320 mg, 5.396 mmol, 1.0 equiv.) 
using CuI (105 mg, 0.540 mmol, 10 mol%) as catalyst at 0 °C. The solution was stirred at this 
temperature for 16 h and was worked-up as usual. The crude product was purified by column 
chromatography on silica using pentane:diethyl ether (2:1) as an eluent to afford R-42f as a colourless 
oil (94%, 934 mg, 5.07 mmol). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 3.84 (tq, J = 6.1 Hz, 1H), 2.30 – 2.21 (m, 2H), 1.71 – 1.49 
(m, 4H), 1.38 (s, 1H), 1.20 (d, J = 6.2 Hz, 3H), 0.14 (s, 9H). 
13C-NMR (101 MHz, CDCl3, ppm):δ = 107.4, 84.9, 67.8, 38.5, 25.0, 23.7, 20.0, 0.3. 
FT-IR (ATR, cm−1): �̃ = 3345, 2962, 2174, 1456, 1408, 1374, 1326, 1248, 1183, 1128, 1086, 1055, 
1026, 1015, 994, 909, 837, 758, 697. 
MS (EI, 70 eV): m/z (%) = 151 (19), 109 (21), 96 (17), 76 (16), 75 (71), 73 (100), 71 (16), 59 (11), 45 
(25), 43 (12). 
HR-MS (EI, 70 eV): [C9H17OSi], calcd.: 169.1049; found: 169.1037 ([M−Me]+). [�] ���  = –9° (c = 0.89, CH2Cl2); –8° (c = 0.90, CHCl3). Lit.: –6.83° (c = 0.55, CHCl3).[137] 
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Alcohol S-42f. Following TP1, (4-(trimethylsilyl)but-3-yn-1-yl)magnesium bromide 41 (0.67 M, 
11.0 mL, 7.37 mmol, 1.1 equiv.) reacts with S-(−)-propylene oxide (381 mg, 6.70 mmol, 1.0 equiv.) 
using CuI (125 mg, 0.670 mmol, 10 mol%) as catalyst at 0 °C. The solution was stirred at this 
temperature overnight and was worked-up as usual. The crude product was purified by column 
chromatography on silica using pentane:diethyl ether (2:1) as an eluent to afford S-42f as a colourless 
oil (94%, 1.16 g, 6.27 mmol). 
 
1H-NMR (599 MHz, CDCl3, ppm): δ = 3.89 – 3.80 (m, 1H), 2.31 – 2.23 (m, 2H), 1.69 – 1.61 (m, 1H), 
1.61 – 1.52 (m, 3H), 1.31 (s, 1H), 1.21 (d, J = 6.2 Hz, 3H), 0.15 (s, 9H). 
13C-NMR (151 MHz, CDCl3, ppm):δ = 107.4, 84.9, 67.8, 38.5, 25.0, 23.7, 20.0, 0.3. 
FT-IR (ATR, cm−1): �̃ = 3350, 2962, 2930, 2868, 2174, 1456, 1430, 1408, 1374, 1326, 1248, 1128, 
1086, 1056, 1026, 994, 932, 910, 836, 758, 698. 
MS (EI, 70 eV): m/z (%) = 91 (15), 79 (16), 75 (100), 73 (34). 
HR-MS (EI, 70 eV): [C10H20OSi], calcd.: 184.1283; found: 184.1277 ([M−Me]+). [�] ���  = 11° (c = 0.94, CH2Cl2), 11° (c = 1.01, CHCl3). Lit.: 7.9° (c = 0.55, CHCl3).[138] 
 
Alcohol S4. A dry and argon-flushed flask was charged with a solution of oxalyl chloride (0.48 mL, 
5.56 mmol, 1.1 equiv.) in dichloromethane (25 mL) and the solution was cooled to −78 °C. DMSO 
(2.4 M in dichloromethane, 5.1 mL, 12.1 mmol, 12.4 equiv.) was slowly added. After 10 min, hept-
6-yn-1-ol (597 mg, 5.06 mmol, 1.0 equiv.) in dichloromethane (10 mL) was slowly added. The reaction 
mixture was stirred for 10 min and trimethylamine (3.4 mL, 25.3 mmol, 5.0 equiv.) was added. The 
solution was stirred at room temperature for 1 h. After the addition of water, the phases were separated 
and the aqueous phase was extracted with diethyl ether. The combined organic layers were dried over 
MgSO4 and the solvents were evaporated. 
The crude material in THF (34 mL) was treated with MeMgCl (2.62 M, 2.32 mL, 6.07 mmol, 1.2 equiv.) 
at −78 °C. After 10 min at this temperature, the reaction mixture was allowed to warm to room 
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temperature. Saturated aqueous NH4Cl solution was added, the phases were separated and the aqueous 
phase was extracted with diethyl ether. The combined organic layers were dried over MgSO4. The crude 
product was purified by column chromatography on silica using pentane:diethyl ether (1:3) as an eluent 
to afford alcohol S4 as a colourless oil (85%, 545 mg, 4.32 mmol). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 3.85 – 3.76 (m, 1H), 2.26 – 2.16 (m, 2H), 1.94 (t, J = 2.7 Hz, 
1H), 1.60 – 1.36 (m, 7H), 1.19 (d, J = 6.2 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm):δ = 84.4, 68.3, 67.9, 38.7, 28.4, 24.8, 23.5, 18.3. 
FT-IR (ATR, cm−1): �̃ = 3298, 2936, 2862, 1462, 1374, 1128, 1092, 1032, 932, 840. 
MS (EI, 70 eV): m/z (%) = 95 (10), 93 (34), 91 (71), 81 (26), 79 (78), 78 (12), 77 (27), 67 (100), 65 
(17). 
HR-MS (EI, 70 eV): [C8H12O], calcd.: 124.0888; found: 124.0883 ([M−2H]+). 
 
Alcohol S5. A dry and argon-flushed flask was charged with a solution of 3-methylbut-1-yne (681 mg, 
10.0 mmol, 1.0 equiv.) in diethyl ether (10.0 mL) and the solution was cooled to −20 °C. TMEDA 
(1.51 mL, 10 mmol, 1.0 equiv.) and n-BuLi (2.62 M in hexane, 7.63 mL, 20.0 mmol, 2.0 equiv.) was 
added slowly at this temperature. The reaction mixture was heated to 40 °C for 15 h. Then, it was cooled 
to −78 °C, ethylene oxide (5.49 M in THF, 5.49 mL, 13.0 mmol, 1.3 equiv.) was added dropwise. After 
2 h at −78 °C, TMSCl (2.56 mL, 20 mmol, 2.0 equiv.) was added and the reaction mixture was stirred 
for 5 h at room temperature. HCl (2 N, 18.5 mL) was added and the solution was stirred overnight. 
Saturated aqueous NH4Cl solution was added, the phases were separated and the aqueous phase was 
extracted with diethyl ether. The combined organic layers were dried over MgSO4. The crude product 
was purified by column chromatography on silica using pentane:diethyl ether (2:1) as an eluent to afford 
alcohol S5 as a colourless oil (26%, 487 mg, 2.64 mmol). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 3.85 (dt, J = 6.1 Hz, 2H), 2.19 (t, J = 5.9 Hz, 1H), 1.70 (t, 
J = 6.3 Hz, 2H), 1.23 (s, 6H), 0.14 (s, 9H). 
13C-NMR (101 MHz, CDCl3, ppm):δ = 114.3, 84.9, 60.5, 45.4, 30.0, 29.6, 0.0. 
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FT-IR (ATR, cm−1): �̃ = 3338, 2966, 2162, 1364, 1250, 1062, 1028, 992, 952, 928, 884, 838, 758, 738, 
698. 
MS (EI, 70 eV): m/z (%) = 169 (18), 151 (13), 141 (12), 140 (82), 139 (13), 123 (21), 99 (17), 97 (61), 
75 (100), 73 (35). 
HR-MS (EI, 70 eV): [C10H19OSi], calcd.: 183.1205; found: 183.1206 ([M−H]+). 
 
Bromide S6. A dry and argon-flushed flask was charged with a solution of PPh3 (1.38 g, 5.26 mmol, 
2.0 equiv.) and alcohol S5 (485 mg, 2.63 mmol, 1.0 equiv.) in dichloromethane (4.0 mL). CBr4 (1.74 g, 
5.26 mmol, 2.0 equiv.) was added slowly at −78 °C. The reaction mixture was allowed to stir at room 
temperature for 2 h. A mixture of hexane:diethyl ether (4:1) was added and the solution was filtered 
through a pad of silica gel. The crude product was purified by column chromatography on silica using 
pentane as an eluent to afford bromide S6 as a colourless oil (92%, 597 mg, 2.42 mmol). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 3.55 – 3.46 (m, 2H), 2.02 – 1.93 (m, 2H), 1.21 (s, 6H), 0.14 
(s, 9H). 
13C-NMR (101 MHz, CDCl3, ppm):δ = 112.1, 84.9, 46.3, 32.6, 29.1, 29.1, 0.2. 
FT-IR (ATR, cm−1): �̃ = 2968, 2158, 1450, 1364, 1302, 1250, 1238, 936, 838, 758, 698, 658. 
MS (EI, 70 eV): m/z (%) = 233 (32), 231 (31), 163 (10), 161 (10), 151 (11), 139 (100), 137 (93), 97 
(32). 
HR-MS (EI, 70 eV): [C10H19BrSi], calcd.: 246.0439; found: 246.0430 (M+). 
 
Alcohol S7. A dry and argon-flushed flask was charged with dry LiCl (113 mg, 2.66 mmol, 1.1 equiv.) 
and magnesium turnings (71 mg, 2.90 mmol, 1.2 equiv.) in THF (4.0 mL). A solution of bromide S6 
(598 mg, 2.42 mmol, 1.0 equiv.) in THF (0.8 mL) was added slowly at 0 °C. The reaction mixture was 
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allowed to stir at room temperature for 2 h. Following titration with iodine at 0 °C gave a concentration 
of 0.30 M for the corresponding Grignard reagent. 
Following TP1, the Grignard reagent (0.30 M, 4.60 mL, 1.38 mmol, 1.1 equiv.) reacts with propylene 
oxide (73 mg, 1.25 mmol, 1.0 equiv.) using CuI (24 mg, 0.125 mmol, 10 mol%) to prepare S7 at 0 °C. 
The solution was stirred at this temperature overnight and was worked-up as usual. The crude product 
was purified by column chromatography on silica using hexane:diethyl ether (2:1) as an eluent to afford 
S7 as a colourless oil (82%, 256 mg, 1.13 mmol). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 3.83 (h, J = 6.2 Hz, 1H), 1.58 – 1.35 (m, 7H), 1.21 (d, 
J = 6.2 Hz, 3H), 1.18 (s, 3H), 1.18 (s, 3H), 0.13 (s, 9H). 
13C-NMR (101 MHz, CDCl3, ppm):δ = 114.8, 83.3, 68.0, 43.1, 39.6, 31.8, 29.2, 29.1, 23.4, 21.5, 0.3. 
FT-IR (ATR, cm−1): �̃ = 3346, 2966, 2940, 2868, 2160, 1458, 1362, 1250, 1124, 952, 918, 838, 758, 
696. 
MS (EI, 70 eV): m/z (%) = 140 (11), 135 (21), 125 (24), 123 (17), 121 (10), 107 (14), 97 (68), 93 (20), 
75 (100), 73 (65). 
HR-MS (EI, 70 eV): [C12H23OSi], calcd.: 211.1518; found: 211.1510 ([M−Me]+). 
11.2 Iodination 
 
Iodide rac-(2R,3R)-40a. Following TP2, rac-(2S,3R)-42a (1.20 g, 6.05 mmol, 1.0 equiv.) was used as 
starting material. The crude product was purified by column chromatography on silica using 
pentane:diethyl ether (200:1) as an eluent to afford rac-(2R,3R)-40a as a colourless oil (63%, 1.17 g, 
3.80 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 4.38 (qd, J = 7.0, 2.7 Hz, 1H), 2.26 (td, J = 7.2, 2.5 Hz, 2H), 
1.91 (d, J = 7.0 Hz, 3H), 1.61 – 1.42 (m, 2H), 1.04 – 0.94 (m, 1H), 0.92 (d, J = 5.8 Hz, 3H), 0.14 (s, 
9H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 106.7, 85.3, 40.2, 39.7, 36.0, 26.7, 17.4, 17.0, 0.3. 
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FT-IR (ATR, cm−1): �̃ = 2961, 2860, 2175, 1444, 1380, 1307, 1248, 1192, 1182, 1115, 1054, 1042, 
1019, 1007, 988, 954, 836, 758, 698. 
MS (EI, 70 eV): m/z (%) = 185 (14), 121 (15), 107 (26), 74 (12), 73 (39), 73 (100), 73 (68), 59 (13). 
HR-MS (EI, 70 eV): [C11H21ISi], calcd.: 308.0457; found: 308.0453 (M+). 
 
Iodide rac-(2R,3S)-40a. Following TP2, rac-(2S,3S)-42a (1.47 g, 7.41 mmol, 1.0 equiv.) was used as 
starting material. The crude product was purified by column chromatography on silica using 
pentane:diethyl ether (200:1) as an eluent to afford rac-(2R,3S)-40a as a colourless oil (51%, 1.17 g, 
3.80 mmol, d.r.>99:1). 
 
1H-NMR (599 MHz, CDCl3, ppm): δ = 4.35 (qd, J = 7.0, 3.4 Hz, 1H), 2.33 (ddd, J = 17.0, 7.7, 5.4 Hz, 
1H), 2.21 (ddd, J = 17.0, 8.3, 7.3 Hz, 1H), 1.87 (d, J = 7.0 Hz, 3H), 1.73 (dtd, J = 13.2, 7.9, 3.7 Hz, 
1H), 1.48 – 1.39 (m, 1H), 1.39 – 1.31 (m, 1H), 1.01 (d, J = 6.5 Hz, 3H), 0.15 (s, 9H). 
13C-NMR (151 MHz, CDCl3, ppm): δ = 106.9, 85.2, 40.8, 39.1, 33.2, 25.2, 18.7, 17.9, 0.3. 
FT-IR (ATR, cm−1): �̃ = 2961, 2861, 2175, 1441, 1380, 1295, 1248, 1182, 1162, 1103, 1052, 1041, 
987, 974, 837, 758, 698. 
MS (EI, 70 eV): m/z (%) = 185 (12), 121 (11), 107 (19), 73 (100). 
HR-MS (EI, 70 eV): [C11H21ISi], calcd.: 308.0457; found: 308.0448 (M+). 
 
Iodide rac-(2R,4R)-40b. A dry and argon flushed Schlenk-flask was charged with iodine (914 mg, 
3.60 mmol, 1.2 equiv.) and dichloromethane (30 mL). PPh3 (944 mg, 3.60 mmol, 1.2 equiv.) was added 
at 0 °C and the resulting yellow suspension was stirred for 1 h at this temperature. Then, 
N-methylimidazole (248 µL, 3.60 mmol, 1.2 equiv.) was added. After 10 min, rac-(2S,4R)-42b (1.50 g, 
3.00 mmol, 1.0 equiv.) in dichloromethane (5 mL) was added dropwise and the reaction mixture was 
stirred for 30 min at 0 °C. The reaction mixture was quenched with saturated aqueous NaHSO3∙Na2S2O5 
solution, the phases were separated and the aqueous phase was extracted with dichloromethane. The 
combined organic layers were dried over MgSO4 and the solvents were evaporated at 30 °C. The residue 
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was triturated three times with a mixture of hexane:diethyl ether (3:1). The residue was filtered off using 
a plug of silica and all organic phases were combined. All solvents were evaporated and the crude 
product was purified by column chromatography on silica using hexane:diethyl ether (70:1) as an eluent 
to afford rac-(2R,4R)-40b as a colourless solid (82%, 1.50 g, 2.46 mmol, d.r.>99:1). 
 
m.p.: 89.0 – 89.8 °C. 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.67 (dd, J = 7.9, 1.6 Hz, 6H), 7.47 – 7.34 (m, 9H), 4.28 (dqd, 
J = 13.7, 6.8, 2.5 Hz, 1H), 4.12 – 4.03 (m, 1H), 2.63 – 2.54 (m, 2H), 2.24 (ddd, J = 14.8, 11.4, 2.0 Hz, 
1H), 1.97 (d, J = 6.9 Hz, 3H), 1.84 – 1.65 (m, 1H), 0.89 (s, 9H), 0.18 (s, 3H), 0.14 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 135.7, 133.9, 129.9, 128.0, 108.4, 82.5, 71.3, 49.8, 29.9, 29.5, 
28.2, 26.0, 18.1, −4.0, −4.1. 
FT-IR (ATR, cm−1): �̃ = 2955, 2929, 2855, 2173, 1484, 1468, 1428, 1374, 1363, 1257, 1221, 1163, 
1127, 1111, 1104, 1057, 1032, 1004, 981, 929, 899, 836, 823, 806, 775, 740, 706, 696, 677. 
MS (EI, 70 eV): m/z (%) = 425 (49), 259 (21), 185 (100), 105 (10), 73 (30). 
HR-MS (EI, 70 eV): [C27H30OISi2], calcd.: 553.0880; found: 553.0879 ([M−t-Bu]+). 
 
Iodide rac-(2R,4S)-40b. A dry and argon flushed Schlenk-flask was charged with iodine (1.52 mg, 
5.99 mmol, 1.2 equiv.) and dichloromethane (50 mL). PPh3 (1.57 g, 5.99 mmol, 1.2 equiv.) was added 
at 0 °C and the resulting yellow suspension was stirred for 1 h at this temperature. Then, 
N-methylimidazole (474 µL, 6.00 mmol, 1.2 equiv.) was added. After 10 min, rac-(2S,4S)-42b (2.50 g, 
4.99 mmol, 1.0 equiv.) in dichloromethane (5 mL) was added dropwise and the reaction mixture was 
stirred for 30 min at 0 °C. The reaction mixture was quenched with saturated aqueous NaHSO3∙Na2S2O5 
solution, the phases were separated and the aqueous phase was extracted with dichloromethane. The 
combined organic layers were dried over MgSO4 and the solvents were evaporated at 30 °C. The residue 
was triturated three times with a mixture of hexane:diethyl ether (3:1). The residue was filtered off using 
a plug of silica and all organic phases were combined. All solvents were evaporated and the crude 
product was purified by column chromatography on silica using hexane:diethyl ether (70:1) as an eluent 
to afford rac-(2R,4S)-40b as a colourless oil (78%, 2.38 g, 3.90 mmol, d.r.>99:1). 
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1H-NMR (400 MHz, CDCl3, ppm): δ = 7.70 (d, J = 6.3 Hz, 6H), 7.50 – 7.36 (m, 9H), 4.27 (h, 
J = 6.9 Hz, 1H), 4.05 (p, J = 5.7 Hz, 1H), 2.61 (d, J = 5.1 Hz, 2H), 2.30 (qt, J = 14.4, 7.2 Hz, 1H), 2.19 
(dt, J = 14.0 and 6.4, 1H), 1.92 (d, J = 6.8 Hz, 3H), 0.93 (s, 9H), 0.13 (s, 6H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 135.6, 133.9, 130.0, 128.1, 108.0, 82.5, 70.5, 49.8, 28.8, 28.4, 
25.9, 24.3, 18.1, −4.3, −4.5. 
FT-IR (ATR, cm−1): �̃ = 2953, 2928, 2894, 2856, 2178, 1484, 1471, 1462, 1428, 1377, 1360, 1255, 
1211, 1112, 1085, 1029, 998, 982, 937, 921, 835, 804, 775, 739, 707, 696. 
MS (EI, 70 eV): m/z (%) = 425 (50), 357 (19), 305 (14), 283 (13), 259 (32), 218 (36), 185 (100), 105 
(10), 73 (52). 
HR-MS (EI, 70 eV): [C27H30OISi2], calcd.: 553.0880; found: 553.0877 ([M−t-Bu]+). 
 
Iodide syn-40c. Following TP2, anti-42c (636 mg, 3.02 mmol, 1.0 equiv.) was used as starting 
material. The crude product was purified by column chromatography on silica using pentane:diethyl 
ether (300:1) as an eluent to afford syn-40c as a colourless oil (92%, 894 mg, 2.79 mmol, d.r.>99:1). 
 
1H-NMR (599 MHz, CDCl3, ppm): δ = 4.57 (t, J = 4.4 Hz, 1H), 2.38 – 2.18 (m, 4H), 2.01 – 1.91 (m, 
1H), 1.82 – 1.74 (m, 1H), 1.74 – 1.62 (m, 2H), 1.55 (dq, J = 14.0, 7.2 Hz, 1H), 1.43 (dtd, J = 12.3, 11.0, 
6.2 Hz, 1H), 1.14 – 1.04 (m, 1H), 0.14 (s, 9H). 
13C-NMR (151 MHz, CDCl3, ppm): δ = 106.9, 85.0, 45.9, 44.6, 39.1, 35.4, 28.9, 21.8, 18.5, 0.3. 
FT-IR (ATR, cm−1): �̃ = 2957, 2852, 2174, 1447, 1441, 1336, 1324, 1308, 1291, 1248, 1224, 1200, 
1159, 1046, 1021, 999, 905, 836, 758, 697, 667. 
MS (EI, 70 eV): m/z (%) = 119 (17), 73 (100). 
HR-MS (EI, 70 eV): [C12H21ISi], calcd.: 320.0457; found: 320.0471 (M+). 
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Iodide anti-40c. Following TP2, syn-42c (401 mg, 1.91 mmol, 1.0 equiv.) was used as starting 
material. The crude product was purified by column chromatography on silica using pentane:diethyl 
ether (300:1) as an eluent to afford anti-40c as a colourless oil (43%, 260 mg, 0.812 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 3.76 (q, J = 7.9 Hz, 1H), 2.38 – 2.15 (m, 4H), 2.13 – 2.02 (m, 
1H), 2.02 – 1.90 (m, 1H), 1.90 – 1.80 (m, 1H), 1.80 – 1.70 (m, 1H), 1.70 – 1.57 (m, 1H), 1.42 – 1.28 
(m, 1H), 1.27 – 1.14 (m, 1H), 0.15 (s, 9H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 106.8, 84.8, 50.9, 39.0, 32.8, 32.0, 29.2, 23.7, 18.5, 0.1. 
FT-IR (ATR, cm−1): �̃ = 2958, 2872, 2175, 1449, 1328, 1248, 1190, 1113, 1038, 1000, 907, 836, 758, 
697. 
MS (EI, 70 eV): m/z (%) = 193 (10), 185 (17), 119 (30), 73 (100), 59 (11). 
HR-MS (EI, 70 eV): [C12H21ISi], calcd.: 320.0457; found: 320.0451 (M+). 
 
Iodide syn-40d. Following TP2, anti-42d (1.59 g, 7.08 mmol, 1.0 equiv.) was used as starting material. 
The crude product was purified by column chromatography on silica using pentane:diethyl ether (300:1) 
as an eluent to afford syn-40d as a colourless oil (45%, 1.07 g, 3.20 mmol, d.r.>99:1). 
 
1H-NMR (599 MHz, CDCl3, ppm): δ = 4.77 – 4.70 (m, 1H), 2.27 – 2.17 (m, 3H), 1.81 – 1.70 (m, 3H), 
1.62 – 1.54 (m, 1H), 1.52 – 1.44 (m, 2H), 1.44 – 1.24 (m, 3H), 0.71 – 0.62 (m, 1H), 0.15 (s, 9H). 
13C-NMR (151 MHz, CDCl3, ppm): δ = 106.8, 85.3, 47.2, 41.3, 36.8, 36.5, 28.8, 25.6, 22.9, 16.7, 0.3. 
FT-IR (ATR, cm−1): �̃ = 2931, 2855, 2835, 2174, 1458, 1445, 1433, 1356, 1312, 1297, 1248, 1191, 
1180, 1154, 1065, 1041, 994, 966, 912, 896, 886, 865, 836, 758, 697. 
MS (EI, 70 eV): m/z (%) = 207 (29), 185 (10), 147 (22), 133 (27), 91 (14), 73 (100), 59 (11). 
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HR-MS (EI, 70 eV): [C13H23ISi], calcd.: 334,0614; found: 334.0608 (M+). 
 
Iodide syn-40e. Following TP2, anti-42e (1.81 g, 6.63 mmol, 1.0 equiv.) was used as starting material. 
The crude product was purified by column chromatography on silica using pentane:diethyl ether (200:1) 
as an eluent to afford syn-40e as a sticky yellow oil (3%, 67 mg, 0.175 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.44 (dd, J = 7.5, 1.2 Hz, 1H), 7.31 (td, J = 7.6, 1.5 Hz, 1H), 
7.18 (td, J = 7.5, 1.3 Hz, 1H), 7.13 (d, J = 8.0 Hz, 1H), 5.26 – 5.19 (m, 1H), 2.59 (dt, J = 12.1, 2.8 Hz, 
1H), 2.36 – 2.26 (m, 1H), 2.05 (qd, J = 12.6, 3.5 Hz, 1H), 1.99 – 1.84 (m, 3H), 1.75 – 1.63 (m, 2H), 
1.62 – 1.48 (m, 1H), 0.27 (s, 9H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 146.9, 132.5, 128.5, 127.0, 126.5, 122.1, 103.6, 99.1, 47.4, 
46.3, 37.1, 27.3, 26.4, 22.3, 0.2. 
FT-IR (ATR, cm−1): �̃ = 2932, 2858, 2152, 1480, 1446, 1432, 1294, 1248, 1224, 1180, 1156, 1042, 
988, 902, 890, 858, 838, 754, 734, 698. 
MS (EI, 70 eV): m/z (%) = 256 (19), 255 (92), 196 (13), 195 (100), 185 (13), 185 (10), 181 (23), 167 
(11), 165 (12), 73 (28). 
HR-MS (EI, 70 eV): [C17H23ISi], calcd.: 382.0614; found: 382.0602 (M+). 
 
Iodide R-40f. Following TP2, S-42f (855 mg, 4.64 mmol, 1.0 equiv.) was used as starting material. The 
crude product was purified by column chromatography on silica using pentane:diethyl ether (200:1) as 
an eluent to afford R-40f as a colourless oil (90%, 1.23 g, 4.19 mmol, e.r.(R:S) = 98:2VIII). 
 
                                                     
VIII Flow rate = 2.1 mL/min; T = 80 °C; average velocity = 60; hold 80 °C for 20 min, 2 °C/min heating rate to 
140 °C and holding for 10 min. Retention times: 48.1 min (minor), 48.3 min (major). 
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1H-NMR (400 MHz, CDCl3, ppm): δ = 4.28 – 4.15 (m, 1H), 2.31 – 2.21 (m, 2H), 1.96 – 1.84 (m, 4H), 
1.80 – 1.68 (m, 2H), 1.67 – 1.55 (m, 1H), 0.15 (s, 9H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 106.7, 85.3, 41.9, 29.5, 29.1, 28.7, 19.1, 0.3. 
FT-IR (ATR, cm−1): �̃ = 2958, 2900, 2864, 2834, 2174, 1444, 1430, 1408, 1378, 1326, 1298, 1274, 
1248, 1218, 1204, 1186, 1138, 1116, 1090, 1056, 1032, 1022, 992, 972, 922, 906, 836, 758, 698. 
MS (EI, 70 eV): m/z (%) = 185 (43), 127 (22), 93 (20), 75 (34), 73 (100). 
HR-MS (EI, 70 eV): [C10H19ISi], calcd.: 294.0301; found: 294.0293 (M+). [�] ���  = –39° (c = 0.94, CH2Cl2). 
 
Iodide S-40f. Following TP2, S-42f (313 mg, 1.70 mmol, 1.0 equiv.) was used as starting material. The 
crude product was purified by column chromatography on silica using pentane:diethyl ether (200:1) as 
an eluent to afford S-40f as a colourless oil (88%, 442 mg, 1.50 mmol, e.r.(R:S) = 97:3IX). 
 
1H-NMR (599 MHz, CDCl3, ppm): δ = 4.26 – 4.16 (m, 1H), 2.30 – 2.22 (m, 2H), 1.94 (d, J = 6.8 Hz, 
3H), 1.92 – 1.86 (m, 1H), 1.79 – 1.69 (m, 2H), 1.65 – 1.57 (m, 1H), 0.15 (s, 9H). 
13C-NMR (151 MHz, CDCl3, ppm): δ = 106.7, 85.3, 41.9, 29.6, 29.1, 28.7, 19.1, 0.3. 
FT-IR (ATR, cm−1): �̃ = 2958, 2863, 2174, 1444, 1378, 1326, 1298, 1248, 1218, 1187, 1139, 1116, 
1090, 1032, 992, 972, 905, 837, 758, 698. 
MS (EI, 70 eV): m/z (%) = 184 (15), 93 (12), 73 (100). 
HR-MS (EI, 70 eV): [C10H19ISi], calcd.: 294.0301; found: 294.0297 (M+). [�] ���  = 42° (c = 1.0, CH2Cl2). 
                                                     
IX Flow rate = 2.1 mL/min; T = 80 °C; average velocity = 60; hold 80 °C for 20 min, 2 °C/min heating rate to 
140 °C and holding for 10 min. Retention times: 48.1 min (major), 48.4 min (minor). 
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Iodide 61a. Alcohol S4 (535 mg, 4.239 mmol, 1.0 equiv.) in THF (4.2 mL) was treated with n-BuLi 
(2.62 M, 3.3 mL, 8.69 mmol, 2.05 equiv.) at −78 °C and stirred for 1 h at this temperature. TMSCl 
(1.13 mL, 8.69 mmol, 2.05 equiv.) was added. The reaction mixture was allowed to warm to room 
temperature and was stirred for 30 min. HCl (2 N, 4.2 mL) was added and the solution as stirred 
overnight. The reaction mixture was neutralised with saturated aqueous NaHCO3 solution. The phases 
were separated and the aqueous phase was extracted with diethyl ether. The combined organic layers 
were dried over MgSO4 and the solvents were evaporated. 
Following TP2, the crude material without further purification. The crude product was purified by 
column chromatography on silica using hexane:diethyl ether (100:1) as an eluent to afford 61a as a 
colourless oil (88%, 1.12 g, 3.62 mmol). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 4.22 – 4.14 (m, 1H), 2.27 – 2.19 (m, 2H), 1.93 (d, J = 6.8 Hz, 
3H), 1.90 – 1.80 (m, 1H), 1.69 – 1.43 (m, 5H), 0.15 (s, 9H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 107.0, 84.8, 42.2, 30.0, 28.8, 28.8, 27.6, 19.7, 0.1. 
FT-IR (ATR, cm−1): �̃ = 2938, 2860, 2174, 1444, 1378, 1248, 1136, 1042, 930, 838, 758, 696. 
MS (EI, 70 eV): m/z (%) = 278 (11), 277 (29), 262 (28), 185 (25), 183 (28), 107 (20), 73 (100), 58 (16), 
43 (31). 
HR-MS (EI, 70 eV): [C11H21ISi], calcd.: 308.0457; found: 308.0444 (M+). 
 
Iodide 61b. Following TP2, S7 (203 mg, 0.896 mmol, 1.0 equiv.) was used as starting material. The 
crude product was purified by column chromatography on silica using hexane as an eluent to afford 61b 
as a colourless oil (94%, 284 mg, 0.844 mmol). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 4.28 – 4.17 (m, 1H), 1.93 (d, J = 6.8 Hz, 3H), 1.92 – 1.82 (m, 
1H), 1.70 – 1.58 (m, 2H), 1.57 – 1.48 (m, 1H), 1.46 – 1.31 (m, 2H), 1.18 (s, 6H), 0.14 (s, 9H). 
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13C-NMR (101 MHz, CDCl3, ppm): δ = 114.4, 83.5, 43.1, 42.2, 31.7, 30.3, 29.2, 29.0, 28.8, 25.5, 0.3. 
FT-IR (ATR, cm−1): �̃ = 2962, 2162, 1446, 1378, 1362, 1248, 1202, 1192, 1178, 950, 928, 890, 838, 
758, 696. 
MS (EI, 70 eV): m/z (%) = 185 (39), 136 (10), 135 (100), 123 (12), 109 (10), 107 (33), 97 (47), 93 (18), 
75 (52), 73 (81). 
HR-MS (EI, 70 eV): [C10H15], calcd.: 135.1174; found: 135.1168 ([M−I−SiMe3−H]+). 
11.3 Intramolecular Carbolithiations 
 
Cyclopentane syn-49a. Following TP3, syn-40a (91 mg, 0.295 mmol, 1.0 equiv., d.r.>99:1) reacted 
with t-BuLi (2.08 M, 0.35 mL, 0.738 mmol, 2.5 equiv.) and I2 (188 mg, 0.738 mmol, 2.5 equiv.) in 
diethyl ether (1.0 mL). The crude product was purified by column chromatography on silica using 
pentane as an eluent to afford syn-49a as a colourless oil (71%, 64 mg, 0.208 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, C6D6, ppm): δ = 2.94 (dq, J = 7.1 Hz, 1H), 2.31 (ddt, J = 17.4, 9.2, 1.4 Hz, 1H), 
2.10 (ddd, J = 17.5, 10.7, 8.4 Hz, 1H), 1.81 (tq, J = 12.3, 6.1, 5.7 Hz, 1H), 1.76 – 1.67 (m, 1H), 
1.41 – 1.25 (m, 1H), 0.94 (d, J = 7.2 Hz, 3H), 0.78 (d, J = 6.7 Hz, 3H), 0.26 (s, 9H). 
13C-NMR (101 MHz, C6D6, ppm): δ = 168.4, 99.7, 53.8, 36.7, 33.7, 32.7, 14.9, 11.1, 1.2. 
FT-IR (ATR, cm−1): �̃ = 2957, 2871, 1592, 1463, 1431, 1405, 1378, 1368, 1352, 1284, 1261, 1247, 
1159, 1073, 1032, 966, 940, 909, 867, 833, 755, 746, 688, 654. 
MS (EI, 70 eV): m/z (%) = 308 (13), 184 (15), 180 (13), 107 (18), 73 (100). 
HR-MS (EI, 70 eV): [C11H21ISi], calcd.: 308.0457; found: 308.0452 (M+). 
 
Cyclopentane anti-49a. Following TP3, anti-40a (91 mg, 0.295 mmol, 1.0 equiv., d.r.>99:1) reacted 
with t-BuLi (1.96 M, 0.38 mL, 0.738 mmol, 2.5 equiv.) and I2 (188 mg, 0.738 mmol, 2.5 equiv.) in THF 
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(1.0 mL). The crude product was purified by column chromatography on silica using pentane as an 
eluent to afford anti-49a as a colourless oil (77%, 70 mg, 0.227 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, C6D6, ppm): δ = 2.61 – 2.48 (m, 1H), 2.39 – 2.27 (m, 1H), 2.14 (dddd, J = 16.5, 
8.4, 6.6, 1.6 Hz, 1H), 1.78 (ddt, J = 12.6, 8.6, 6.5 Hz, 1H), 1.61 – 1.48 (m, 1H), 1.29 – 1.15 (m, 1H), 
1.15 (d, J = 7.1 Hz, 3H), 0.79 (d, J = 6.9 Hz, 3H), 0.26 (s, 9H). 
13C-NMR (101 MHz, C6D6, ppm): δ = 167.6, 100.7, 56.7, 40.7, 33.8, 32.6, 19.8, 18.6, 1.2. 
FT-IR (ATR, cm−1): �̃ = 2952, 2925, 2869, 1594, 1454, 1434, 1405, 1369, 1304, 1262, 1247, 1179, 
1090, 1006, 988, 922, 910, 865, 834, 755, 688. 
MS (EI, 70 eV): m/z (%) = 308 (12), 184 (13), 181 (11), 107 (17), 73 (100). 
HR-MS (EI, 70 eV): [C11H21ISi], calcd.: 308.0457; found: 308.0456 (M+). 
 
Cyclopentane anti-50. A dry and argon-flushed Schlenk-tube was charged with CuI (123 mg, 
0.633 mmol, 3.0 equiv.) and THF (1.3 mL). A lithium thiophenolate solution (1.16 M in THF, 0.55 mL, 
0.633 mmol, 3.0 equiv.) was added and the reaction mixture was stirred for 5 min. After cooling to 
−78 °C, n-BuLi (2.62 M in hexane, 0.24 mL, 0.627 mmol, 2.97 equiv) was added. After 5 min at 
−78 °C, a precooled solution of anti-49a (65 mg, 0.211 mmol, 1.0 equiv.) in THF (1.0 mL) was 
injected. The reaction mixture was stirred at −5 °C for 45 h. Saturated aqueous NH4Cl solution was 
added, the phases were separated and the aqueous phase was extracted with diethyl ether. The combined 
organic layers were dried over MgSO4. The solvents were evaporated and the crude product was 
purified by column chromatography on silica using pentane as an eluent to afford anti-50 as a colourless 
oil (80%, 40 mg, 0.168 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, C6D6, ppm): δ = 2.46 – 2.34 (m, 2H), 2.34 – 2.24 (m, 2H), 2.22 – 2.11 (m, 1H), 
1.84 (ddt, J = 12.4, 8.5, 6.3 Hz, 1H), 1.65 – 1.53 (m, 1H), 1.44 – 1.34 (m, 4H), 1.19 (dtd, J = 12.4, 7.2, 
5.3 Hz, 1H), 1.05 (d, J = 7.0 Hz, 3H), 0.94 (t, J = 7.2 Hz, 3H), 0.90 (d, J = 6.9 Hz, 3H), 0.23 (s, 9H). 
13C-NMR (101 MHz, C6D6, ppm): δ = 159.0, 130.8, 45.2, 41.3, 33.9, 33.3, 32.2, 31.6, 23.5, 20.9, 20.5, 
14.4, 0.5. 
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FT-IR (ATR, cm−1): �̃ = 2952, 2926, 2870, 1612, 1456, 1404, 1372, 1246, 1056, 1004, 896, 856, 830, 
754, 708, 684. 
MS (EI, 70 eV): m/z (%) = 238 (14), 223 (21), 164 (83), 149 (18), 139 (10), 121 (17), 108 (15), 95 (21), 
73 (100). 
HR-MS (EI, 70 eV): [C15H30Si], calcd.: 238.2117; found: 238.2129 (M+). 
 
Cyclopentane syn-49b. Following TP3, syn-40a (91 mg, 0.295 mmol, 1.0 equiv., d.r.>99:1) reacted 
with t-BuLi (2.21 M, 0.33 mL, 0.738 mmol, 2.5 equiv.) and ClCO2Et (80 mg, 0.738 mmol, 2.5 equiv.). 
The crude product was purified by column chromatography on silica using pentane:diethyl ether (30:1) 
as an eluent to afford syn-49b as a colourless oil (65%, 49 mg, 0.193 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, C6D6, ppm): δ = 4.16 – 4.01 (m, 2H), 3.09 (dq, J = 7.2 Hz, 1H), 2.40 (ddt, 
J = 17.9, 9.3, 1.7 Hz, 1H), 2.21 (ddd, J = 17.9, 10.2, 8.6 Hz, 1H), 1.87 – 1.71 (m, 1H), 1.59 – 1.47 (m, 
1H), 1.25 (tdd, J = 12.3, 9.9, 9.1 Hz, 1H), 1.05 (t, J = 7.1 Hz, 3H), 1.00 (d, J = 7.3 Hz, 3H), 0.81 (d, 
J = 6.8 Hz, 3H), 0.25 (s, 9H). 
13C-NMR (101 MHz, C6D6, ppm): δ = 171.5, 169.2, 127.6, 59.8, 44.1, 37.4, 32.3, 30.8, 15.0, 14.5, 
13.7, −0.1. 
FT-IR (ATR, cm−1): �̃ = 2958, 2902, 2874, 1708, 1612, 1464, 1450, 1428, 1378, 1368, 1282, 1248, 
1224, 1188, 1140, 1096, 1074, 1040, 1014, 998, 980, 960, 916, 878, 834, 794, 782, 758, 716, 692. 
MS (EI, 70 eV): m/z (%) = 238 (15), 224 (10), 223 (100), 109 (16), 195 (14), 193 (19), 179 (17), 103 
(11), 75 (26), 73 (13). 
HR-MS (EI, 70 eV): [C14H26O2Si], calcd.: 254.1702; found: 254.1696 (M+). 
 
Cyclopentane anti-49b. Following TP3, anti-40a (91 mg, 0.295 mmol, 1.0 equiv., d.r.>99:1) reacted 
with t-BuLi (2.09 M, 0.35 mL, 0.738 mmol, 2.5 equiv.) and ClCO2Et (80 mg, 0.738 mmol, 2.5 equiv.). 
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The crude product was purified by column chromatography on silica using pentane:diethyl ether (20:1) 
as an eluent to afford anti-49b as a colourless oil (77%, 58 mg, 0.228 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, C6D6, ppm): δ = 4.16 – 4.00 (m, 2H), 2.69 – 2.57 (m, 1H), 2.38 (ddd, J = 17.0, 
7.7, 5.5 Hz, 1H), 2.22 (dddd, J = 16.9, 8.6, 7.7, 2.0 Hz, 1H), 1.71 (ddt, J = 11.9, 8.7, 5.8 Hz, 1H), 1.47 
(dq, J = 13.2, 6.7 Hz, 1H), 1.15 (d, J = 7.0 Hz, 3H), 1.12 – 1.01 (m, 4H), 0.83 (d, J = 6.8 Hz, 3H), 0.25 
(s, 9H). 
13C-NMR (101 MHz, C6D6, ppm): δ = 171.5, 167.6, 128.1, 59.8, 47.7, 41.6, 32.1, 32.0, 19.7, 19.7, 
14.5, –0.1. 
FT-IR (ATR, cm−1): �̃ = 2954, 2871, 1708, 1612, 1457, 1374, 1365, 1248, 1224, 1198, 1178, 1145, 
1096, 1040, 1006, 970, 877, 835, 760, 693. 
MS (EI, 70 eV): m/z (%) = 254 (14), 239 (24), 238 (43), 224 (17), 223 (100), 209 (28), 195 (13), 193 
(23), 121 (12), 103 (40), 95 (20), 75 (43), 73 (47). 
HR-MS (EI, 70 eV): [C14H26O2Si], calcd.: 254.1702; found: 254.1697 (M+). 
 
Cyclopentane syn-49c. Following TP3, syn-40a (91 mg, 0.295 mmol, 1.0 equiv., d.r.>99:1) reacted 
with t-BuLi (2.16 M, 0.34 mL, 0.738 mmol, 2.5 equiv.) and benzophenone (134 mg, 0.738 mmol, 
2.5 equiv.) in diethyl ether (1.0 mL). The crude product was purified by column chromatography on 
silica using pentane:diethyl ether (40:1) as an eluent to afford syn-49c as a colourless solid (65%, 70 mg, 
0.192 mmol, d.r.>99:1). Recrystallization of the product from pentane gave crystals suitable for single 
crystal X-ray diffraction analysis. 
 
m.p.: 76.4 – 84.6 °C. 
1H-NMR (400 MHz, C6D6, ppm): δ = 7.46 – 7.40 (m, 2H), 7.32 – 7.26 (m, 2H), 7.16 – 7.12 (m, 2H), 
7.11 – 7.02 (m, 4H), 2.73 – 2.51 (m, 2H), 2.37 (s, 1H), 1.78 – 1.54 (m, 3H), 1.28 – 1.08 (m, 1H), 0.67 
(d, J = 6.4 Hz, 3H), 0.32 (d, J = 6.9 Hz, 3H), 0.30 (s, 9H). 
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13C-NMR (101 MHz, C6D6, ppm): δ = 161.6, 148.9, 148.7, 138.3, 128.9, 128.5, 128.2, 127.9, 127.4, 
127.3, 85.1, 42.2, 37.0, 32.7, 29.2, 15.5, 11.7, 4.1. 
FT-IR (ATR, cm−1): �̃ = 3578, 3462, 3058, 2966, 2938, 2894, 2872, 1584, 1488, 1468, 1444, 1412, 
1376, 1370, 1318, 1296, 1284, 1260, 1242, 1220, 1178, 1158, 1080, 1072, 1024, 1016, 990, 982, 962, 
936, 918, 906, 896, 866, 836, 764, 740, 700, 672. 
MS (EI, 70 eV): m/z (%) = 346 (21), 331 (15), 279 (12), 274 (12), 273 (16), 272 (16), 217 (21), 184 
(12), 183 (100), 178 (20), 135 (22), 105 (35), 77 (10), 75 (14), 73 (54). 
HR-MS (EI, 70 eV): [C24H32OSi], calcd.: 364.2222; found: 364.2219 (M+). 
 
Cyclopentane anti-49c. Following TP3, anti-40a (91 mg, 0.295 mmol, 1.0 equiv., d.r.>99:1) reacted 
with t-BuLi (2.21 M, 0.33 mL, 0.738 mmol, 2.5 equiv.) and benzophenone (134 mg, 0.738 mmol, 
2.5 equiv.) in diethyl ether (1.0 mL). The crude product was purified by column chromatography on 
silica using pentane:diethyl ether (40:1) as an eluent to afford syn-49c as a colourless oil (76%, 82 mg, 
0.225 mmol, d.r.>99:1). 
1H-NMR (400 MHz, C6D6, ppm): δ = 7.44 – 7.38 (m, 2H), 7.26 – 7.20 (m, 2H), 7.20 – 7.17 (m, 2H), 
7.14 – 7.08 (m, 1H), 7.03 – 6.98 (m, 3H), 2.62 (ddd, J = 15.7, 7.6, 4.8 Hz, 1H), 2.59 – 2.46 (m, 1H), 
2.41 (s, 1H), 1.82 – 1.70 (m, 1H), 1.39 – 1.26 (m, 1H), 1.24 – 1.14 (m, 1H), 1.04 (dtd, J = 12.2, 7.9, 
6.0 Hz, 1H), 0.66 (d, J = 6.8 Hz, 3H), 0.63 (d, J = 7.0 Hz, 3H), 0.26 (s, 9H). 
13C-NMR (101 MHz, C6D6, ppm): δ = 160.4, 149.7, 147.1, 139.9, 129.0, 128.8, 128.2, 127.9, 127.4, 
127.3, 84.9, 43.7, 41.6, 34.3, 31.6, 21.2, 20.6, 3.6. 
FT-IR (ATR, cm−1): �̃ = 3610, 3084, 3060, 3024, 2950, 2924, 2898, 2868, 1584, 1490, 1446, 1408, 
1370, 1280, 1260, 1246, 1180, 1158, 1094, 1082, 1048, 1030, 1002, 994, 976, 922, 898, 862, 832, 786, 
760, 742, 700, 676. 
MS (EI, 70 eV): m/z (%) = 346 (45), 331 (34), 279 (29), 274 (28), 273 (34), 272 (39), 217 (33), 183 
(100), 178 (23), 135 (20), 105 (28), 73 (52). 
HR-MS (EI, 70 eV): [C24H32OSi], calcd.: 364.2222; found: 364.2214 (M+). 
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Cyclopentane syn-49d. Following TP3, anti-40b (176 mg, 0.288 mmol, 1.0 equiv., d.r.>99:1) reacted 
with t-BuLi (2.22 M, 0.32 mL, 0.720 mmol, 2.5 equiv.) and was quenched with saturated aqueous 
NH4Cl solution. The crude product was purified by column chromatography on silica using 
hexane:diethyl ether (700:1) as an eluent to afford syn-49d as a colourless oil (99%, 138 mg, 
0.285 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.59 – 7.52 (m, 6H), 7.40 – 7.33 (m, 9H), 5.91 – 5.82 (m, 1H), 
4.04 (p, J = 6.7 Hz, 1H), 2.63 – 2.51 (m, 1H), 2.18 (dd, J = 17.4, 6.6 Hz, 1H), 2.12 – 2.03 (m, 1H), 
1.97 – 1.87 (m, 1H), 1.32 (dt, J = 12.3, 8.4 Hz, 1H), 1.25 (d, J = 6.8 Hz, 3H), 0.78 (s, 9H), −0.09 (s, 
3H), −0.15 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 170.3, 135.9, 135.8, 129.4, 128.0, 112.3, 72.4, 43.8, 43.5, 
40.0, 26.0, 20.4, 18.2, −4.7, −4.7. 
FT-IR (ATR, cm−1): �̃ = 3069, 3050, 2999, 2956, 2928, 2856, 1622, 1485, 1472, 1462, 1428, 1388, 
1369, 1362, 1332, 1304, 1255, 1188, 1157, 1110, 1052, 1030, 1006, 998, 938, 919, 874, 836, 808, 776, 
739, 699, 670, 656. 
MS (EI, 70 eV): m/z (%) = 427 (40), 349 (37), 333 (47), 271 (41), 269 (28), 260 (23), 259 (100), 258 
(24), 257 (92), 255 (56), 197 (21), 183 (49), 179 (23), 75 (39), 73 (28). 
HR-MS (EI, 70 eV): [C31H40OSi2], calcd.: 484.2618; found: 484.2601 (M+). 
 
Cyclopentane anti-49d. Following TP3, syn-40b (171 mg, 0.280 mmol, 1.0 equiv., d.r.>99:1) reacted 
with t-BuLi (2.15 M, 0.33 mL, 0.700 mmol, 2.5 equiv.) and was quenched with saturated aqueous 
NH4Cl solution. The crude product was purified by column chromatography on silica using 
hexane:diethyl ether (700:1) as an eluent to afford anti-49d as a colourless oil (55%, 75 mg, 
0.155 mmol, d.r.>99:1). Recrystallization of the product from hexane gave crystals suitable for single 
crystal X-ray diffraction analysis. 
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m.p.: 79.3 – 87.5 °C. 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.63 – 7.51 (m, 6H), 7.42 – 7.32 (m, 9H), 5.89 (q, J = 2.3 Hz, 
1H), 4.13 (tt, J = 4.9, 2.6 Hz, 1H), 3.00 – 2.84 (m, 1H), 2.14 – 1.97 (m, 2H), 1.89 (ddt, J = 12.5, 7.7, 
2.3 Hz, 1H), 1.39 – 1.27 (m, 1H), 1.19 (d, J = 7.0 Hz, 3H), 0.83 (s, 9H), -0.06 (s, 3H), -0.11 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 171.3, 135.9, 135.8, 129.3, 127.9, 111.6, 71.9, 44.2, 43.9, 
39.1, 26.0, 19.3, 18.2, −4.7, −4.7. 
FT-IR (ATR, cm−1): �̃ = 3069, 3049, 2955, 2927, 2856, 1616, 1471, 1462, 1428, 1409, 1373, 1361, 
1307, 1254, 1198, 1109, 1084, 1052, 1030, 1012, 998, 947, 924, 896, 835, 802, 774, 739, 699. 
MS (EI, 70 eV): m/z (%) = 271 (29), 259 (48), 257 (21), 255 (21), 207 (23), 199 (23), 183 (27), 181 
(26), 179 (41), 91 (21), 79 (28), 78 (78), 77 (31), 75 (100). 
HR-MS (EI, 70 eV): [C21H25OSi2], calcd.: 349.1444; found: 349.1434 ([M−H−Ph−t-Bu]+). 
 
Bicyclo[3.3.0]octane syn-51a. Following TP3, syn-40c (96 mg, 0.300 mmol, 1.0 equiv., d.r.>99:1) 
reacted with t-BuLi (1.96 M, 0.38 mL, 0.750 mmol, 2.5 equiv.) and I2 (191 mg, 0.750 mmol, 2.5 equiv.) 
in diethyl ether (1.0 mL). The crude product was purified by column chromatography on silica using 
pentane as an eluent to afford syn-51a as a colourless oil (63%, 61 mg, 0.190 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, C6D6, ppm): δ = 3.12 (dt, J = 8.4 Hz, 1H), 2.47 – 2.33 (m, 1H), 2.33 – 2.10 (m, 
3H), 1.72 – 1.54 (m, 2H), 1.54 – 1.44 (m, 1H), 1.44 – 1.27 (m, 3H), 1.22 – 1.07 (m, 1H), 0.27 (s, 9H). 
13C-NMR (101 MHz, C6D6, ppm): δ = 169.5, 100.4, 59.4, 43.2, 34.1, 33.7, 33.7, 32.8, 26.9, 1.4. 
FT-IR (ATR, cm−1): �̃ = 2946, 2864, 1596, 1448, 1432, 1405, 1313, 1260, 1246, 1204, 1176, 1084, 
936, 835, 810, 756, 733, 688. 
MS (EI, 70 eV): m/z (%) = 320 (12), 185 (14), 119 (50), 74 (15), 73 (100), 59 (25), 45 (21), 44 (12). 
HR-MS (EI, 70 eV): [C12H21ISi], calcd.: 320.0457; found: 320.0456 (M+). 
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Bicyclo[3.3.0]octane syn-51b. Following TP3, syn-40c (95 mg, 0.297 mmol, 1.0 equiv., d.r.>99:1) 
reacted with t-BuLi (1.96 M, 0.38 mL, 0.743 mmol, 2.5 equiv.) and ClCO2Et (81 mg, 0.743 mmol, 
2.5 equiv.). The crude product was purified by column chromatography on silica using pentane:diethyl 
ether (20:1) as an eluent to afford syn-51b as a colourless oil (56%, 44 mg, 0.165 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, C6D6, ppm): δ = 4.08 (qd, J = 7.1, 4.3 Hz, 2H), 3.35 (td, J = 9.0, 6.5 Hz, 1H), 
2.37 – 2.12 (m, 4H), 1.69 – 1.59 (m, 1H), 1.59 – 1.46 (m, 3H), 1.42 – 1.31 (m, 1H), 1.31 – 1.21 (m, 
1H), 1.21 – 1.11 (m, 1H), 1.06 (t, J = 7.2 Hz, 3H), 0.26 (s, 9H). 
13C-NMR (101 MHz, C6D6, ppm): δ = 171.4, 169.3, 127.2, 59.7, 50.3, 43.5, 35.2, 33.6, 33.6, 31.4, 
27.3, 14.5, 0.1. 
FT-IR (ATR, cm−1): �̃ = 2948, 2902, 2866, 1708, 1610, 1448, 1430, 1364, 1294, 1248, 1218, 1192, 
1170, 1096, 1048, 1038, 992, 936, 910, 836, 760, 718, 692. 
MS (EI, 70 eV): m/z (%) = 250 (36), 103 (66), 97 (42), 85 (27), 81 (33), 75 (79), 73 (100), 71 (35), 57 
(80), 55 (39), 44 (83), 43 (51), 41 (47). 
HR-MS (EI, 70 eV): [C14H22O2Si], calcd.: 250.1389; found: 250.1396 ([M−H−Me]+). 
 
Bicyclo[4.3.0]nonane syn-51c. Following TP3, syn-40d (98 mg, 0.293 mmol, 1.0 equiv., d.r.>99:1) 
reacted with t-BuLi (2.08 M, 0.35 mL, 0.733 mmol, 2.5 equiv.) and I2 (187 mg, 0.733 mmol, 2.5 equiv.) 
in diethyl ether (1.0 mL). The crude product was purified by column chromatography on silica using 
pentane as an eluent to afford syn-51c as a colourless oil (65%, 64 mg, 0.191 mmol, d.r.>99:1). 
 
1H-NMR (599 MHz, C6D6, ppm): δ = 2.88 (dt, J = 12.0, 5.9 Hz, 1H), 2.37 (ddt, J = 17.6, 9.3, 1.4 Hz, 
1H), 2.25 – 2.18 (m, 1H), 2.14 (ddd, J = 17.5, 10.4, 8.7 Hz, 1H), 1.93 (dq, J = 12.2, 5.6 Hz, 1H), 
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1.80 – 1.71 (m, 1H), 1.59 – 1.51 (m, 2H), 1.47 (ddq, J = 13.9, 4.3, 2.0 Hz, 1H), 1.44 – 1.36 (m, 1H), 
1.35 – 1.29 (m, 1H), 1.23 – 1.15 (m, 1H), 1.11 (qt, J = 13.0, 3.1 Hz, 1H), 0.88 (qd, J = 13.1, 3.4 Hz, 
1H), 0.27 (s, 9H). 
13C-NMR (151 MHz, C6D6, ppm): δ = 167.4, 98.4, 55.8, 37.7, 32.3, 29.2, 26.3, 25.4, 24.0, 21.1, 1.1. 
FT-IR (ATR, cm−1): �̃ = 2921, 2850, 1593, 1469, 1457, 1446, 1405, 1367, 1304, 1285, 1261, 1246, 
1208, 1187, 1153, 1048, 1022, 940, 898, 872, 833, 794, 778, 754, 688, 657. 
MS (EI, 70 eV): m/z (%) = 334 (25), 207 (24), 185 (15), 133 (65), 73 (100). 
HR-MS (EI, 70 eV): [C13H23ISi], calcd.: 334.0614; found: 334.0610 (M+). 
 
Bicyclo[4.3.0]nonane syn-51d. Following TP3, syn-40d (100 mg, 0.299 mmol, 1.0 equiv., d.r.>99:1) 
reacted with t-BuLi (2.16 M, 0.35 mL, 0.748 mmol, 2.5 equiv.) and CH3OSO2CF3 (123 mg, 
0.748 mmol, 2.5 equiv.). The crude product was purified by column chromatography on silica using 
pentane as an eluent to afford syn-51d as a colourless oil (77%, 51 mg, 0.229 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, C6D6, ppm): δ = 2.64 (dt, J = 12.0, 5.9 Hz, 1H), 2.50 (dddd, J = 16.9, 9.1, 3.1, 
1.6 Hz, 1H), 2.38 – 2.25 (m, 1H), 1.98 – 1.88 (m, 1H), 1.82 – 1.68 (m, 4H), 1.67 – 1.49 (m, 4H), 
1.49 – 1.38 (m, 2H), 1.38 – 1.23 (m, 1H), 1.13 (qt, J = 12.3, 3.1 Hz, 1H), 1.07 – 0.92 (m, 1H), 0.20 (s, 
9H). 
13C-NMR (101 MHz, C6D6, ppm): δ = 159.0, 123.2, 44.0, 38.5, 31.8, 27.1, 27.0, 26.2, 26.1, 21.4, 18.7, 
0.0. 
FT-IR (ATR, cm−1): �̃ = 2922, 2870, 2850, 1618, 1470, 1446, 1404, 1372, 1286, 1260, 1246, 1190, 
1088, 1018, 984, 936, 884, 860, 850, 830, 752, 714, 684. 
MS (EI, 70 eV): m/z (%) = 149 (11), 148 (100), 147 (14), 133 (34), 119 (29), 106 (37), 105 (15), 91 
(20), 73 (40). 
HR-MS (EI, 70 eV): [C14H26Si], calcd.: 222.1804; found: 222.1797 (M+). 
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Tricyclic compound syn-51e. Following TP3, syn-40e (55 mg, 0.144 mmol, 1.0 equiv., d.r.>99:1) 
reacted with t-BuLi (1.96 M, 0.18 mL, 0.360 mmol, 2.5 equiv.) and I2 (92 mg, 0.360 mmol, 2.5 equiv.) 
in diethyl ether (1.0 mL). The crude product was purified by column chromatography on silica using 
pentane as an eluent to afford syn-51e as a colourless oil (92%, 51 mg, 0.133 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, C6D6, ppm): δ = 7.57 – 7.51 (m, 1H), 7.09 (tdd, J = 7.4, 1.2, 0.4 Hz, 1H), 7.00 
(dt, J = 7.5, 1.2 Hz, 1H), 6.99 – 6.94 (m, 1H), 3.51 (dt, J = 11.5, 5.8 Hz, 1H), 3.20 (t, J = 5.5 Hz, 1H), 
2.30 (ddt, J = 13.4, 5.5, 2.6 Hz, 1H), 2.02 – 1.93 (m, 1H), 1.45 – 1.38 (m, 2H), 1.32 – 1.25 (m, 1H), 
1.13 – 0.81 (m, 3H), 0.39 (s, 9H). 
13C-NMR (101 MHz, C6D6, ppm): δ = 165.8, 151.1, 139.2, 128.9, 126.7, 125.7, 123.8, 102.2, 61.9, 
41.1, 25.7, 25.1, 24.3, 21.5, 2.4. 
FT-IR (ATR, cm−1): �̃ = 2924, 2852, 1602, 1562, 1460, 1446, 1406, 1378, 1360, 1328, 1302, 1248, 
1156, 1090, 1024, 980, 940, 924, 906, 886, 858, 836, 824, 780, 756, 740, 718, 678. 
MS (EI, 70 eV): m/z (%) = 383 (27), 382 (100), 255 (25), 239 (12), 196 (11), 195 (55), 185 (16), 181 
(18), 167 (12), 165 (10), 73 (23). 
HR-MS (EI, 70 eV): [C17H23ISi], calcd.: 382.0614; found: 382.0609 (M+). 
11.4 Cyclisation and Cross-Coupling Reactions 
 
Cyclopentane syn-49e. Following TP4, syn-40a (127 mg, 0.411 mmol, 1.35 equiv., d.r.>99:1) reacted 
with t-BuLi (1.96 M, 0.52 mL, 1.03 mmol, 3.38 equiv.) and a ZnCl2-solution (1.0 M in THF, 0.61 mL, 
0.608 mmol, 2.0 equiv.). SPhos (12.3 mg, 0.030 mmol, 10 mol%), Pd(OAc)2 (3.4 mg, 0.015 mmol, 
5 mol%) and ethyl 4-iodobenzoate (84 mg, 0.304 mmol, 1.0 equiv.) were used for the cross-coupling 
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reaction. The crude product was purified by column chromatography on silica using pentane:ether 
(50:1) as an eluent to afford syn-49e as a colourless oil (84%, 84 mg, 0.254 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, C6D6, ppm): δ = 8.19 (d, J = 8.6 Hz, 2H), 6.96 (d, J = 8.2 Hz, 2H), 4.17 (q, 
J = 7.1 Hz, 2H), 2.57 – 2.41 (m, 2H), 2.35 (ddd, J = 17.4, 10.1, 8.6 Hz, 1H), 1.91 – 1.74 (m, 1H), 
1.69 – 1.59 (m, 1H), 1.33 (tt, J = 12.3, 9.8 Hz, 1H), 1.05 (t, J = 7.1 Hz, 3H), 0.79 (d, J = 6.8 Hz, 3H), 
0.60 (d, J = 7.2 Hz, 3H), 0.08 (s, 9H). 
13C-NMR (101 MHz, C6D6, ppm): δ = 166.4, 162.6, 150.9, 134.1, 130.0, 128.7, 128.1, 60.6, 42.6, 37.5, 
31.8, 31.2, 15.1, 14.4, 13.0, 0.1. 
FT-IR (ATR, cm−1): �̃ = 2956, 2872, 1716, 1604, 1464, 1448, 1432, 1404, 1378, 1366, 1304, 1268, 
1246, 1204, 1172, 1108, 1096, 1072, 1020, 972, 942, 924, 886, 864, 830, 780, 754, 724, 702, 688, 664. 
MS (EI, 70 eV): m/z (%) = 331 (16), 330 (64), 315 (14), 285 (21), 257 (49), 212 (27), 211 (32), 207 
(39), 197 (15), 184 (13), 183 (32), 73 (100). 
HR-MS (EI, 70 eV): [C20H30O2Si], calcd.: 330.2015; found: 330.2005 (M+). 
 
Bicyclo[4.3.0]nonane syn-51f. Following TP4, syn-40d (135 mg, 0.404 mmol, 1.35 equiv., d.r.>99:1) 
reacted with t-BuLi (2.21 M, 0.46 mL, 1.01 mmol, 3.38 equiv.) and a ZnCl2-solution (1.0 M in THF, 
0.60 mL, 0.598 mmol, 2.0 equiv.). SPhos (12.3 mg, 0.030 mmol, 10 mol%), Pd(OAc)2 (3.4 mg, 
0.015 mmol, 5 mol%) and 2-bromonaphthalene (64 mg, 0.299 mmol, 1.0 equiv.) were used for the 
cross-coupling reaction. The crude product was purified by column chromatography on silica using 
pentane as an eluent to afford syn-51f as a colourless oil (99%, 84 mg, 0.296 mmol, d.r.>99:1). 
 
1H-NMR (599 MHz, C6D6, ppm): δ = 7.62 (d, J = 8.1 Hz, 1H), 7.62 – 7.55 (m, 2H), 7.48 (s, 1H), 
7.24 – 7.16 (m, 2H), 7.14 (dd, J = 8.3, 1.7 Hz, 1H), 2.61 (ddt, J = 17.5, 9.6, 1.5 Hz, 1H), 2.51 – 2.32 
(m, 2H), 1.96 (dq, J = 12.0, 6.0 Hz, 1H), 1.75 (tt, J = 12.6, 9.8 Hz, 1H), 1.54 – 1.43 (m, 2H), 
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1.43 – 1.34 (m, 1H), 1.34 – 1.23 (m, 2H), 1.20 – 1.11 (m, 2H), 1.04 – 0.94 (m, 1H), 0.64 – 0.54 (m, 
1H), 0.12 (s, 9H). 
13C-NMR (151 MHz, C6D6, ppm): δ = 161.5, 133.9, 133.6, 131.7, 127.9, 127.8, 127.6, 127.3, 127.2, 
125.8, 124.9, 44.3, 38.2, 31.2, 26.7, 26.5, 26.3, 25.2, 20.6, −0.1. 
FT-IR (ATR, cm−1): �̃ = 3052, 2948, 2922, 2870, 2854, 2174, 1626, 1610, 1594, 1500, 1466, 1458, 
1448, 1430, 1404, 1378, 1366, 1350, 1336, 1314, 1306, 1288, 1268, 1244, 1218, 1202, 1178, 1140, 
1122, 1090, 1044, 1024, 1016, 998, 976, 962, 944, 922, 898, 888, 872, 832, 820, 804, 796, 784, 756, 
742, 714, 686. 
MS (EI, 70 eV): m/z (%) = 334 (62), 261 (39), 260 (100), 132 (26), 231 (18), 217 (20), 185 (29), 179 
(30), 178 (19), 167(11), 165 (33), 141 (34), 75 (23), 73(57). 
HR-MS (EI, 70 eV): [C23H30Si], calcd.: 334.2117; found: 334.2107 (M+). 
 
Iodide syn-53. Syn-49e (62 mg, 0.185 mmol, 1.0 equiv.) was treated with NIS (166 mg, 0.370 mmol, 
4.0 equiv.) in acetonitrile (4.0 mL). The reaction mixture was stirred at room temperature for 71 h. The 
reaction process was monitored by GC. Saturated aqueous NaHSO3∙Na2S2O5 solution was added, the 
phases were separated and the aqueous phase was extracted with diethyl ether. The combined organic 
layers were dried over MgSO4. The crude product was purified by column chromatography on silica 
using pentane:diethyl ether (50:1) as an eluent to afford syn-53 as a colourless solid (87%, 62 mg, 
0.161 mmol, d.r.>99:1). 
 
m.p.: 52.2–53.1 °C. 
1H-NMR (599 MHz, CDCl3, ppm): δ = 7.99 (d, J = 8.6 Hz, 2H), 7.35 (d, J = 8.6 Hz, 2H), 4.38 (q, 
J = 7.1 Hz, 2H), 2.66 – 2.55 (m, 2H), 2.37 (ddd, J = 18.4, 10.0, 8.7 Hz, 1H), 2.21 – 2.11 (m, 1H), 
1.85 – 1.76 (m, 1H), 1.50 (tt, J = 12.3, 9.7 Hz, 1H), 1.39 (t, J = 7.1 Hz, 3H), 0.87 (d, J = 6.8 Hz, 3H), 
0.63 (d, J = 7.2 Hz, 3H). 
13C-NMR (151 MHz, CDCl3, ppm): δ = 166.3, 158.9, 148.8, 129.7, 129.5, 128.8, 88.8, 61.2, 42.4, 
40.4, 39.9, 30.4, 15.5, 14.5, 13.0. 
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FT-IR (ATR, cm−1): �̃ = 2960, 2938, 2872, 1716, 1604, 1566, 1464, 1448, 1424, 1402, 1366, 1306, 
1266, 1226, 1174, 1100, 1020, 966, 942, 904, 862, 844, 828, 808, 774, 758, 736, 710, 678. 
MS (EI, 70 eV): m/z (%) = 257 (100), 229 (33), 211 (59), 184 (25), 169 (92), 157 (63), 155 (31), 153 
(31), 143 (95), 142 (79), 141 (75), 129 (88), 128 (65), 127 (93), 115 (46). 
HR-MS (EI, 70 eV): [C17H21O2I], calcd.: 384.0586; found: 384.0580 (M+). 
 
Cyclopentane syn-54. A dry and argon-flushed Schlenk-tube was charged with syn-53 (75 mg, 
0.195 mmol,1.0 equiv.), Pd(OAc)2 (2.2 mg, 0.010 mmol, 5 mol%), SPhos (8.2 mg, 0.020 mmol, 
10 mol%) and THF (4.0 mL). MeZnCl (0.46 M, 0.55 mL, 0.254 mmol, 1.3 equiv.) was added dropwise 
at 0 °C. The reaction mixture was stirred at 0 °C for 4 h. Saturated aqueous NH4Cl solution was added, 
the phases were separated and the aqueous phase was extracted with diethyl ether. The combined 
organic layers were dried over MgSO4. The solvents were evaporated and the crude product was 
purified by column chromatography on silica using pentane:diethyl ether (50:1) as an eluent to afford 
syn-54 as a colourless oil (77%, 41 mg, 0.151 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.98 (d, J = 8.4 Hz, 2H), 7.25 (d, J = 7.1 Hz, 2H), 4.37 (q, 
J = 7.1 Hz, 2H), 2.59 – 2.40 (m, 2H), 2.38 – 2.26 (m, 1H), 1.99 (dq, J = 11.8, 6.7 Hz, 1H), 1.90 (q, 
J = 1.3 Hz, 3H), 1.84 – 1.72 (m, 1H), 1.48 – 1.34 (m, 4H), 0.88 (d, J = 6.8 Hz, 3H), 0.57 (d, J = 7.2 Hz, 
3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 166.8, 150.3, 146.8, 129.6, 128.1, 128.1, 126.4, 60.9, 40.4, 
38.4, 30.6, 30.0, 21.4, 15.3, 14.5, 13.4. 
FT-IR (ATR, cm−1): �̃ = 2958, 2936, 2912, 2870, 1716, 1606, 1464, 1448, 1432, 1402, 1368, 1306, 
1268, 1174, 1098, 1058, 1018, 986, 858, 774, 740, 710. 
MS (EI, 70 eV): m/z (%) = 272 (60), 257 (90), 199 (100), 184 (41), 159 (48), 157 (60), 156 (29), 115 
(30), 105 (20), 103 (20), 95 (57), 91 (30). 
HR-MS (EI, 70 eV): [C18H24O2], calcd.: 272.1776; found: 272.1762 (M+). 
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Cyclopentane syn-55. Syn-54 (41 mg, 0.151 mmol,1.0 equiv.) and Pd/C (5%, 31 mg, 0.015 mmol, 
10 mol%) in methanol (3.0 mL) were stirred under a H2 atmosphere for 21 h. After filtration over celite, 
the solvent was evaporated and the crude product was purified by column chromatography on silica 
using pentane:diethyl ether (50:1) as an eluent to afford syn-55 as a colourless oil (quant., 41 mg, 
0.153 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.94 (d, J = 8.4 Hz, 2H), 7.24 (d, J = 8.3 Hz, 2H), 4.36 (q, 
J = 7.1 Hz, 2H), 2.65 – 2.52 (m, 1H), 2.10 – 1.94 (m, 3H), 1.68 – 1.56 (m, 1H), 1.38 (t, J = 7.1 Hz, 
3H), 1.24 (d, J = 6.8 Hz, 3H), 1.18 – 1.08 (m, 3H), 0.94 (d, J = 6.5 Hz, 3H), 0.74 (d, J = 6.6 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 166.9, 153.4, 129.7, 128.2, 127.4, 60.8, 51.7, 42.3, 39.1, 38.5, 
29.9, 28.0, 21.3, 16.3, 14.5, 7.1. 
FT-IR (ATR, cm−1): �̃ = 2958, 2906, 2870, 1716, 1610, 1574, 1454, 1418, 1366, 1344, 1310, 1270, 
1178, 1146, 1102, 1050, 1020, 1012, 960, 856, 772, 708. 
MS (EI, 70 eV): m/z (%) = 179 (12), 178 (100), 164 (12), 150 (24), 149 (58), 105 (18). 
HR-MS (EI, 70 eV): [C18H26O2], calcd.: 274.1933; found: 274.1925 (M+). 
 
Acid syn-56. Syn-55 (42 mg, 0.153 mmol,1.0 equiv.) in methanol (2.5 mL) was treated with potassium 
hydroxide (40 mg, 0.712 mmol, 4.0 equiv.) and the reaction mixture was stirred at 40 °C for 69 h. Water 
was added, the phases were separated and the aqueous phase was extracted with diethyl ether. The 
aqueous phase was acidified with HCl (2 N) until a pH = 2 was reached. After extraction with diethyl 
ether, the combined organic layers were dried over MgSO4. The solvent was evaporated and the crude 
product was purified by column chromatography on silica using hexane:diethyl ether (2:1; 1% HOAc) 
as an eluent to afford syn-56 as a colourless solid (90%, 34 mg, 0.138 mmol, d.r.>99:1). 
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Recrystallization of the product from methanol gave crystals suitable for single crystal X-ray diffraction 
analysis. 
 
m.p.: 160.6 – 163.8 °C. 
1H-NMR (400 MHz, CDCl3, ppm): δ = 8.01 (d, J = 8.3 Hz, 2H), 7.28 (d, J = 8.3 Hz, 2H), 2.66 – 2.55 
(m, 1H), 2.11 – 1.97 (m, 3H), 1.26 (d, J = 6.8 Hz, 3H), 1.21 – 1.09 (m, 3H), 0.95 (d, J = 6.5 Hz, 3H), 
0.74 (d, J = 6.6 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 171.7, 154.6, 130.4, 127.6, 126.9, 51.7, 42.4, 39.1, 38.5, 29.9, 
28.0, 21.2, 16.2, 7.1. 
FT-IR (ATR, cm−1): �̃ = 2958, 2940, 2902, 2868, 2672, 2598, 2540, 1678, 1608, 1574, 1468, 1454, 
1426, 1378, 1358, 1340, 1316, 1286, 1178, 1144, 1130, 1108, 1052, 1010, 988, 976, 952, 908, 878, 
856, 828, 814, 782, 772, 756, 736, 708, 654. 
MS (EI, 70 eV): m/z (%) = 151 (11), 150 (100), 149 (11), 97 (18), 55 (16). 
HR-MS (EI, 70 eV): [C16H22O2], calcd.: 246.1620; found: 246.1625 (M+). 
 
Cyclopentane R-49f. Following TP4, R-40f (121 mg, 0.411 mmol, 1.35 equiv., e.r. = 98:2) reacted 
with t-BuLi (2.35 M, 0.44 mL, 1.03 mmol, 3.38 equiv.) and ZnCl2-solution (1.0 M in THF, 0.61 mL, 
0.608 mmol, 2.0 equiv.). SPhos (12.3 mg, 0.030 mmol, 10 mol%), Pd(OAc)2 (3.4 mg, 0.015 mmol, 
5 mol%) and ethyl 4-iodobenzoate (84 mg, 0.304 mmol, 1.0 equiv.) were used for the cross-coupling 
reaction. The crude product was purified by column chromatography on silica using pentane:ether 
(40:1) as an eluent to afford R-49f as a colourless oil (74%, 71 mg, 0.224 mmol, e.r.(R:S) = 95:5X). 
 
                                                     
X Flow rate = 2.1 mL/min; T = 80 °C; average velocity = 60; hold 80 °C for 20 min, 2 °C/min heating rate to 
200 °C and holding for 10 min. Retention times: 84.9 min (major), 85.2 min (minor). 
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1H-NMR (400 MHz, C6D6, ppm): δ = 8.19 (d, J = 8.6 Hz, 2H), 6.93 (d, J = 8.3 Hz, 2H), 4.17 (q, 
J = 7.1 Hz, 2H), 2.63 – 2.50 (m, 1H), 2.46 – 2.29 (m, 2H), 1.70 – 1.49 (m, 3H), 1.24 – 1.15 (m, 1H), 
1.05 (t, J = 7.1 Hz, 3H), 0.68 (d, J = 7.1 Hz, 3H), 0.08 (s, 9H). 
13C-NMR (101 MHz, C6D6, ppm): δ = 165.9, 161.2, 150.2, 133.6, 129.4, 128.1, 127.6, 60.1, 37.8, 33.7, 
32.3, 23.7, 19.6, 13.8, −0.4. 
FT-IR (ATR, cm−1): �̃ = 2954, 2868, 1716, 1604, 1462, 1448, 1432, 1404, 1366, 1304, 1280, 1268, 
1246, 1218, 1172, 1108, 1096, 1022, 968, 946, 902, 890, 864, 830, 754, 724, 704, 688. 
MS (EI, 70 eV): m/z (%) = 317 (15), 316 (70), 301 (14), 271 (16), 243 (14), 207 (15), 198 (22), 197 
(26), 179 (11), 170 (19), 169 (21), 142 (15), 128 (11), 73 (100). 
HR-MS (EI, 70 eV): [C19H28O2Si], calcd.: 316.1859; found: 316.1854 (M+). [�] ���  = 66° (c = 0.89, CH2Cl2). 
 
Cyclopentane S-49f. Following TP4, S-40f (121 mg, 0.411 mmol, 1.35 equiv., e.r. = 97:3) reacted 
with t-BuLi (1.96 M, 0.52 mL, 1.03 mmol, 3.38 equiv.) and a ZnCl2-solution (1.0 M in THF, 0.61 mL, 
0.608 mmol, 2.0 equiv.). SPhos (12.3 mg, 0.030 mmol, 10 mol%), Pd(OAc)2 (3.4 mg, 0.015 mmol, 
5 mol%) and ethyl 4-iodobenzoate (84 mg, 0.304 mmol, 1.0 equiv.) were used for the cross-coupling 
reaction. The crude product was purified by column chromatography on silica using pentane:ether 
(40:1) as an eluent to afford R-49f as a colourless oil (70%, 67 mg, 0.212 mmol, e.r.(R:S) = 96:4XI). 
 
1H-NMR (400 MHz, C6D6, ppm): δ = 8.20 (d, J = 8.2 Hz, 2H), 6.93 (d, J = 8.1 Hz, 2H), 4.17 (q, 
J = 7.1 Hz, 2H), 2.62 – 2.52 (m, 1H), 2.46 – 2.29 (m, 2H), 1.70 – 1.50 (m, 3H), 1.24 – 1.15 (m, 1H), 
1.04 (t, J = 7.1 Hz, 3H), 0.68 (d, J = 7.1 Hz, 3H), 0.08 (s, 9H). 
                                                     
XI Flow rate = 2.1 mL/min; T = 80 °C; average velocity = 60; hold 80 °C for 20 min, 2 °C/min heating rate to 
200 °C and holding for 10 min. Retention times: 84.9 min (minor), 85.2 min (major). 
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13C-NMR (101 MHz, C6D6, ppm): δ = 166.4, 161.8, 150.8, 134.1, 130.0, 128.7, 128.1, 60.6, 38.4, 34.2, 
32.9, 24.3, 20.2, 14.4, 0.1. 
FT-IR (ATR, cm−1): �̃ = 2954, 2869, 1716, 1603, 1563, 1502, 1463, 1403, 1367, 1305, 1279, 1268, 
1247, 1218, 1173, 1107, 1096, 1021, 968, 945, 903, 889, 864, 830, 755, 725, 704, 689. 
MS (EI, 70 eV): m/z (%) = 316 (29), 243 (11), 198 (11), 169 (12), 73 (100). 
HR-MS (EI, 70 eV): [C19H28O2Si], calcd.: 316.1859; found: 316.1852 (M+). [�] ���  = –70° (c = 1.1, CH2Cl2). 
 
Iodide 57a. Syn-51f (79 mg, 0.235 mmol, 1.0 equiv.) was treated with NIS (318 mg, 1.41 mmol, 
6.0 equiv.) in acetonitrile (4.0 mL) and dichloromethane
 
 (2.0 mL). The reaction mixture was stirred at 
room temperature for 23 h. The reaction process was monitored by GC. Saturated aqueous 
NaHSO3∙Na2S2O5 solution was added, the phases were separated and the aqueous phase was extracted 
with diethyl ether. The combined organic layers were dried over MgSO4. The crude product was 
purified by column chromatography on silica using pentane as an eluent to afford 57a as a colourless 
oil (75%, 69 mg, 0.178 mmol, d.r.>99:1). 
 
 
The relative stereochemistry was established by key NOE 
correlation as depicted aside. 
1H-NMR (599 MHz, CDCl3, ppm): δ =  7.84 – 7.80 (m, 2H), 7.78 (d, J = 8.5 Hz, 1H), 7.72 (dd, 
J = 0.5 Hz, 1H), 7.50 – 7.45 (m, 2H), 7.39 (dd, J = 8.4, 1.8 Hz, 1H), 2.65 (ddt, J = 18.1, 9.4, 1.7 Hz, 
1H), 2.54 (dt, J = 11.6, 6.2 Hz, 1H), 2.45 (ddd, J = 18.4, 9.7, 8.9 Hz, 1H), 2.25 (dqd, J = 12.3, 7.0, 6.5, 
2.6 Hz, 1H), 1.92 (tt, J = 12.4, 9.7 Hz, 1H), 1.69 – 1.62 (m, 1H), 1.61 – 1.54 (m, 1H), 1.49 – 1.41 (m, 
2H), 1.40 – 1.30 (m, 2H), 1.27 (ddd, J = 14.4, 5.6, 3.0 Hz, 1H), 1.20 – 1.09 (m, 1H), 0.92 – 0.80 (m, 
1H). 
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13C-NMR (151 MHz, CDCl3, ppm): δ = 157.1, 141.9, 133.1, 132.7, 128.3, 127.9, 127.8, 127.3, 127.1, 
126.3, 90.5, 44.7, 40.8, 40.1, 27.0, 26.8, 26.2, 25.2, 20.8. 
FT-IR (ATR, cm−1): �̃ = 3052, 2920, 2850, 1644, 1628, 1594, 1572, 1502, 1466, 1456, 1444, 1422, 
1380, 1364, 1342, 1314, 1306, 1288, 1268, 1248, 1230, 1214, 1202, 1186, 1172, 1152, 1142, 1124, 
1096, 1072, 1060, 1048, 1040, 1022, 996, 960, 948, 938, 906, 886, 852, 836, 814, 778, 768, 756, 744, 
732, 698. 
MS (EI, 70 eV): m/z (%) = 262 (23), 261 (100), 191 (10), 179 (25), 178 (19), 167 (15), 166 (11), 165 
(35), 141 (44). 
HR-MS (EI, 70 eV): [C20H21I], calcd.: 388.0688; found: 388.0676 (M+). 
 
Bicyclo[4.3.0]nonane Z-58a. A dry and argon-flushed Schlenk-tube was charged with 57a (69 mg, 
0.178 mmol,1.0 equiv.), Pd(OAc)2 (2.0 mg, 0.009 mmol, 5 mol%), SPhos (7.4 mg, 0.018mmol, 
10 mol%) and THF (4.0 mL). MeZnCl (0.45 M, 0.51 mL, 0.231 mmol, 1.3 equiv.) was added dropwise 
at 0 °C. The reaction mixture was stirred at 0 °C for 2 h. Saturated aqueous NH4Cl solution was added, 
the phases were separated and the aqueous phase was extracted with diethyl ether. The combined 
organic layers were dried over MgSO4. The solvents were evaporated and the crude product was 
purified by column chromatography on silica using pentane as an eluent to afford Z-58a as a colourless 
oil (79%, 39 mg, 0.141 mmol, d.r.>99:1). 
 
 
The relative stereochemistry was established by key 
NOE correlation as depicted aside. 
1H-NMR (599 MHz, CDCl3, ppm): δ = 7.85 – 7.76 (m, 3H), 7.62 (s, 1H), 7.49 – 7.40 (m, 2H), 7.33 
(dt, J = 8.4, 1.6 Hz, 1H), 2.54 (ddt, J = 17.4, 9.7, 1.7 Hz, 1H), 2.47 – 2.34 (m, 2H), 2.13 – 2.05 (m, 1H), 
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1.97 (s, 3H), 1.92 – 1.81 (m, 1H), 1.66 – 1.57 (m, 2H), 1.53 – 1.45 (m, 1H), 1.46 – 1.39 (m, 1H), 
1.39 – 1.25 (m, 2H), 1.25 – 1.19 (m, 1H), 1.13 – 1.00 (m, 1H), 0.93 – 0.83 (m, 1H). 
13C-NMR (151 MHz, CDCl3, ppm): δ = 145.0, 143.0, 133.6, 132.0, 127.9, 127.7, 127.5, 127.3, 126.7, 
126.1, 125.8, 125.3, 42.8, 39.4, 29.6, 27.3, 26.8, 26.3, 25.6, 21.8, 21.1. 
FT-IR (ATR, cm−1): �̃ = 3054, 2918, 2850, 1628, 1598, 1502, 1468, 1444, 1430, 1372, 1342, 1266, 
1248, 1230, 1196, 1188, 1156, 1142, 1128, 1076, 1056, 1036, 1018, 990, 960, 950, 932, 892, 876, 854, 
816, 770, 744, 666. 
MS (EI, 70 eV): m/z (%) = 276 (25), 182 (14), 181 (100), 179 (13), 178 (16), 166 (21), 165 (23). 
HR-MS (EI, 70 eV): [C21H24], calcd.: 276.1878; found: 276.1871 (M+). 
 
Bicyclo[4.3.0]nonane 59. Z-58a(34 mg, 0.123 mmol,1.0 equiv.) and Pd/C (5%, 26 mg, 0.012 mmol, 
10 mol%) in methanol (3.0 mL) were stirred under a H2 atmosphere for 2 h. After filtration over celite, 
the solvent was evaporated and the crude product was purified by column chromatography on silica 
using pentane as an eluent to afford 59 as a colourless solid (76%, 26 mg, 0.093 mmol, d.r.>99:1). 
Recrystallization of the product from THF/MeCN gave crystals suitable for single crystal X-ray 
diffraction analysis. 
 
 
The relative stereochemistry was established by key NOE 
correlation as depicted aside. 
m.p.: 61.7 – 63.5 °C. 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.82 – 7.74 (m, 3H), 7.59 (s, 1H), 7.46 – 7.42 (m, 1H), 
7.42 – 7.38 (m, 1H), 7.36 (dd, J = 8.5, 1.8 Hz, 1H), 2.71 (dq, J = 11.1, 6.8 Hz, 1H), 2.20 – 2.08 (m, 
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2H), 2.00 – 1.92 (m, 1H), 1.80 – 1.73 (m, 1H), 1.65 – 1.57 (m, 3H), 1.57 – 1.34 (m, 4H), 1.31 (d, 
J = 6.8 Hz, 3H), 1.29 – 1.05 (m, 4H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 145.6, 133.8, 132.3, 127.9, 127.7, 127.6, 126.1, 125.8, 125.6, 
125.0, 51.9, 41.5, 41.3, 39.6, 28.1, 27.5, 25.8, 25.4, 21.9, 21.9, 21.2. 
FT-IR (ATR, cm−1): �̃ = 3052, 2920, 2868, 2854, 1600, 1508, 1470, 1452, 1444, 1380, 1270, 1020, 
888, 854, 816, 744. 
MS (EI, 70 eV): m/z (%) = 278 (15), 156 (61), 155 (100), 154 (13), 153 (23), 141 (18), 81 (19). 
HR-MS (EI, 70 eV): [C21H26], calcd.: 278.2035; found: 278.2028 (M+). 
 
Iodide 57b. Syn-51d (84 mg, 0.378 mmol, 1.0 equiv.) was treated with NIS (174 mg, 0.756 mmol, 
2.0 equiv.) in acetonitrile (4.3 mL). The reaction mixture was stirred at room temperature for 1.5 h. The 
reaction conversion was monitored by GC. Saturated aqueous NaHSO3∙Na2S2O5 solution was added, 
the phases were separated and the aqueous phase was extracted with diethyl ether. The combined 
organic layers were dried over MgSO4. The crude product was purified by column chromatography on 
silica using pentane as an eluent to afford 57b as a colourless oil (85%, 89 mg, 0.322 mmol, d.r.>99:1). 
 
 
The relative stereochemistry was established by key NOE 
correlation as depicted aside. 
1H-NMR (400 MHz, CDCl3, ppm): δ = 2.61 (dt, J = 11.7, 5.9 Hz, 1H), 2.47 (t, J = 2.1 Hz, 3H), 
2.45 – 2.34 (m, 1H), 2.26 – 2.10 (m, 2H), 1.93 – 1.76 (m, 1H), 1.67 – 1.43 (m, 6H), 1.35 (qt, J = 12.9, 
3.8 Hz, 1H), 1.26 – 1.04 (m, 2H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 153.3, 89.3, 43.9, 40.6, 39.6, 30.0, 27.1, 26.4, 26.2, 25.5, 20.9. 
FT-IR (ATR, cm−1): �̃ = 2920, 2848, 1652, 1468, 1458, 1444, 1426, 1374, 1250, 1212, 1172, 1158, 
1122, 1076, 1058, 1036, 1020, 968, 884, 850, 828, 656. 
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MS (EI, 70 eV): m/z (%) = 276 (17), 150 (12), 149 (100), 121 (21), 107 (33), 105 (12), 95 (19), 93 (52), 
91 (38), 81 (35), 79 (32), 77 (13), 67 (18). 
HR-MS (EI, 70 eV): [C11H17I], calcd.: 276.0375; found: 276.0370 (M+). 
 
Bicyclo[4.3.0]nonane E-58a. A dry and argon-flushed Schlenk-tube was charged with 57b (81 mg, 
0.293 mmol, 1.0 equiv.), Pd(OAc)2 (3.4 mg, 0.015 mmol, 5 mol%), SPhos (11.9 mg, 0.029 mmol, 
10 mol%) and THF (6.0 mL). Naphthylzinc chloride (0.43 M, 0.89 mL, 0.381 mmol, 1.3 equiv.) was 
added dropwise at 0 °C. The reaction mixture was stirred at 0 °C for 2.5 h. Saturated aqueous NH4Cl 
solution was added, the phases were separated and the aqueous phase was extracted with diethyl ether. 
The combined organic layers were dried over MgSO4. The solvents were evaporated and the crude 
product was purified by column chromatography on silica using pentane as an eluent to afford E-58a 
as a colourless oil (88%, 71 mg, 0.257 mmol, d.r.>99:1). 
 
 
The relative stereochemistry was established by key NOE 
correlation as depicted aside. 
1H-NMR (599 MHz, CDCl3, ppm): δ = 7.82 – 7.75 (m, 3H), 7.63 (s, 1H), 7.47 – 7.38 (m, 2H), 7.36 
(dd, J = 8.4, 1.7 Hz, 1H), 2.67 (dt, J = 11.7, 5.9 Hz, 1H), 2.39 (ddq, J = 17.4, 9.2, 1.7 Hz, 1H), 
2.26 – 2.16 (m, 1H), 2.16 – 2.09 (m, 1H), 2.08 (t, J = 2.0 Hz, 3H), 1.84 – 1.63 (m, 5H), 1.53 – 1.43 (m, 
2H), 1.43 – 1.33 (m, 1H), 1.30 – 1.15 (m, 2H). 
13C-NMR (151 MHz, CDCl3, ppm): δ = 145.1, 142.8, 133.6, 132.0, 127.8, 127.7, 127.5, 127.0, 126.3, 
126.2, 125.9, 125.3, 43.5, 39.0, 30.2, 27.0, 26.5, 25.9, 21.2. 
FT-IR (ATR, cm−1): �̃ = 3054, 2920, 2848, 1628, 1598, 1502, 1468, 1456, 1444, 1432, 1374, 1344, 
1266, 1194, 1188, 1166, 1154, 1142, 1128, 1078, 1056, 1036, 1020, 960, 948, 890, 854, 816, 784, 768, 
744, 666. 
MS (EI, 70 eV): m/z (%) = 276 (27), 182 (14), 181 (100), 179 (13), 178 (16), 166 (23), 165 (23). 
HR-MS (EI, 70 eV): [C21H24], calcd.: 276.1878; found: 276.1871 (M+). 
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Bicyclo[4.3.0]nonane 58b. A dry and argon-flushed Schlenk-tube was charged with 57b (15 mg, 
0.054 mmol, 1.0 equiv.) in diethyl ether (0.66 mL). t-BuLi (2.21 M, 0.07 mL, 0.145 mmol, 2.5 equiv.) 
was added dropwise at −78 °C. Ethyl chloroformate (14 µL, 0.145 mL, 2.5 equiv.) was added 
subsequently, the reaction was stirred at −78 °C for 5 min and was then allowed to warm to room 
temperature. Saturated aqueous NH4Cl solution was added, the phases were separated and the aqueous 
phase was extracted with diethyl ether. The combined organic layers were dried over MgSO4. The 
solvents were evaporated and the crude product was purified by column chromatography on silica using 
pentane:diethyl ether (40:1) as an eluent to afford 58b as a colourless oil (91%, 11 mg, 0.049 mmol, 
d.r.>99:1). 
 
 
The relative stereochemistry was established by key NOE 
correlation as depicted aside. 
1H-NMR (400 MHz, CDCl3, ppm): δ = 4.16 (q, J = 7.1 Hz, 2H), 2.91 (dddd, J = 19.8, 8.8, 3.0, 1.3 Hz, 
1H), 2.72 – 2.58 (m, 2H), 2.12 – 1.99 (m, 1H), 1.88 (t, J = 2.0 Hz, 3H), 1.91 – 1.78 (m, 1H), 1.74 – 1.46 
(m, 6H), 1.37 (qt, J = 13.0, 3.6 Hz, 1H), 1.29 (t, J = 7.1 Hz, 3H), 1.25 – 1.14 (m, 1H), 1.06 (qd, J = 12.9, 
3.1 Hz, 1H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 168.7, 164.2, 117.9, 59.7, 45.3, 37.9, 32.3, 26.5, 26.1, 25.5, 
24.7, 20.7, 15.7, 14.4. 
FT-IR (ATR, cm−1): �̃ = 2926, 2858, 1710, 1638, 1446, 1304, 1284, 1270, 1214, 1180, 1124, 1096, 
1076, 1048. 
MS (EI, 70 eV): m/z (%) =  222 (36), 177 (35), 176 (100), 175 (38), 149 (37), 134 (50), 128 (53), 119 
(31), 105 (31), 100 (42), 95 (33), 93 (31), 91 (46). 
HR-MS (EI, 70 eV): [C14H22O2], calcd.: 222.1620; found: 222.1613 (M+). 
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Bicyclo[4.3.0]nonane 60. E-58a (71 mg, 0.257 mmol, 1.0 equiv.) and Pd/C (5%, 55 mg, 0.026 mmol, 
10 mol%) in methanol (4.0 mL) and pentane (2.0 mL) were stirred under a H2 atmosphere for 2.5 h. 
After filtration over celite, the solvent was evaporated and the crude product was purified by column 
chromatography on silica using pentane as an eluent to afford 60 as a colourless oil (92%, 66 mg, 
0.237 mmol, d.r. = 79:21). 
 
 
The relative stereochemistry for the major compound was 
established by key NOE correlation as depicted aside. 
Only the chemical shifts of the major diastereomers are reported (assignment by 2D NMR analysis). 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.83 – 7.75 (m, 3.0H), 7.62 (s, 1H), 7.48 – 7.33 (m, 3H), 
2.78 – 2.65 (m, 1H), 2.35 – 2.24 (m, 1H), 2.12 – 1.90 (m, 2H), 1.74 – 1.47 (m, 5H), 1.46 – 1.29 (m, 
5H), 1.22 (d, J = 6.9 Hz, 3H), 1.06 – 0.94 (m, 1H), 0.88 – 0.74 (m, 1H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 145.9, 133.8, 132.2, 127.9, 127.7, 127.7, 126.2, 125.8, 125.5, 
125.0, 51.0, 41.9, 41.2, 39.4, 27.8, 27.3, 25.6, 25.6, 23.2, 21.9, 20.9. 
FT-IR (ATR, cm−1): �̃ = 3052, 2920, 2866, 2854, 1632, 1600, 1506, 1470, 1452, 1444, 1378, 1370, 
1270, 1128, 1022, 956, 946, 888, 852, 816, 768, 742, 660. 
MS (EI, 70 eV): m/z (%) = 278 (11), 156 (67), 155 (100), 154 (13), 153 (22), 141 (19), 81 (22). 
HR-MS (EI, 70 eV): [C21H26], calcd.: 278.2035; found: 278.2028 (M+). 
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11.5 Synthesis of Cyclohexane Derivatives 
 
Cyclohexane 62b. A dry and argon-flushed Schlenk-tube with diethyl ether (3.2 mL) was cooled to 
−78 °C and charged with a solution of t-BuLi (2.49 M, 0.30 mL, 0.743 mmol, 2.5 equiv.). Iodide 61b 
(100 mg, 0.297 mmol, 1.0 equiv.) in diethyl ether (0.75 mL) was added dropwise over 10 min and the 
reaction mixture was stirred for 10 min. Then, the reaction mixture was stirred at room temperature for 
30 min. After the iodine (190 mg, 0.743 mmol, 2.5 equiv.) in diethyl ether (1.0 mL) at −78 °C, the 
solution was allowed to warm up to room temperature. Saturated aqueous (NaHSO3·Na2S2O5) solution 
was added, the phases were separated and the aqueous phase was extracted with diethyl ether. The 
combined organic layers were dried over MgSO4. The crude product was purified by column 
chromatography on silica using pentane as an eluent to afford 62b as a colourless oil (50%, 50 mg, 
0.149 mmol). 
 
1H-NMR (400 MHz, C6D6, ppm): δ = 3.01 (qdd, J = 7.5, 5.4, 2.4 Hz, 1H), 1.84 – 1.74 (m, 1H), 1.58 
(s, 3H), 1.56 (d, J = 0.8 Hz, 3H), 1.56 – 1.49 (m, 1H), 1.49 – 1.42 (m, 2H), 1.36 – 1.28 (m, 1H), 
1.22 – 1.15 (m, 1H), 1.06 (dd, J = 7.4, 0.4 Hz, 3H), 0.32 (s, 9H). 
13C-NMR (101 MHz, C6D6, ppm): δ = 167.7, 102.2, 39.6, 38.7, 38.6, 28.4, 26.7, 26.6, 23.9, 15.8, 3.4. 
FT-IR (ATR, cm−1): �̃ = 2952, 2930, 2868, 1538, 1470, 1460, 1384, 1372, 1362, 1262, 1248, 1198, 
868, 832, 760, 692, 680. 
MS (EI, 70 eV): m/z (%) = 185 (14), 136 (11), 135 (100), 107 (22), 93 (20), 75 (26), 73 (70). 
HR-MS (EI, 70 eV): [C13H25ISi], calcd.: 336.0770; found: 336.0767 (M+). 
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11.6 Single Crystal X-Ray Analysis 
Single crystals of the compounds, suitable for X-ray diffraction, were obtained by slow evaporation of 
solvents solutions. The crystals were introduced into perfluorinated oil and a suitable single crystal was 
carefully mounted on the top of a thin glass wire. Data collections were performed on an Oxford 
Xcalibur 3 diffractometer equipped with a Spellman generator (50 kV, 40 mA) and a Kappa CCD 
detector, operating with Mo-Kα radiation (Ȝ = 0.71071 Å). Data collection was performed with the 
CrysAlis CCD software;XII CrysAlis RED softwareXIII was used for data reduction. Absorption 
correction using the SCALE3 ABSPACK multiscan methodXIV was applied. The structures were solved 
with SHELXS-97,XV refined with SHELXL-97XVI and finally checked using PLATON.XVII Details for 
data collection and structure refinement are summarized in the tables at the different sections. 
  
                                                     
XII CrysAlis CCD, Oxford Diffraction Ltd., Version 1.171.27p5 beta (release 01-04-2005 CrysAlis171.NET) 
(compiled Apr 1 2005, 17:53:34). 
XIII CrysAlis RED, Oxford Diffraction Ltd., Version 1.171.27p5 beta (release 01-04-2005 CrysAlis171.NET) 
(compiled Apr 1 2005, 17:53:34). 
XIV SCALE3 ABSPACK – An Oxford Diffraction Program (1.0.4, gui:1.0.3) (C), Oxford Diffraction, Ltd., 2005. 
XV Sheldrick, G. M. (1997) SHELXS-97: Program for Crystal Structure Solution, University of Göttingen, Germany. 
XVI Sheldrick, G. M. (1997) SHELXL-97: Program for the Refinement of Crystal Structures, University of 
Göttingen, Germany. 
XVII Spek, A. L. (1999) PLATON: A Multipurpose Crystallographic Tool, Utrecht University, Utrecht, The 
Netherlands. 
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Cyclopentane syn-49c. 
 
Figure 6: Molecular structure of cyclopentane syn-49c in the crystal, view of the two crystallographically independent 
molecules, DIAMONDXVIII representation; thermal ellipsoids are drawn at 50% probability level. 
 
Figure 7: Hydrogen bonding in the crystal structure of cyclopentane syn-49c, DIAMOND representation; thermal ellipsoids 
are drawn at 50% probability level. Symmetry code for the left molecule: x, 1+y, z. 
Table 8: Details for X-ray data collection and structure refinement for cyclopentane syn-49c. 
Empirical formula C24H32OSi 
Formula mass 364.58 
T/ K 173(2) 
Crystal size [mm] 0.41 × 0.29 × 0.24 
Crystal description colorless block 
                                                     
XVIII DIAMOND, Crystal Impact GbR., Version 3.2i. 
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Crystal system triclinic 
Space group P-1 
a/ Å 11.3833(4) 
b/ Å 13.4945(4) 
c/ Å 14.7067(5) 
α/ ° 100.473(3) 
ȕ/ ° 93.153(3) 
Ȗ/ ° 104.257(3) 
V/ Å3 2141.24(13) 
Z 4 
ρcalcd./ g cm−3 1.131 
μ/ mm−1 0.119 
F(000) 792 
Θ range/ ° 4.21 – 25.24 
Index ranges −16 ≤ h ≤ 16 
 −19 ≤ k ≤ 19 
 −21 ≤ l ≤ 21 
Reflns. collected 42866 
Reflns. obsd. 9280 
Reflns. unique 13016 
(Rint = 0.0357) 
R1, wR2 (βσ data) 0.0473, 0.1131 
R1, wR2 (all data) 0.0747, 0.1304 
GOOF on F2 1.025 
Peak/hole/ e Å−3 0.365 / −0.220 
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Cyclopentane anti-49d. 
 
Figure 8: Molecular structure of cyclopentane anti-49d in the crystal, DIAMONDXIX representation; thermal ellipsoids are 
drawn at 50% probability level. 
Table 9: Details for X-ray data collection and structure refinement for cyclopentane anti-49d. 
Empirical formula C31H40OSi2 
Formula mass 484.81 
T/ K 123(2) 
Crystal size [mm] 0.40 × 0.40 × 0.10 
Crystal description colorless block 
Crystal system monoclinic 
Space group P21/n 
a/ Å 8.1022(3) 
b/ Å 16.4356(5) 
c/ Å 21.6510(7) 
α/ ° 90.0 
ȕ/ ° 100.280(3) 
Ȗ/ ° 90.0 
V/ Å3 2836.86(17) 
Z 4 
ρcalcd./ g cm−3 1.135 
                                                     
XIX DIAMOND, Crystal Impact GbR., Version 3.2i. 
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μ/ mm−1 0.146 
F(000) 1048 
Θ range/ ° 4.18 – 25.24 
Index ranges −9 ≤ h ≤ 10 
 −21 ≤ k ≤ 20 
 −28 ≤ l ≤ 28 
Reflns. collected 24112 
Reflns. obsd. 5240 
Reflns. unique 7001 
(Rint = 0.0464) 
R1, wR2 (βσ data) 0.0462, 0.1107 
R1, wR2 (all data) 0.0693, 0.1215 
GOOF on F2 1.057 
Peak/hole/ e Å−3 0.410 / −0.259 
 
Acid syn-56. 
 
Figure 9: Molecular structure of acid syn-56 in the crystal, DIAMONDXX representation; thermal ellipsoids are drawn at 
50% probability level. 
                                                     
XX DIAMOND, Crystal Impact GbR., Version 3.2i. 
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Figure 10: Hydrogen bonding in the crystal of acid syn-56, DIAMOND representation; thermal ellipsoids are drawn at 50% 
probability level. Symmetry code for O2i: 1–x, 1–y, 1–z. 
Table 10: Details for X-ray data collection and structure refinement for acid syn-56. 
Empirical formula C16H22O2 
Formula mass 246.33 
T/ K 143(2) 
Crystal size [mm] 0.12 × 0.06 × 0.01 
Crystal description colorless platelet 
Crystal system triclinic 
Space group P-1 
a/ Å 6.3433(11) 
b/ Å 10.0842(15) 
c/ Å 12.023(2) 
α/ ° 101.204(13) 
ȕ/ ° 101.301(15) 
Ȗ/ ° 103.274(14) 
V/ Å3 710.6(2) 
Z 2 
ρcalcd./ g cm−3 1.151 
μ/ mm−1 0.074 
F(000) 268 
Θ range/ ° 4.21 – 25.24 
Index ranges −5 ≤ h ≤ 7 
 −12 ≤ k ≤ 12 
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 −14 ≤ l ≤ 14 
Reflns. collected 4899 
Reflns. obsd. 888 
Reflns. unique 2783 
(Rint = 0.0823) 
R1, wR2 (βσ data) 0.0757, 0.0731 
R1, wR2 (all data) 0.2632, 0.1174 
GOOF on F2 0.948 
Peak/hole/ e Å−3 0.169 / −0.220 
 
Bicyclo[4.3.0]nonane 59. 
 
Figure 11: Molecular structure of bicyclo[4.3.0]nonane 59 in the crystal, DIAMONDXXI representation; thermal ellipsoids 
are drawn at 50% probability level. 
Table 11: Details for X-ray data collection and structure refinement for bicyclo[4.3.0]nonane 59. 
Empirical formula C21H26 
Formula mass 278.42 
T/ K 143(2) 
Crystal size [mm] 0.39 × 0.35 × 0.17 
Crystal description colorless block 
Crystal system monoclinic 
Space group P21/c 
a/ Å 5.5039(3) 
b/ Å 45.1131(18) 
                                                     
XXI DIAMOND, Crystal Impact GbR., Version 3.2i. 
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c/ Å 7.0986(6) 
α/ ° 90.0 
ȕ/ ° 114.343(5) 
Ȗ/ ° 90.0 
V/ Å3 1605.86(18) 
Z 4 
ρcalcd./ g cm−3 1.152 
μ/ mm−1 0.064 
F(000) 608 
Θ range/ ° 4.16 – 25.24 
Index ranges −7 ≤ h ≤ 6 
 −60 ≤ k ≤ 46 
 −9 ≤ l ≤ 9 
Reflns. collected 14914 
Reflns. obsd. 3251 
Reflns. unique 3969 
(Rint = 0.0417) 
R1, wR2 (βσ data) 0.0567, 0.1267 
R1, wR2 (all data) 0.0693, 0.1353 
GOOF on F2 1.042 
Peak/hole/ e Å−3 0.284 / −0.184 
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12 Experimental Section Part I: Intramolecular Acylation Reactions 
Typical Procedure (TP5) for Esterification 
A solution of the diol (1.0 equiv.) in THF (3.1 M) was added to sodium hydride (1.05 equiv.) in THF 
(1.0 M) at 0 °C. The reaction mixture was allowed to warm to room temperature and was stirred for 1 h. 
After cooling to 0 °C, the acid chloride (1.0 equiv.) was added. After 16 h at room temperature, the 
reaction mixture was quenched with saturated aqueous NH4Cl solution. The phases were separated and 
the aqueous phase was extracted with diethyl ether. The combined organic layers were dried over 
MgSO4. The crude product was purified by column chromatography on silica. 
Typical Procedure (TP6) for Iodination 
A dry and argon-flushed Schlenk-flask was charged with a solution of PPh3 (1.2 equiv.) and 
N-methylimidazole (1.2 equiv.) in dichloromethane (0.3 M) and was cooled to −10 °C. Iodine 
(1.2 equiv.) was added and the resulting yellow solution was stirred for 15 min at −10 °C. The alcohol 
(1.0 equiv.) dissolved in dichloromethane (1.0 M) was added dropwise and the resulting reaction 
mixture was stirred for 2 h at −10 °C. The reaction mixture was quenched with saturated aqueous 
NaHSO3∙Na2S2O5 solution,XXII the phases were separated and the aqueous phase was extracted with 
dichloromethane. The combined organic layers were dried over MgSO4 and the solvents were 
evaporated at 30 °C. XXIII The residue was triturated three times with a mixture of hexane:diethyl ether 
(4:1).XXIV The residue was filtered off using a plug of silica and all organic phases were combined. All 
solvents were evaporated and the crude residue was subjected to column chromatography purification 
on silica yielding the respective title compound. 
Typical Procedure (TP7) for the Intramolecular Acylation and TBS-Protection 
A dry and argon-flushed Schlenk-tube with diethyl ether (0.2 M based on t-BuLi) was cooled to −100 °C 
and charged with a solution of t-BuLi (in pentane, 2.5 equiv.). The appropriate alkyl iodide (1.0 equiv.) 
in diethyl ether (0.4 M) was added dropwise over 10 min and the reaction mixture was stirred for 5 min 
at −100 °C. Saturated aqueous NH4Cl solution (10 drops) was added and the reaction mixture as allowed 
                                                     
XXII Quenching with water or unsaturated aqueous (NaHSO3·Na2S2O5) solution sometimes causes epimerisation 
of the product. 
XXIII Evaporation at higher temperatures (>30 °C) sometimes causes epimerisation of the product. 
XXIV Removal of triphenylphosphine oxide before column chromatography is recommended to get higher yield 
by washing and filtering the crude product with a mixture of hexane: ethyl ether. 
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to warm to room temperature. MgSO4 was added, the solution was filtrated over celite and the solvents 
were evaporated. 
The crude mixture and imidazole (2.5 equiv.) were dissolved in DMF (0.2 M). After cooling to 0 °C, 
TBSCl (1.2 equiv.) was added and the reaction mixture was allowed to stir at room temperature for 
16 h. Saturated aqueous NH4Cl solution was added, the phases were separated and the aqueous phase 
was extracted with diethyl ether. The combined organic layers were dried over MgSO4. The solvents 
were evaporated and the crude residue was subjected to column chromatography purification on silica 
yielding the respective title compound. 
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12.1 Preparation of the Esters 
 
In an argon-flushed Schlenk-flask, thionyl chloride (3.74 mL, 51.0 mmol, 1.0 equiv.) was added 
dropwise to a solution of hexane-2,5-diol 63 (6.28 g, 51.0 mmol, 1.0 equiv.) in dichloromethane 
(50 mL) at 0 °C. The reaction mixture was stirred at room temperature for 3 h. Volatile reagents and 
solvents were removed at 0 °C under high vacuum using a trap. The crude product was purified and the 
two diastereoisomers were separated by column chromatography on silica using hexane:diethyl ether 
(9:1) as an eluent to afford syn-S8 (16%, 1.29 g, 8.53 mmol) and anti-S8 (40%, 3.28 g, 19.9 mmol) as 
colourless oils.[93] 
 
anti-Hexane-2,5-diol anti-63.[93] anti-S8 (1.35 g, 8.22 mmol, 1.0 equiv.) was dissolved in aqueous 
NaOH (13.1 mL, 26.2 mmol, 3.2 equiv.) and the reaction mixture was refluxed for 1.5 h. The reaction 
mixture was saturated with sodium chloride, the phases were separated and the aqueous phase was 
extracted with ethyl acetate. The combined organic layers were dried over MgSO4. The crude product 
was purified by column chromatography on silica using ethyl acetate as an eluent to afford anti-63 as a 
colourless oil (94%, 913 mg, 7.73 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 3.87 – 3.76 (m, 2H), 2.50 (br s, 2H), 1.64 – 1.47 (m, 4H), 1.21 
(d, J = 6.2 Hz, 3H), 1.19 (d, J = 6.2 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 68.3, 35.9, 23.8. 
FT-IR (ATR, cm−1): �̃ = 3316, 2966, 2929, 2872, 1460, 1417, 1373, 1334, 1251, 1198, 1147, 1118, 
1056, 1017, 940, 923, 901, 879, 856, 840, 822. 
MS (EI, 70 eV): m/z (%) = 85 (100), 67 (33), 58 (10), 56 (15), 45 (40), 43 (27), 41 (39). 
HR-MS (EI, 70 eV): [C6H11O], calcd.: 99.0810; found: 99.0804 ([M−H−H2O]+). 
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syn-Hexane-2,5-diol syn-63.[93] syn-S8 (1.40 g, 8.52 mmol, 1.0 equiv.) was dissolved in aqueous 
NaOH (13.6 mL, 27.2 mmol, 3.2 equiv.) and the reaction mixture was refluxed for 1.5 h. The reaction 
mixture was saturated with sodium chloride, the phases were separated and the aqueous phase was 
extracted with ethyl acetate. The combined organic layers were dried over MgSO4. The crude product 
was purified by column chromatography on silica using ethyl acetate as an eluent to afford syn-63 as a 
colourless oil (90%, 905 mg, 7.66 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 3.91 – 3.81 (m, 2H), 1.93 (s, 2H), 1.60 – 1.48 (m, 4H), 1.21 
(d, J = 6.3 Hz, 6H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 68.0, 35.0, 23.5. 
FT-IR (ATR, cm−1): �̃ = 3319, 2967, 2930, 2872, 1461, 1414, 1374, 1330, 1124, 1056, 1012, 940, 896, 
857, 839, 823, 761. 
MS (EI, 70 eV): m/z (%) = 85 (100), 67 (32), 56 (15), 45 (20), 43 (17), 41 (19). 
HR-MS (EI, 70 eV): [C6H11O], calcd.: 99.0810; found: 99.0805 ([M−H−H2O]+). 
 
anti-5-Hydroxyhexan-2-yl benzoate anti-65a. Following TP5, deprotonated diol anti-63 (562 mg, 
4.76 mmol, 1.0 equiv.) was reacted with benzoyl chloride (550 µL, 4.76 mmol, 1.0 equiv.). The crude 
product was purified by column chromatography on silica using hexane:diethyl ether (1:2) as an eluent 
to afford anti-65a as a colourless oil (84%, 884 mg, 3.98 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 8.08 – 8.00 (m, 2H), 7.60 – 7.51 (m, 1H), 7.48 – 7.39 (m, 2H), 
5.19 (dqd, J = 7.6, 6.2, 4.9 Hz, 1H), 3.85 (h, J = 6.2 Hz, 1H), 1.87 (dddd, J = 13.4, 10.4, 7.5, 5.1 Hz, 
1H), 1.69 (dddd, J = 13.4, 9.7, 6.1, 5.0 Hz, 1H), 1.64 – 1.45 (m, 3H), 1.36 (d, J = 6.2 Hz, 3H), 1.21 (d, 
J = 6.2 Hz, 3H). 
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13C-NMR (101 MHz, CDCl3, ppm): δ = 166.2, 132.7, 130.6, 129.5, 128.3, 71.4, 67.7, 34.7, 32.1, 23.6, 
20.1. 
FT-IR (ATR, cm−1): �̃ = 3403, 2973, 2932, 2872, 1714, 1602, 1585, 1452, 1378, 1355, 1315, 1276, 
1177, 1113, 1099, 1070, 1044, 1026, 1015, 1003, 935, 920, 852, 712, 688, 674. 
MS (EI, 70 eV): m/z (%) = 122 (100), 106 (12), 85 (12), 77 (40). 56 (16), 45 (12). 
HR-MS (EI, 70 eV): [C13H19O3], calcd.: 223.1329; found: 223.1329 ([M+H]+). 
 
syn-5-Hydroxyhexan-2-yl benzoate syn-113f. Following TP5, deprotonated diol syn-63 (262 mg, 
2.22 mmol, 1.0 equiv.) was reacted with benzoyl chloride (260 µL, 2.22 mmol, 1.0 equiv.). The crude 
product was purified by column chromatography on silica using hexane:diethyl ether (1:2) as an eluent 
to afford syn-65a as a colourless oil (97%, 478 mg, 2.15 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 8.08 – 8.01 (m, 2H), 7.60 – 7.51 (m, 1H), 7.48 – 7.32 (m, 2H), 
5.18 (h, J = 6.3 Hz, 1H), 3.90 – 3.78 (m, 1H), 1.86 – 1.70 (m, 2H), 1.65 – 1.43 (m, 2H), 1.36 (d, 
J = 6.3 Hz, 3H), 1.21 (d, J = 6.2 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 166.2, 132.8, 130.6, 129.5, 128.3, 71.6, 67.9, 35.0, 32.3, 23.6, 
20.1. 
FT-IR (ATR, cm−1): �̃ = 3410, 2973, 2933, 1714, 1451, 1378, 1355, 1315, 1275, 1176, 1113, 1099, 
1070, 1046, 1026, 1012, 938, 712, 688, 674. 
MS (EI, 70 eV): m/z (%) = 123 (58), 105 (100), 77 (33). 
HR-MS (EI, 70 eV): [C13H17O2], calcd.: 205.1229; found: 205.1226 ([M−OH]+). 
 
anti-5-Hydroxyhexan-2-yl cyclohexanecarboxylate anti-65b. Following TP6, deprotonated diol 
anti-63 (244 mg, 2.07 mmol, 1.0 equiv.) was reacted with cyclohexanecarbonyl chloride (280 µL, 
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2.07 mmol, 1.0 equiv.). The crude product was purified by column chromatography on silica using 
hexane:diethyl ether (1:2) as an eluent to afford anti-65b as a colourless oil (79%, 373 mg, 1.63 mmol, 
d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 4.99 – 4.85 (m, 1H), 3.87 – 3.73 (m, 1H), 2.26 (tt, J = 11.3, 
3.6 Hz, 1H), 1.93 – 1.84 (m, 2H), 1.77 – 1.39 (m, 10H), 1.32 – 1.23 (m, 3H), 1.21 (d, J = 4.6 Hz, 3H), 
1.19 (d, J = 4.5 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 175.8, 70.0, 67.7, 43.4, 34.7, 32.0, 29.1, 28.9, 25.7, 25.4, 25.4, 
23.6, 20.0. 
FT-IR (ATR, cm−1): �̃ = 3435, 2931, 2856, 1727, 1708, 1451, 1377, 1354, 1330, 1312, 1297, 1279, 
1248, 1229, 1195, 1174, 1133, 1100, 1076, 1057, 1036, 1017, 947, 930, 896, 855, 845, 668, 660, 652. 
MS (EI, 70 eV): m/z (%) = 129 (61), 83 (100). 
HR-MS (EI, 70 eV): [C13H23O2], calcd.: 211.1698; found: 211.1673 ([M−OH]+). 
 
syn-5-Hydroxyhexan-2-yl cyclohexanecarboxylate syn-65b. Following TP5, deprotonated diol syn-
63 (248 mg, 2.10 mmol, 1.0 equiv.) was reacted with cyclohexanecarbonyl chloride (290 µL, 
2.10 mmol, 1.0 equiv.). The crude product was purified by column chromatography on silica using 
pentane:diethyl ether (1:2) as an eluent to afford syn-65b as a colourless oil (78%, 375 mg, 1.64 mmol, 
d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 4.90 (h, J = 6.3 Hz, 1H), 3.79 (dq, J = 12.3, 6.2 Hz, 1H), 2.25 
(tt, J = 11.3, 3.6 Hz, 1H), 1.88 (dtt, J = 12.3, 3.5, 1.7 Hz, 2H), 1.81 – 1.70 (m, 2H), 1.68 – 1.56 (m, 2H), 
1.53 – 1.35 (m, 4H), 1.35 – 1.21 (m, 4H), 1.21 (d, J = 4.3 Hz, 3H), 1.19 (d, J = 4.3 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 175.8, 70.3, 67.8, 43.4, 34.9, 32.2, 29.0, 28.9, 25.7, 25.4, 25.4, 
23.5, 20.0. 
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FT-IR (ATR, cm−1): �̃ = 3432, 2932, 2856, 1728, 1710, 1451, 1378, 1354, 1330, 1312, 1297, 1278, 
1248, 1229, 1195, 1174, 1131, 1076, 1059, 1037, 1019, 947, 896, 844. 
MS (EI, 70 eV): m/z (%) = 111 (100), 101 (29), 99 (20), 85 (27), 84 (12), 67 (12), 56 (29), 55 (80), 45 
(39), 43 (14), 41 (21). 
HR-MS (EI, 70 eV): [C13H25O3], calcd.: 229.1798; found: 229.1808 ([M+H]+). 
 
anti-5-Hydroxyhexan-2-yl isobutyrate anti-65c. Following TP5, deprotonated diol anti-63 (285 mg, 
2.41 mmol, 1.0 equiv.) was reacted with isobutyryl chloride (260 µL, 2.41 mmol, 1.0 equiv.). The crude 
product was purified by column chromatography on silica using hexane:diethyl ether (1:2) as an eluent 
to afford anti-65c as a colourless oil (75%, 342 mg, 1.82 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 4.92 (dqd, J = 7.7, 6.2, 4.8 Hz, 1H), 3.87 – 3.74 (m, 1H), 2.51 
(hept, J = 7.0 Hz, 1H), 1.76 – 1.65 (m, 1H), 1.62 – 1.30 (m, 4H), 1.21 (d, J = 6.3 Hz, 3H), 1.20 (d, 
J = 6.1 Hz, 3H), 1.16 (d, J = 7.0 Hz, 3H), 1.15 (d, J = 7.0 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 176.8, 70.2, 67.7, 34.7, 34.1, 32.0, 23.6, 19.9, 19.0, 18.9. 
FT-IR (ATR, cm−1): �̃ = 3422, 2973, 2935, 2877, 1729, 1712, 1470, 1462, 1385, 1378, 1359, 1335, 
1266, 1196, 1161, 1123, 1096, 1072, 1045, 1015, 943, 930, 900, 892, 858, 823, 756. 
MS (EI, 70 eV): m/z (%) = 115 (12), 89 (69), 71 (100). 
HR-MS (EI, 70 eV): [C10H21O3], calcd.: 189.1485; found: 189.1485 ([M+H]+). 
 
syn-5-Hydroxyhexan-2-yl isobutyrate syn-65c. Following TP5, deprotonated diol syn-63 (238 mg, 
2.01 mmol, 1.0 equiv.) was reacted with isobutyryl chloride (220 µL, 2.01 mmol, 1.0 equiv.). The crude 
product was purified by column chromatography on silica using hexane:diethyl ether (1:2) as an eluent 
to afford syn-65c as a colourless oil (76%, 287 mg, 1.52 mmol, d.r.>99:1). 
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1H-NMR (400 MHz, CDCl3, ppm): δ = 4.90 (h, J = 6.3 Hz, 1H), 3.86 – 3.73 (m, 1H), 2.50 (hept, 
J = 7.0 Hz, 1H), 1.71 – 1.53 (m, 3H), 1.53 – 1.39 (m, 2H), 1.21 (d, J = 6.3 Hz, 3H), 1.19 (d, J = 6.1 Hz, 
3H), 1.15 (d, J = 7.0 Hz, 3H), 1.15 (d, J = 7.0 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 176.9, 70.5, 67.8, 34.9, 34.1, 32.2, 23.5, 19.9, 19.0, 18.9. 
FT-IR (ATR, cm−1): �̃ = 3432, 2973, 2935, 2877, 1730, 1713, 1470, 1462, 1385, 1335, 1266, 1197, 
1162, 1126, 1097, 1070, 1046, 1012, 943, 858. 
MS (EI, 70 eV): m/z (%) = 101 (52), 99 (18), 95 (17), 93 (10), 91 (18), 89 (20), 83 (100), 81 (25). 
HR-MS (EI, 70 eV): [C10H19O2], calcd.: 171.1385; found: 171.1379 ([M−OH]+). 
 
anti-5-Hydroxyhexan-2-yl pentanoate anti-65d. Following TP5, deprotonated diol anti-63 (240 mg, 
2.03 mmol, 1.0 equiv.) was reacted with valeroyl chloride (250 µL, 2.03 mmol, 1.0 equiv.). The crude 
product was purified by column chromatography on silica using hexane:diethyl ether (1:2) as an eluent 
to afford anti-65d as a colourless oil (77%, 317 mg, 1.57 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 4.98 – 4.88 (m, 1H), 3.86 – 3.76 (m, 1H), 2.28 (dd, J = 7.5 Hz, 
2H), 1.76 – 1.65 (m, 1H), 1.65 – 1.53 (m, 3H), 1.53 – 1.40 (m, 3H), 1.40 – 1.29 (m, 2H), 1.22 (d, 
J = 6.3 Hz, 3H), 1.20 (d, J = 6.2 Hz, 3H), 0.91 (t, J = 7.4 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 173.5, 70.4, 67.7, 34.7, 34.4, 32.0, 27.1, 23.6, 22.2, 20.0, 13.7. 
FT-IR (ATR, cm−1): �̃ = 3406, 2962, 2933, 2874, 1730, 1713, 1457, 1419, 1376, 1333, 1311, 1289, 
1260, 1181, 1151, 1138, 1125, 1109, 1093, 1058, 1045, 1015, 942, 912, 889, 853, 754, 734, 668. 
MS (EI, 70 eV): m/z (%) = 157 (16), 103 (47), 85 (100), 57 (37). 
HR-MS (EI, 70 eV): [C11H21O2], calcd.: 185.1542; found: 185.1541 ([M−OH]+). 
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syn-5-Hydroxyhexan-2-yl pentanoate syn-65d. Following TP5, deprotonated diol syn-63 (241 mg, 
2.04 mmol, 1.0 equiv.) was reacted with valeroyl chloride (250 µL, 2.04 mmol, 1.0 equiv.). The crude 
product was purified by column chromatography on silica using hexane:diethyl ether (1:2) as an eluent 
to afford syn-65d as a colourless oil (79%, 326 mg, 1.61 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 4.91 (h, J = 6.3 Hz, 1H), 3.86 – 3.74 (m, 1H), 2.28 (t, 
J = 7.5 Hz, 2H), 1.70 – 1.54 (m, 5H), 1.55 – 1.41 (m, 2H), 1.34 (dq, J = 14.6, 7.3 Hz, 2H), 1.22 (d, 
J = 6.3 Hz, 3H), 1.20 (d, J = 6.1 Hz, 3H), 0.91 (t, J = 7.4 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 173.6, 70.6, 67.8, 34.9, 34.4, 32.2, 27.1, 23.6, 22.2, 20.0, 13.7. 
FT-IR (ATR, cm−1): �̃ = 3420, 2962, 2934, 2874, 1731, 1714, 1460, 1419, 1377, 1333, 1310, 1289, 
1262, 1182, 1128, 1109, 1094, 1060, 1046, 1012, 941. 
MS (EI, 70 eV): m/z (%) = 103 (46), 85 (100), 83 (20), 57 (34), 56 (27), 55 (15), 45 (22), 43 (13), 41 
(18). 
HR-MS (EI, 70 eV): [C11H21O2], calcd.: 185.1542; found: 185.1534 ([M−OH]+). 
 
anti-5-Hydroxyhexan-2-yl thiophene-2-carboxylate anti-65e. Following TP5, deprotonated diol 
anti-63 (259 mg, 2.19 mmol, 1.0 equiv.) was reacted with 2-thiophenecarbonyl chloride (240 µL, 
2.19 mmol, 1.0 equiv.). The crude product was purified by column chromatography on silica using 
hexane:diethyl ether (1:2) as an eluent to afford anti-65e as a colourless oil (70%, 349 mg, 1.53 mmol, 
d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.79 (dd, J = 3.8, 1.3 Hz, 1H), 7.54 (dd, J = 5.0, 1.2 Hz, 1H), 
7.10 (dd, J = 5.0, 3.7 Hz, 1H), 5.15 (dqd, J = 7.7, 6.3, 4.9 Hz, 1H), 3.85 (h, J = 6.2 Hz, 1H), 1.91 – 1.78 
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(m, 1H), 1.75 – 1.63 (m, 1H), 1.63 – 1.45 (m, 2H), 1.37 (br s, 1H), 1.35 (d, J = 6.3 Hz, 3H), 1.21 (d, 
J = 6.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 161.9, 134.4, 133.1, 132.1, 127.6, 71.8, 67.7, 34.7, 32.1, 23.6, 
20.1. 
FT-IR (ATR, cm−1): �̃ = 3393, 1972, 2932, 1701, 1526, 1450, 1417, 1225, 1364, 1263, 1225, 1092, 
1076, 1038, 1013, 932, 861, 752, 720. 
MS (EI, 70 eV): m/z (%) = 186 (43), 184 (10), 128 (98), 112 (17), 99 (24), 85 (31), 83 (13), 82 (12), 
58 (45), 56 (35), 55 (20), 45 (51), 43 (34), 41 (19). 
HR-MS (EI, 70 eV): [C11H16O3S], calcd.: 228.0820; found: 228.0820 (M+). 
 
syn-5-Hydroxyhexan-2-yl thiophene-2-carboxylate syn-65e. Following TP5, deprotonated diol 
syn-63 (246 mg, 2.08 mmol, 1.0 equiv.) was reacted with 2-thiophenecarbonyl chloride (230 µL, 
2.08 mmol, 1.0 equiv.). The crude product was purified by column chromatography on silica using 
hexane:diethyl ether (1:2) as an eluent to afford syn-65e as a colourless oil (72%, 340 mg, 1.49 mmol, 
d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.79 (dd, J = 3.7, 1.3 Hz, 1H), 7.54 (dd, J = 5.0, 1.2 Hz, 1H), 
7.10 (dd, J = 5.0, 3.7 Hz, 1H), 5.13 (h, J = 6.3 Hz, 1H), 3.83 (dqd, J = 7.5, 6.2, 5.0 Hz, 1H), 1.82 – 1.71 
(m, 2H), 1.62 – 1.45 (m, 3H), 1.35 (d, J = 6.2 Hz, 3H), 1.21 (d, J = 6.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 161.9, 134.3, 133.1, 132.1, 127.6, 72.0, 67.8, 34.9, 32.3, 23.6, 
20.1. 
FT-IR (ATR, cm−1): �̃ = 3392, 2971, 2932, 2871, 1698, 1526, 1459, 1450, 1417, 1364, 1261, 1225, 
1128, 1090, 1076, 1060, 1037, 1009, 938, 914, 861, 816, 750, 717, 660. 
MS (EI, 70 eV): m/z (%) = 186 (82), 184 (17), 113 (20), 112 (31), 99 (31), 85 (41), 83 (17), 58 (30), 
56 (24), 55 (16), 45 (35), 42 (19). 
HR-MS (EI, 70 eV): [C11H17O3S], calcd.: 229.0893; found: 229.0900 ([M+H]+). 
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12.2 Preparation of the Iodides 
 
syn-5-Iodohexan-2-yl benzoate syn-64a. Following TP6, anti-65a (622 mg, 2.80 mmol, 1.0 equiv.) 
was used as starting material. The crude product was purified by column chromatography on silica 
using hexane:diethyl ether (20:1) as an eluent to afford syn-64a as a colourless oil (97%, 901 mg, 
2.71 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 8.08 – 8.01 (m, 2H), 7.61 – 7.52 (m, 1H), 7.49 – 7.40 (m, 2H), 
5.24 – 5.12 (m, 1H), 4.25 – 4.12 (m, 1H), 1.93 (d, J = 6.9 Hz, 3H), 1.91 – 1.73 (m, 4H), 1.37 (d, 
J = 6.2 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 166.1, 132.8, 130.5, 129.5, 128.3, 70.9, 38.8, 36.3, 29.6, 28.9, 
20.1. 
FT-IR (ATR, cm−1): �̃ = 2977, 1715, 1450, 1379, 1355, 1314, 1275, 1228, 1176, 1111, 1070, 1046, 
1026, 712, 688. 
MS (EI, 70 eV): m/z (%) = 205 (11), 123 (17), 105 (100), 83 (39), 77 (30), 55 (24). 
HR-MS (EI, 70 eV): [C13H17O2], calcd.: 205.1229; found: 205.1223 ([M−I]+). 
 
anti-5-Iodohexan-2-yl benzoate anti-64a. Following TP6, syn-65a (358 mg, 1.61 mmol, 1.0 equiv.) 
was used as starting material. The crude product was purified by column chromatography on silica 
using hexane:diethyl ether (20:1) as an eluent to afford anti-64a as a colourless oil (98%, 525 mg, 
1.58 mmol, d.r.>99:1). 
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1H-NMR (400 MHz, CDCl3, ppm): δ = 8.08 – 8.01 (m, 2H), 7.61 – 7.52 (m, 1H), 7.49 – 7.40 (m, 2H), 
5.20 (dqd, J = 8.0, 6.3, 4.3 Hz, 1H), 4.21 (dqd, J = 8.5, 6.8, 4.4 Hz, 1H), 2.02 – 1.86 (m, 5H), 1.84 – 1.63 
(m, 2H), 1.37 (d, J = 6.2 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 166.1, 132.8, 130.5, 129.5, 128.3, 70.4, 38.4, 36.1, 29.5, 29.0, 
20.2. 
FT-IR (ATR, cm−1): �̃ = 2978, 2918, 1714, 1450, 1379, 1352, 1314, 1274, 1229, 1176, 1130, 1110, 
1070, 1045, 1026, 711, 688. 
MS (EI, 70 eV): m/z (%) = 205 (23), 123 (27), 106 (13), 83 (87), 77 (44), 55 (39), 41 (12). 
HR-MS (EI, 70 eV): [C13H17O2], calcd.: 205.1229; found: 205.1222 ([M−I]+). 
 
syn-5-Iodohexan-2-yl cyclohexanecarboxylate syn-64b. Following TP6, anti-65b (357 mg, 
1.56 mmol, 1.0 equiv.) was used as starting material. The crude product was purified by column 
chromatography on silica using hexane:diethyl ether (20:1) as an eluent to afford syn-64b as a colourless 
oil (86%, 456 mg, 1.35 mmol, d.r. = 87:13). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 4.98 – 4.85 (m, 1H), 4.20 – 4.09 (m, 1H), 2.26 (tt, J = 11.2, 
3.6 Hz, 1H), 1.92 (d, J = 6.8 Hz, 3H), 1.90 – 1.58 (m, 9H), 1.49 – 1.37 (m, 2H), 1.34 – 1.22 (m, 3H), 
1.21 (d, J = 6.3 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 175.7, 69.5, 43.3, 38.7, 36.1, 29.5, 29.0, 28.9, 28.9, 25.7, 25.4, 
25.4, 20.0. 
FT-IR (ATR, cm−1): �̃ = 2976, 2930, 2854, 1724, 1448, 1378, 1328, 1312, 1274, 1246, 1228, 1192, 
1170, 1126, 1076, 1060, 1034, 986, 948, 896, 844, 760. 
MS (EI, 70 eV): m/z (%) = 211 (12). 129 (21), 84 (11), 57 (12), 55 (61), 41 (19). 
HR-MS (EI, 70 eV): [C13H23O2], calcd.: 211.1698; found: 211.1705 ([M−I]+). 
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anti-5-Iodohexan-2-yl cyclohexanecarboxylate anti-64b. Following TP5, syn-65b (175 mg, 
0.776 mmol, 1.0 equiv.) was used as starting material. The crude product was purified by column 
chromatography on silica using pentane:diethyl ether (20:1) as an eluent to afford anti-64b as a 
colourless oil (50%, 130 mg, 0.384 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 4.99 – 4.89 (m, 1H), 4.22 – 4.12 (m, 1H), 2.26 (tt, J = 11.3, 
3.6 Hz, 1H), 1.94 – 1.70 (m, 8H), 1.68 – 1.57 (m, 3H), 1.49 – 1.36 (m, 2H), 1.35 – 1.19 (m, 7H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 175.7, 69.0, 43.3, 38.3, 35.9, 29.5, 29.1, 28.9, 28.9, 25.7, 25.4, 
25.4, 20.1. 
FT-IR (ATR, cm−1): �̃ = 2975, 2931, 2855, 1726, 1449, 1378, 1329, 1311, 1275, 1247, 1227, 1193, 
1172, 1131, 1076, 1035, 896, 845. 
MS (EI, 70 eV): m/z (%) = 129 (13), 111 (16), 83 (100), 55 (25). 
HR-MS (EI, 70 eV): [C13H23O2], calcd.: 211.1698; found: 211.1690 ([M−I]+). 
 
syn-5-Iodohexan-2-yl isobutyrate syn-64c. Following TP6, anti-65c (335 mg, 1.78 mmol, 1.0 equiv.) 
was used as starting material. The crude product was purified by column chromatography on silica 
using hexane:diethyl ether (20:1) as an eluent to afford syn-64c as a colourless oil (69%, 365 mg, 
1.22 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 4.98 – 4.85 (m, 1H), 4.21 – 4.09 (m, 1H), 2.51 (hept, 
J = 7.0 Hz, 1H), 1.92 (d, J = 6.8 Hz, 3H), 1.87 – 1.58 (m, 4H), 1.22 (d, J = 6.3 Hz, 3H), 1.16 (d, 
J = 7.0 Hz, 3H), 1.15 (d, J = 7.0 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 176.7, 69.7, 38.7, 36.0, 34.1, 29.5, 28.9, 19.9, 19.0, 18.9. 
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FT-IR (ATR, cm−1): �̃ = 2975, 2360, 2340, 1730, 1468, 1384, 1262, 1195, 1161, 1126, 1069, 668. 
MS (EI, 70 eV): m/z (%) = 171 (14), 89 (12), 83 (100), 71 (53), 55 (46), 43 (40), 41 (19). 
HR-MS (EI, 70 eV): [C9H16O2I], calcd.: 283.0195; found: 283.0194 ([M−Me]+). 
 
anti-5-Iodohexan-2-yl isobutyrate anti-64c. Following TP6, syn-65c (287 mg, 1.52 mmol, 1.0 equiv.) 
was used as starting material. The crude product was purified by column chromatography on silica 
using hexane:diethyl ether (20:1) as an eluent to afford anti-64c as a colourless oil (90%, 408 mg, 
1.37 mmol, d.r. = 92:8). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 4.98 – 4.88 (m, 1H), 4.23 – 4.11 (m, 1H), 2.51 (hept, 
J = 7.0 Hz, 1H), 1.92 (d, J = 6.8 Hz, 3H), 1.89 – 1.70 (m, 2H), 1.70 – 1.58 (m, 2H), 1.22 (d, J = 6.3 Hz, 
3H), 1.16 (d, J = 7.0 Hz, 3H), 1.15 (d, J = 7.0 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 176.7, 69.2, 38.3, 35.9, 34.1, 29.4, 28.9, 20.0, 19.0, 18.9. 
FT-IR (ATR, cm−1): �̃ = 2974, 2934, 2876, 1728, 1468, 1458, 1446, 1384, 1356, 1334, 1296, 1262, 
1228, 1194, 1160, 1126, 1096, 1070, 1046, 1034, 984, 942, 910, 896, 852, 760. 
MS (EI, 70 eV): m/z (%) = 185 (13), 103 (10), 85 (60), 83 (100). 
HR-MS (EI, 70 eV): [C10H18O2I], calcd.: 297.0351; found: 297.0346 ([M−H]+). 
 
syn-5-Iodohexan-2-yl pentanoate syn-64d. Following TP6, anti-63 (304 mg, 1.50 mmol, 1.0 equiv.) 
was used as starting material. The crude product was purified by column chromatography on silica 
using hexane:diethyl ether (20:1) as an eluent to afford syn-64d as a colourless oil (88%, 414 mg, 
1.33 mmol, d.r. = 93:7). 
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1H-NMR (400 MHz, CDCl3, ppm): δ = 4.96 – 4.87 (m, 1H), 4.20 – 4.09 (m, 1H), 2.28 (dd, J = 7.5 Hz, 
2H), 1.92 (d, J = 6.8 Hz, 3H), 1.86 – 1.55 (m, 6H), 1.42 – 1.28 (m, 2H), 1.22 (d, J = 6.2 Hz, 3H), 0.92 
(t, J = 7.3 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 173.4, 69.9, 38.7, 36.1, 34.3, 29.5, 28.9, 27.1, 22.2, 20.0, 13.7. 
FT-IR (ATR, cm−1): �̃ = 2958, 2932, 2872, 1730, 1446, 1420, 1378, 1334, 1310, 1290, 1252, 1228, 
1178, 1126, 1108, 1090, 1060, 1048, 1030, 986, 946, 898, 844, 758. 
MS (EI, 70 eV): m/z (%) = 185 (15), 103 (13), 85 (69), 83 (100), 57 (33), 55( 48), 41 (15). 
HR-MS (EI, 70 eV): [C11H21O2], calcd.: 185.1542; found: 185.1537 ([M−I]+). 
 
anti-5-Iodohexan-2-yl pentanoate anti-64d. Following TP6, syn-63 (313 mg, 1.55 mmol, 1.0 equiv.) 
was used as starting material. The crude product was purified by column chromatography on silica 
using hexane:diethyl ether (20:1) as an eluent to afford anti-64d as a colourless oil (86%, 414 mg, 
1.33 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 4.99 – 4.90 (m, 1H), 4.22 – 4.12 (m, 1H), 2.28 (dd, J = 7.5 Hz, 
2H), 1.92 (d, J = 6.8 Hz, 3H), 1.89 – 1.71 (m, 2H), 1.68 – 1.54 (m, 4H), 1.40 – 1.29 (m, 2H), 1.23 (d, 
J = 6.3 Hz, 3H), 0.92 (t, J = 7.3 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 173.5, 69.4, 38.3, 35.9, 34.3, 29.4, 28.9, 27.1, 22.2, 20.1, 13.7. 
FT-IR (ATR, cm−1): �̃ = 2959, 2933, 2872, 2362, 1731, 1456, 1446, 1420, 1378, 1334, 1289, 1253, 
1228, 1179, 1129, 1109, 1092, 1059, 1046, 1034, 984, 949. 
MS (EI, 70 eV): m/z (%) = 185 (15), 103 (14), 85 (68), 83 (100), 57 (41), 55( 61), 41 (27). 
HR-MS (EI, 70 eV): [C10H18O2I], calcd.: 297.0351; found: 297.0352 ([M−Me]+). 
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syn-5-Iodohexan-2-yl thiophene-2-carboxylate syn-64e. Following TP6, anti-65e (348 mg, 
1.52 mmol, 1.0 equiv.) was used as starting material. The crude product was purified by column 
chromatography on silica using hexane:diethyl ether (20:1) as an eluent to afford syn-64e as a colourless 
oil (96%, 495 mg, 1.46 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.80 (dd, J = 3.8, 1.3 Hz, 1H), 7.55 (dd, J = 5.0, 1.3 Hz, 1H), 
7.10 (dd, J = 5.0, 3.7 Hz, 1H), 5.22 – 5.06 (m, 1H), 4.25 – 4.10 (m, 1H), 1.93 (d, J = 6.9 Hz, 3H), 
1.91 – 1.72 (m, 4H), 1.36 (d, J = 6.3 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 161.8, 134.2, 133.2, 132.2, 127.7, 71.4, 38.7, 36.2, 29.6, 28.9, 
20.1. 
FT-IR (ATR, cm−1): �̃ = 3101, 2977, 2359, 1703, 1525, 1444, 1418, 1378, 1363, 1280, 1258, 1225, 
1179, 1128, 1091, 1075, 1035, 986, 915, 861, 816, 751, 720. 
MS (EI, 70 eV): m/z (%) = 211 (35), 129 (30), 112 (13), 83 (100), 55 (41), 41 (12). 
HR-MS (EI, 70 eV): [C11H15O2S], calcd.: 211.0793; found: 211.0792 ([M−I]+). 
 
anti-5-Iodohexan-2-yl thiophene-2-carboxylate anti-64e. Following TP6, syn-65e (340 mg, 
1.49 mmol, 1.0 equiv.) was used as starting material. The crude product was purified by column 
chromatography on silica using hexane:diethyl ether (20:1) as an eluent to afford anti-64e as a 
colourless oil (92%, 464 mg, 1.37 mmol, d.r.>99:1). 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.79 (dd, J = 3.7, 1.3 Hz, 1H), 7.55 (dd, J = 5.0, 1.3 Hz, 1H), 
7.10 (dd, J = 5.0, 3.7 Hz, 1H), 5.15 (dqd, J = 7.9, 6.3, 4.3 Hz, 1H), 4.26 – 4.16 (m, 1H), 1.98 – 1.86 (m, 
5H), 1.80 – 1.64 (m, 2H), 1.36 (d, J = 6.3 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 161.8, 134.2, 133.2, 132.2, 127.7, 70.8, 38.3, 36.0, 29.5, 28.9, 
20.2. 
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FT-IR (ATR, cm−1): �̃ = 3101, 2977, 2934, 2864, 1700, 1525, 1444, 1418, 1378, 1363, 1279, 1258, 
1223, 1177, 1131, 1089, 1075, 1035, 983, 916, 897, 862, 817, 749, 718, 660. 
MS (EI, 70 eV): m/z (%) = 211 (53), 129 (56), 112 (19), 83 (11), 41 (35). 
HR-MS (EI, 70 eV): [C11H15O2S], calcd.: 211.0793; found: 211.0778 ([M−I]+). 
12.3 Preparation of Ketones 
 
Ketone syn-69a. Following TP7, iodide syn-64a (102 mg, 0.307 mmol, 1.0 equiv., d.r.>99:1) was 
reacted with t-BuLi (1.95 M, 0.39 mL, 0.768 mmol, 2.5 equiv.). TBS-protection was carried out with 
imidazole (53 mg, 0.758 mmol, 2.5 equiv.) and TBSCl (55 mg, 0.368 mmol, 1.2 equiv.). The crude 
product was purified by column chromatography on silica using hexane:diethyl ether (50:1) as an eluent 
to afford syn-69a as a colourless oil (42%, 41 mg, 0.128 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 8.00 – 7.90 (m, 2H), 7.60 – 7.51 (m, 1H), 7.50 – 7.42 (m, 2H), 
3.83 – 3.70 (m, 1H), 3.45 (h, J = 6.8 Hz, 1H), 1.84 – 1.72 (m, 1H), 1.61 – 1.51 (m, 1H), 1.45 – 1.33 (m, 
2H), 1.20 (d, J = 6.9 Hz, 3H), 1.09 (d, J = 6.1 Hz, 3H), 0.86 (s, 9H), 0.02 (s, 6H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 204.4, 136.7, 132.8, 128.6, 128.2, 68.6, 40.7, 37.2, 29.8, 25.8, 
23.7, 18.1, 17.4, −4.4, −4.8. 
FT-IR (ATR, cm−1): �̃ = 2956, 2930, 2857, 1684, 1462, 1448, 1374, 1361, 1254, 1230, 1197, 1132, 
1093, 1057, 1002, 990, 971, 835, 809, 796, 774, 703, 688. 
MS (EI, 70 eV): m/z (%) = 263 (55), 221 (19), 171 (11), 146 (11), 145 (100), 105 (26), 91 (12), 77 (22), 
75 (67), 73 (34), 57 (14), 55 (11). 
HR-MS (EI, 70 eV): [C19H31O2Si], calcd.: 319.2093; found: 319.2088 ([M−H]+). 
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Ketone anti-69a. Following TP7, iodide anti-64a (102 mg, 0.307 mmol, 1.0 equiv., d.r.>99:1) was 
reacted with t-BuLi (1.95 M, 0.39 mL, 0.768 mmol, 2.5 equiv.). TBS-protection was carried out with 
imidazole (53 mg, 0.758 mmol, 2.5 equiv.) and TBSCl (55 mg, 0.368 mmol, 1.2 equiv.). The crude 
product was purified by column chromatography on silica using pentane as an eluent to afford anti-69a 
as a colourless oil (81%, 80 mg, 0.250 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.98 – 7.91 (m, 2H), 7.60 – 7.52 (m, 1H), 7.50 – 7.43 (m, 2H), 
3.79 – 3.68 (m, 1H), 3.48 – 3.38 (m, 1H), 1.96 – 1.83 (m, 1H), 1.48 – 1.35 (m, 3H), 1.20 (d, J = 6.8 Hz, 
3H), 1.10 (d, J = 6.1 Hz, 3H), 0.84 (s, 9H), 0.01 (s, 3H), –0.02 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 204.3, 136.6, 132.7, 128.6, 128.2, 68.4, 40.6, 37.1, 29.6, 25.8, 
23.6, 18.0, 16.9, −4.5, −4.9. 
FT-IR (ATR, cm−1): �̃ = 2956, 2930, 2886, 2856, 1684, 1598, 1472, 1462, 1448, 1374, 1362, 1274, 
1252, 1230, 1198, 1180, 1132, 1092, 1056, 1002, 988, 968, 938, 898, 880, 832, 810, 796, 772, 702, 
686, 656. 
MS (EI, 70 eV): m/z (%) = 319 (18), 225 (11), 221 (20), 161 (29), 15 (100), 131 (17), 75 (47), 73 (10). 
HR-MS (EI, 70 eV): [C18H29O2Si], calcd.: 305.1935; found: 305.1931 ([M−Me]+). 
 
Ketone syn-69b. Following TP7, iodide syn-64b (99 mg, 0.293 mmol, 1.0 equiv., d.r. = 87:13) was 
reacted with t-BuLi (1.95 M, 0.38 mL, 0.733 mmol, 2.5 equiv.). TBS-protection was carried out with 
imidazole (50 mg, 0.733 mmol, 2.5 equiv.) and TBSCl (53 mg, 0.352 mmol, 1.2 equiv.). The crude 
product was purified by column chromatography on silica using hexane:diethyl ether (50:1) as an eluent 
to afford syn-69b as a colourless oil (34%, 33 mg, 0.101 mmol, d.r. = 90:10). 
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1H-NMR (400 MHz, CDCl3, ppm): δ = 3.78 – 3.68 (m, 1H), 2.70 – 2.57 (m, 1H), 2.50 – 2.39 (m, 1H), 
1.84 – 1.70 (m, 4H), 1.69 – 1.63 (m, 1H), 1.63 – 1.51 (m, 1H), 1.46 – 1.18 (m, 8H), 1.09 (d, J = 6.1 Hz, 
3H), 1.05 – 0.99 (m, 3H), 0.87 (s, 9H), 0.03 (s, 6H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 217.7, 68.6, 49.7, 44.5, 37.3, 29.2, 28.6, 28.4, 25.8, 25.8, 25.7, 
25.6, 23.8, 18.1, 16.7, −4.4, −4.8. 
FT-IR (ATR, cm−1): �̃ = 2930, 2856, 1708, 1472, 1462, 1450, 1374, 1362, 1256, 1134, 1100, 1056, 
994, 894, 836, 808, 794, 774. 
MS (EI, 70 eV): m/z (%) = 269 (17), 177 (21), 159 (17), 145 (100), 135 (18), 121 (12), 119 (12), 95 
(22), 93 (12), 83 (13), 81 (13), 75 (69), 73 (19). 
HR-MS (EI, 70 eV): [C19H37O2Si], calcd.: 325.2563; found: 325.2554 ([M−H]+). 
 
Ketone anti-69b. Following TP7, iodide anti-64b (118 mg, 0.349 mmol, 1.0 equiv., d.r.>99:1) was 
reacted with t-BuLi (1.95 M, 0.45 mL, 0.873 mmol, 2.5 equiv.). TBS-protection was carried out with 
imidazole (60 mg, 0.873 mmol, 2.5 equiv.) and TBSCl (63 mg, 0.419 mmol, 1.2 equiv.). The crude 
product was purified by column chromatography on silica using hexane:diethyl ether (50:1) as an eluent 
to afford anti-69b as a colourless oil (64%, 73 mg, 0.224 mmol, d.r. = 92:8). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 3.79 – 3.68 (m, 1H), 2.60 (h, J = 6.8 Hz, 1H), 2.50 – 2.40 (m, 
1H), 1.82 – 1.60 (m, 6H), 1.39 – 1.18 (m, 8H), 1.10 (d, J = 6.1 Hz, 3H), 1.03 (d, J = 6.9 Hz, 3H), 0.87 
(s, 9H), 0.03 (s, 3H), 0.02 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 217.5, 68.4, 49.5, 44.6, 37.3, 28.9, 28.6, 28.4, 25.8, 25.8, 25.7, 
25.6, 23.6, 18.0, 16.4, −4.4, −4.8. 
FT-IR (ATR, cm−1): �̃ = 2929, 2856, 1707, 1472, 1462, 1450, 1374, 1362, 1253, 1140, 1134, 1098, 
1050, 993, 939, 892, 883, 833, 808, 772, 714, 677, 662. 
MS (EI, 70 eV): m/z (%) = 269 (16), 177 (20), 159 (16), 145 (100), 135 (18), 121 (11), 119 (19), 95 
(23), 93 (11), 83 (12), 81 (13), 75 (68), 73 (17), 55 (11). 
HR-MS (EI, 70 eV): [C18H35O2Si], calcd.: 311.2406; found: 311.2398 ([M−Me]+). 
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Ketone syn-69c. Following TP7, iodide syn-64c (83 mg, 0.278 mmol, 1.0 equiv., d.r.>99:1) was 
reacted with t-BuLi (2.15 M, 0.32 mL, 0.695 mmol, 2.5 equiv.). TBS-protection was carried out with 
imidazole (48 mg, 0.695 mmol, 2.5 equiv.) and TBSCl (50 mg, 0.334 mmol, 1.2 equiv.). The crude 
product was purified by column chromatography on silica using hexane:diethyl ether (50:1) as an eluent 
to afford syn-69c as a colourless oil (50%, 40 mg, 0.140 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 3.80 – 3.70 (m, 1H), 2.79 – 2.61 (m, 2H), 1.65 – 1.54 (m, 1H), 
1.48 – 1.37 (m, 1H), 1.37 – 1.24 (m, 2H), 1.10 (d, J = 6.1 Hz, 3H), 1.08 (d, J = 5.4 Hz, 3H), 1.06 (d, 
J = 4.0 Hz, 3H), 1.06 – 1.04 (m, 3H), 0.88 (s, 9H), 0.04 (s, 6H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 218.4, 68.6, 44.5, 39.5, 37.3, 29.3, 25.8, 23.8, 18.4, 18.2, 18.1, 
16.8, −4.4, −4.8. 
FT-IR (ATR, cm−1): �̃ = 2963, 2931, 2858, 1714, 1472, 1463, 1380, 1375, 1362, 1255, 1160, 1135, 
1061, 1020, 1006, 895, 883, 836, 810, 796, 774. 
MS (EI, 70 eV): m/z (%) = 229 (29), 187 (14), 173 (14), 169 (13), 159 (25), 155 (10), 145 (70), 141 
(12), 137 (17), 119 (26), 95 (28), 81 (14), 75 (100), 73 (21). 
HR-MS (EI, 70 eV): [C16H33O2Si], calcd.: 285.2250; found: 285.2239 ([M−H]+). 
 
Ketone anti-69c. Following TP7, iodide anti-64c (90 mg, 0.301 mmol, 1.0 equiv., d.r. = 92:8) was 
reacted with t-BuLi (2.22 M, 0.34 mL, 0.753 mmol, 2.5 equiv.). TBS-protection was carried out with 
imidazole (52 mg, 0.753 mmol, 2.5 equiv.) and TBSCl (54 mg, 0.361 mmol, 1.2 equiv.). The crude 
product was purified by column chromatography on silica using hexane:diethyl ether (50:1) as an eluent 
to afford anti-69c as a colourless oil (47%, 40 mg, 0.140 mmol, d.r. = 90:10). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 3.80 – 3.70 (m, 1H), 2.73 (m, 1H), 2.69 – 2.59 (m, 1H), 
1.78 – 1.67 (m, 1H), 1.40 – 1.21 (m, 3H), 1.11 (d, J = 6.1 Hz, 3H), 1.08 (d, J = 5.8 Hz, 3H), 1.06 (d, 
J = 5.8 Hz, 3H), 1.05 (d, J = 6.9 Hz, 3H), 0.88 (s, 9H), 0.04 (s, 3H), 0.03 (s, 3H). 
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13C-NMR (101 MHz, CDCl3, ppm): δ = 218.3, 68.4, 44.5, 39.3, 37.3, 29.0, 25.8, 23.6, 18.5, 18.3, 18.1, 
16.5, −4.4, −4.8. 
FT-IR (ATR, cm−1): �̃ = 2962, 2930, 2858, 1712, 1462, 1376, 1362, 1254, 1134, 1078, 1046, 1016, 
1006, 980, 938, 894, 884, 834, 810, 772, 712, 662. 
MS (EI, 70 eV): m/z (%) = 229 (23), 187 (22), 173 (10), 169 (15), 159 (16), 145 (80), 137 (15), 133 
(10), 119 (25), 95 (31), 81 (11), 75 (100), 73 (21). 
HR-MS (EI, 70 eV): [C16H33O2Si], calcd.: 285.2250; found: 285.2243 ([M−H]+). 
 
Ketone syn-69d. Following TP7, iodide syn-64d (92 mg, 0.295 mmol, 1.0 equiv., d.r. = 93:7) was 
reacted with t-BuLi (1.95 M, 0.38 mL, 0.738 mmol, 2.5 equiv.). TBS-protection was carried out with 
imidazole (51 mg, 0.738 mmol, 2.5 equiv.) and TBSCl (53 mg, 0.354 mmol, 1.2 equiv.). The crude 
product was purified by column chromatography on silica using hexane:diethyl ether (50:1) as an eluent 
to afford syn-69d as a colourless oil (20%, 18 mg, 0.060 mmol, d.r. = 91:9). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 3.79 – 3.69 (m, 1H), 2.53 – 2.45 (m, 1H), 2.41 (td, J = 7.3, 
2.9 Hz, 2H), 1.65 – 1.48 (m, 3H), 1.48 – 1.37 (m, 1H), 1.37 – 1.23 (m, 4H), 1.10 (d, J = 6.1 Hz, 3H), 
1.05 (d, J = 7.0 Hz, 3H), 0.90 (t, J = 7.4 Hz, 3H), 0.87 (s, 9H), 0.03 (s, 6H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 215.0, 68.5, 46.3, 40.8, 37.1, 29.1, 25.8, 25.7, 23.7, 22.4, 18.1, 
16.4, 13.8, −4.4, −4.8. 
FT-IR (ATR, cm−1): �̃ = 2958, 2930, 2858, 1714, 1462, 1376, 1362, 1256, 1164, 1136, 1104, 1078, 
1058, 1042, 1006, 994, 896, 882, 836, 810, 774. 
MS (EI, 70 eV): m/z (%) = 243 (35), 201 (16), 159 (15), 145 (100), 109 (11), 95 (14), 75 (67), 73 (16). 
HR-MS (EI, 70 eV): [C17H35O2Si], calcd.: 299.2406; found: 299.2392 ([M−H]+). 
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Ketone anti-69d. Following TP7, iodide anti-64d (95 mg, 0.304 mmol, 1.0 equiv., d.r.>99:1) was 
reacted with t-BuLi (1.95 M, 0.39 mL, 0.760 mmol, 2.5 equiv.). TBS-protection was carried out with 
imidazole (52 mg, 0.760 mmol, 2.5 equiv.) and TBSCl (55 mg, 0.365 mmol, 1.2 equiv.). The crude 
product was purified by column chromatography on silica using hexane:diethyl ether (50:1) as an eluent 
to afford anti-69d as a colourless oil (39%, 36 mg, 0.120 mmol, d.r. = 98:2). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 3.75 (h, J = 6.0 Hz, 1H), 2.54 – 2.43 (m, 1H), 2.41 (td, J = 7.2, 
1.0 Hz, 2H), 1.78 – 1.67 (m, 1H), 1.59 – 1.48 (m, 2H), 1.40 – 1.23 (m, 5H), 1.10 (d, J = 6.1 Hz, 3H), 
1.05 (d, J = 6.9 Hz, 3H), 0.89 (t, J = 7.3 Hz, 3H), 0.87 (s, 9H), 0.04 (s, 3H), 0.03 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 214.8, 68.3, 46.3, 40.5, 37.1, 28.9, 25.8, 25.8, 23.6, 22.4, 18.1, 
16.2, 13.8, −4.4, −4.8. 
FT-IR (ATR, cm−1): �̃ = 2958, 2930, 2858, 1712, 1472, 1462, 1375, 1362, 1254, 1135, 1041, 1004, 
939, 881, 834, 809, 773, 714, 663. 
MS (EI, 70 eV): m/z (%) = 243 (24), 201 (22), 159 (10), 145 (100), 109 (10), 95 (11), 75 (63), 73 (13). 
HR-MS (EI, 70 eV): [C16H33O2Si], calcd.: 285.2250; found: 285.2242 ([M−Me]+). 
 
Ketone syn-69e. Following TP7, iodide syn-64e (97 mg, 0.287 mmol, 1.0 equiv., d.r.>99:1) was 
reacted with t-BuLi (2.15 M, 0.33 mL, 0.718 mmol, 2.5 equiv.). TBS-protection was carried out with 
imidazole (49 mg, 0.718 mmol, 2.5 equiv.) and TBSCl (52 mg, 0.344 mmol, 1.2 equiv.). The crude 
product was purified by column chromatography on aluminium oxide using hexane:diethyl ether (20:1) 
as an eluent to afford syn-69e as a colourless oil (38%, 36 mg, 0.110 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.72 (dd, J = 3.8, 1.1 Hz, 1H), 7.63 (dd, J = 4.9, 1.1 Hz, 1H), 
7.13 (dd, J = 4.9, 3.8 Hz, 1H), 3.82 – 3.70 (m, 1H), 3.26 (h, J = 6.9 Hz, 1H), 1.84 – 1.71 (m, 1H), 
1.64 – 1.55 (m, 1H), 1.48 – 1.34 (m, 2H), 1.22 (d, J = 6.9 Hz, 3H), 1.09 (d, J = 6.1 Hz, 3H), 0.87 (s, 
9H), 0.03 (s, 6H). 
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13C-NMR (101 MHz, CDCl3, ppm): δ = 197.3, 144.3, 133.5, 131.5, 128.0, 68.6, 42.7, 37.3, 30.3, 25.8, 
23.8, 18.1, 17.9, −4.5, −4.8. 
FT-IR (ATR, cm−1): �̃ = 2959, 2929, 2857, 1659, 1518, 1462, 1415, 1367, 1251, 1238, 1195, 1132, 
1055, 1005, 988, 932, 835, 810, 774, 721, 698. 
MS (EI, 70 eV): m/z (%) = 269 (35), 227 (28), 225 (19), 207 (14), 177 (12), 145 (89), 137 (100), 135 
(13), 110 (36), 97 (11), 93 (10), 75 (69), 73 (17). 
HR-MS (EI, 70 eV): [C16H27O2SSi], calcd.: 311.1501; found: 311.1487 ([M−Me]+). 
 
Ketone anti-69e. Following TP7, iodide anti-64e (95 mg, 0.281 mmol, 1.0 equiv., d.r.>99:1) was 
reacted with t-BuLi (2.15 M, 0.33 mL, 0.703 mmol, 2.5 equiv.). TBS-protection was carried out with 
imidazole (48 mg, 0.703 mmol, 2.5 equiv.) and TBSCl (51 mg, 0.341 mmol, 1.2 equiv.). The crude 
product was purified by column chromatography on aluminium oxide using hexane:diethyl ether (50:1) 
as an eluent to afford anti-69e as a colourless oil (21%, 19 mg, 0.058 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.71 (dd, J = 3.8, 1.1 Hz, 1H), 7.62 (dd, J = 5.0, 1.1 Hz, 1H), 
7.13 (dd, J = 5.0, 3.8 Hz, 1H), 3.77 (h, J = 5.9 Hz, 1H), 3.29 – 3.19 (m, 1H), 1.94 – 1.85 (m, 1H), 
1.48 – 1.39 (m, 3H), 1.22 (d, J = 6.9 Hz, 3H), 1.11 (d, J = 6.0 Hz, 3H), 0.85 (s, 9H), 0.02 (s, 3H), 0.00 
(s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 197.1, 144.2, 133.4, 131.4, 128.0, 68.3, 42.6, 37.2, 29.8, 25.8, 
23.6, 18.1, 17.4, −4.5, −4.8. 
FT-IR (ATR, cm−1): �̃ = 2956, 2929, 2856, 1708, 1662, 1518, 1472, 1462, 1416, 1363, 1253, 1237, 
1198, 1131, 1092, 1054, 1005, 986, 929, 835, 809, 774, 719, 662. 
MS (EI, 70 eV): m/z (%) = 325 (68), 225 (78), 209 (26), 207 (58), 193 (42), 185 (35), 167 (26), 145 
(46), 137 (100), 75 (63), 73 (22). 
HR-MS (EI, 70 eV): [C17H29O2SSi], calcd.: 325.1658; found: 325.1649 ([M−H]+). 
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13 Experimental Section Part II: A New Arylthio/Magnesium-
Exchange 
Typical Procedure (TP8) for the Introduction of the Thioether 
A dry and argon-flushed Schlenk-flask was charged with a solution of Boc-protected piperidine 
(1.0 equiv.) and TMEDA in diethyl ether (0.5 M) and cooled to −78 °C. s-BuLi was added and the 
resulting solution was stirred for 3 h at −78 °C. The thioether source dissolved in diethyl ether (0.8 M) 
was added dropwise and the resulting reaction mixture was allowed to warm to room temperature over 
16 h. The reaction mixture was quenched with water, the phases were separated and the aqueous phase 
was extracted with diethyl ether. The combined organic layers were dried over MgSO4 and the solvents 
were evaporated. The crude residue was subjected to column chromatography purification on silica 
yielding the respective title compound. 
Typical Procedure (TP9) for the Preparation of s-BuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu 71a 
A dry and argon-flushed Schlenk-flask was charged with magnesium bis(2-ethylhexanolate) 
Mg[OCH2CH(Et)Bu]2 (0.84 M in heptane, 20.0 mL, 16.8 mmol) and cooled to 0 °C. s-BuLi (1.15 M in 
hexane, 14.6 mL, 16.8 mmol) was added dropwise. The reaction mixture was warmed to room 
temperature and was stirred for 2 h resulting in a slightly yellow solution. Solvents were removed in 
vacuo and dry toluene (7 mL) was added under stirring at 0 °C. Following titration with iodine at 0 °C 
gave a concentration of 1.0–1.3 M. 
Typical Procedure (TP10) for the Preparation of s-Bu2Mg·2LiOCH2CH(Et)Bu 71b 
A dry and argon-flushed Schlenk-flask was charged with magnesium bis(2-ethylhexanolate) 
Mg[OCH2CH(Et)Bu]2 (0.84 M in heptane, 10.0 mL, 8.40 mmol) and cooled to 0 °C. s-BuLi (1.15 M in 
hexane, 14.6 mL, 16.8 mmol) was added dropwise. The reaction mixture was warmed to room 
temperature and was stirred for 2 h resulting in a slightly yellow solution. Solvents were removed in 
vacuo and dry toluene (3.5 mL) was added under stirring at 0 °C. Following titration with iodine at 0 °C 
gave a concentration of 0.90 M. 
Typical Procedure (TP11) for the Exchange of the Thioether 
A dry and argon-flushed Schlenk-tube was charged with a solution of the thioether (1.0 equiv.), 
TMEDA (3.0 equiv.) and undecane (10 µL/0.300 mmol), as internal standard, in toluene (0.5 M). 
s-BuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu 71a (3.0 equiv.) was added via syringe pump 
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(0.05 mL/min) and the resulting solution was stirred for the appropriate time at room temperature. The 
magnesium alkoxide species was reacted with the electrophile under the conditions given below. The 
reaction mixture was quenched with saturated aqueous NH4Cl solution. The phases were separated and 
the aqueous phase was extracted with diethyl ether. The combined organic layers were dried over 
MgSO4. The crude product was purified by column chromatography on silica. 
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13.1 Preparation of N-Boc-Protected Piperidines and Introduction of the Thioether 
 
N-Boc piperidine 108a.[139] Piperidine 107a (19.8 mL, 200 mmol, 1.0 equiv.) was added dropwise to a 
solution of di-tert-butyl dicarbonate (42.8 mL, 200 mmol, 1.0 equiv.) in THF (146 mL) at 0 °C. The 
reaction mixture was stirred at room temperature for 2 h. After the addition of a saturated aqueous 
NaHCO3 solution the reaction mixture was extracted with diethyl ether. The combined organic layers 
were dried over MgSO4. The crude product was purified by distillation (30 °C/1.8·10–1 mbar) to afford 
108a as a colourless liquid (100%, 37.1 g, 200 mmol). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 3.39 – 3.32 (m, 4H), 1.61 – 1.53 (m, 2H), 1.53 – 1.47 (m, 4H), 
1.45 (s, 9H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 154.9, 79.0, 28.4, 27.4, 25.7, 24.5. 
FT-IR (ATR, cm−1): �̃ = 2978, 2934, 2856, 1690, 1474, 1448, 1418, 1392, 1364, 1282, 1268, 1258, 
1238, 1212, 1176, 1144, 1118, 1068, 1026, 988, 956, 908, 868, 852, 812, 768. 
MS (EI, 70 eV): m/z (%) = 130 (51), 129 (55), 128 (100), 126 (10), 114 (30), 112 (28), 84 (75), 69 (11). 
HR-MS (EI, 70 eV): [C10H19O2N], calcd.: 185.1416; found: 185.1408 (M+). 
 
Thioether 106a. Following TP8, N-Boc piperidine 108a (3.71 g, 20.0 mmol, 1.0 equiv.) was reacted 
with TMEDA (6.57 mL, 44.1 mmol, 2.2 equiv.), s-BuLi (1.32 M, 18.2 mL, 24.0 mmol, 1.2 equiv.) and 
diphenyl disulfide (5.30 g, 24.0 mmol, 1.2 equiv.). The crude product was purified by column 
chromatography on silica using dichloromethane as an eluent to afford 106a as a colourless oil (73%, 
4.27 g, 14.6 mmol). NMR experiments show the different signals of the rotamers at 25 °C in CDCl3, 
that merge to sharp signals at 65 °C in CD3CN. 
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1H-NMR (400 MHz, CDCl3, ppm, rotamers): δ = 7.55 – 7.43 (m, 2H), 7.35 – 7.20 (m, 3H), 6.04 (br 
s, 0.4H), 5.78 (br s, 0.6H), 4.06 (br s, 0.7H), 3.85 (s, 0.3H), 3.30 (td, J = 13.1, 2.8 Hz, 1H), 2.07 – 1.78 
(m, 3H), 1.78 – 1.58 (m, 2H), 1.54 – 1.37 (m, 1H), 1.30 (s, 3.2H), 1.18 (d, J = 20.6 Hz, 5.8H). 
13C-NMR (101 MHz, CDCl3, ppm, rotamers): δ = 153.8, 134.9, 133.9, 128.8, 127.9 & 127.4, 79.8, 
64.1 & 61.7, 39.3 & 38.0, 31.2 & 30.3, 27.9, 25.4, 19.7. 
1H-NMR (400 MHz, 65 °C, CD3CN, ppm): δ = 7.52 – 7.48 (m, 2H), 7.33 – 7.28 (m, 3H), 5.91 (s, 1H), 
3.94 (dd, J = 13.2, 2.2 Hz, 1H), 3.24 (td, J = 13.1, 2.9 Hz, 1H), 1.98 – 1.89 (m, 1H), 1.89 – 1.78 (m, 
2H), 1.76 – 1.62 (m, 2H), 1.50 – 1.37 (m, 1H), 1.26 (s, 9H). 
13C-NMR (101 MHz, 65 °C, CD3CN, ppm): δ = 155.0, 135.6, 135.3, 130.3, 129.0, 80.9, 64.7, 40.1, 
32.2, 28.8, 26.5, 20.9. 
FT-IR (ATR, cm−1): �̃ = 2972, 2944, 2926, 1680, 1472, 1442, 1436, 1402, 1390, 1364, 1352, 1334, 
1312, 1280, 1252, 1210, 1180, 1156, 1140, 1112, 1082, 1072, 1032, 1002, 982, 920, 910, 868, 824, 
812, 764, 746, 704, 688. 
MS (EI, 70 eV): m/z (%) = 183 (18), 128 (100), 127 (28), 110 (59), 109 (16), 84 (67), 83 (16), 82 (18), 
57 (82), 41 (17). 
HR-MS (EI, 70 eV): [C16H23O2NS], calcd.: 293.1449; found: 293.1449 (M+). 
 
Thioether 106b. Following TP8, N-Boc piperidine 108a (1.84 g, 9.93 mmol, 1.0 equiv.) was reacted 
with TMEDA (1.92 mL, 12.9 mmol, 1.3 equiv.), s-BuLi (1.15 M, 11.2 mL, 12.9 mmol, 1.3 equiv.) and 
dimethyl disulfide (1.34 mL, 14.9 mmol, 1.5 equiv.). The crude product was purified by column 
chromatography on silica using pentane:diethyl ether (9:1) as an eluent to afford 106b as a colourless 
oil (50%, 1.16 g, 5.00 mmol). 
 
1H-NMR (600 MHz, CDCl3, ppm, rotamers): δ = 5.79 – 5.66 (br s, 0.3H), 5.55 (br s, 0.4H), 4.00 (br 
s, 0.4H), 3.86 (br s, 0.3H), 3.15 (m, 1H), 2.02 (s, 3H), 1.86 – 1.78 (m, 2H), 1.78 – 1.68 (m, 1H), 
1.68 – 1.62 (m, 1H), 1.62 – 1.56 (m, 1H), 1.46 (s, 9H), 1.44 – 1.37 (m, 1H). 
13C-NMR (101 MHz, CDCl3, ppm, rotamers): δ = 154.4, 79.9, 59.6 & 58.9, 38.7 & 37.5, 30.6, 28.3, 
25.4, 19.7, 13.4. 
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FT-IR (ATR, cm−1): �̃ = 2976, 2938, 2866, 1688, 1402, 1364, 1310, 1274, 1250, 1182, 1156, 1138, 
1110, 1032, 986, 866, 760, 666. 
MS (EI, 70 eV): m/z (%) = 184 (25), 128 (100), 84 (87), 57 (56). 
HR-MS (EI, 70 eV): [C11H20O2NS], calcd.: 230.1215; found: 230.1202 ([M−H]+). 
 
Thioether 106c. Following TP8, N-Boc piperidine 108a (2.06 g, 11.1mmol, 1.0 equiv.) was reacted 
with TMEDA (2.15 mL, 14.5 mmol, 1.3 equiv.), s-BuLi (1.32 M, 11.0 mL, 14.5 mmol, 1.3 equiv.) and 
S-(4-methoxyphenyl) phenylthiosulfonate (4.05 g, 14.5 mmol, 1.3 equiv.). The crude product was 
purified by column chromatography on silica using dichloromethane as an eluent to afford 106c as a 
colourless oil (51%, 1.83 g, 5.65 mmol). 
 
1H-NMR (400 MHz, CDCl3, ppm, rotamers): δ = 7.50 – 7.33 (m, 2H), 6.92 – 6.74 (m, 2H), 5.91 (br 
s, 0.3H), 5.66 (br s, 0.6H), 4.04 (d, J = 10.6 Hz, 0.6H), 3.85 (br s, 0.4H), 3.77 (s, 3H), 3.31 (td, J = 13.1, 
2.9 Hz, 1H), 1.97 – 1.60 (m, 5H), 1.51 – 1.37 (m, 1H), 1.33 – 1.22 (br s, 3.2H), 1.16 (br s, 5.9H). 
13C-NMR (101 MHz, CDCl3, ppm, rotamers): δ = 160.0, 153.8, 137.0 & 136.6, 124.2 & 123.7, 114.4, 
79.6, 64.1 & 62.1, 55.2, 39.2 & 37.8, 30.7 & 29.9, 28.1 & 27.9, 25.4, 19.7. 
FT-IR (ATR, cm−1): �̃ = 2938, 1690, 1592, 1492, 1402, 1392, 1364, 1310, 1276, 1262, 1244, 1180, 
1172, 1154, 1140, 1108, 1030, 980, 866, 826, 812, 798, 760, 658. 
MS (EI, 70 eV): m/z (%) = 183 (19), 127 (92), 110 (29), 82 (70), 57 (100). 
HR-MS (EI, 70 eV): [C17H26O3NS], calcd.: 324.1628; found: 324.1626 ([M+H]+). 
 
Thioether 106d. Following TP8, N-Boc piperidine 108a (1.99 g, 10.7 mmol, 1.0 equiv.) was reacted 
with TMEDA (2.08mL, 13.9 mmol, 1.3 equiv.), s-BuLi (1.15 M, 12.1 mL, 13.9 mmol, 1.3 equiv.) and 
S-(4-fluorophenyl) phenylthiosulfonate (4.32 g, 13.9 mmol, 1.3 equiv.). The crude product was purified 
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by column chromatography on silica using dichloromethane as an eluent to afford 106d as a colourless 
solid (48%, 1.61 g, 5.18 mmol). 
 
m.p.: 67.3 – 69.5 °C. 
1H-NMR (400 MHz, –5 °C, CDCl3, ppm, rotamers): δ = 7.51 – 7.40 (m, 2H), 7.05 – 6.91 (m, 2H), 
6.00 – 5.94 (m, 0.4H), 5.73 – 5.68 (m, 0.6H), 4.06 (dd, J = 13.1, 2.5 Hz, 0.6H), 3.83 (d, J = 13.0 Hz, 
0.4H), 3.35 – 3.22 (m, 1H), 2.03 – 1.61 (m, 6H), 1.44 (m, 1H), 1.26 (s, 3.4H), 1.11 (s, 5.6H). 
13C-NMR (101 MHz, –5 °C, CDCl3, ppm, rotamers): δ = 162.9 (d, J = 248.3 Hz) & 162.6 (d, 
J = 247.6 Hz), 153.9 & 153.6, 137.4 (d, J = 8.4 Hz) & 136.8 (d, J = 8.4 Hz), 128.5 (d, J = 3.3 Hz) & 
127.8 (d, J = 3.2 Hz), 115.9 (d, J = 21.6 Hz) & 115.7 (d, J = 21.7 Hz), 79.8 & 79.8, 64.0 (d, J = 1.3 Hz) 
& 61.9 (d, J = 0.8 Hz), 38.9 & 37.5, 30.7 & 29.8, 28.0 & 27.7, 25.3 & 25.2, 19.7 & 19.5. 
FT-IR (ATR, cm−1): �̃ = 2944, 1680, 1590, 1488, 1400, 1364, 1352, 1314, 1280, 1258, 1222, 1210, 
1178, 1154, 1140, 1112, 1088, 1032, 982, 866, 828, 812, 764, 716. 
MS (EI, 70 eV): m/z (%) = 238 (16), 184 (69), 129 (18), 128 (84), 127 (25), 108 (11), 83 (14), 82 (13), 
41 (17). 
HR-MS (EI, 70 eV): [C16H20O2NFS], calcd.: 309.1199; found: 309.1203 ([M−2H]+). 
 
tert-Butyl 4-methylpiperidine-1-carboxylate 108b.[140] Di-tert-butyl dicarbonate (11.5 mL, 
50.1 mmol, 1.0 equiv.) was added portionwise to a solution of 4-methylpiperidine 107b (6.17 mL, 
50.1 mmol, 1.0 equiv.) and trimethylamine (6.94 mL, 50.1 mmol, 1.0 equiv.) in dichloromethane
 
(36 mL) at 0 °C. The reaction mixture was stirred at room temperature for 4 h. After the addition of 
water, the mixture was extracted with dichloromethane. The combined organic layers were dried over 
MgSO4. The crude product was purified by distillation (41 – 43 °C/2.7 – 4.0·10-1 mbar) to afford 108b 
as a colourless liquid (98%, 9.82 g, 49.3 mmol). 
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1H-NMR (400 MHz, CDCl3, ppm): δ = 4.05 (d, J = 13.2 Hz, 2H), 2.67 (td, J = 12.7, 2.6 Hz, 2H), 1.59 
(d, J = 11.2 Hz, 3H), 1.54 – 1.46 (m, 1H), 1.45 (s, 9H), 1.07 (tdd, J = 12.5, 11.2, 4.4 Hz, 2H), 0.93 (d, 
J = 6.5 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 154.9, 79.1, 44.0, 34.0, 30.9, 28.4, 21.8. 
FT-IR (ATR, cm−1): �̃ = 2924, 2848, 1690, 1446, 1416, 1392, 1378, 1364, 1304, 1276, 1258, 1238, 
1212, 1174, 1146, 1084, 1004, 972, 902, 864, 830, 768. 
MS (EI, 70 eV): m/z (%) = 144 (68), 13 (58), 142 (98), 140 (15), 128 (53), 126 (49), 98 (100), 84 (34), 
57 (18). 
HR-MS (EI, 70 eV): [C11H21O2N], calcd.: 199.1572; found: 199.1564 (M+). 
 
Thioether 111. Following TP8, tert-butyl 4-methylpiperidine-1-carboxylate 108b (1.99 g, 10.0 mmol, 
1.0 equiv.) was reacted with TMEDA (1.80 mL, 12.0 mmol, 1.2 equiv.), s-BuLi (1.50 M, 8.00 mL, 
12.0 mmol, 1.2 equiv.) and diphenyl disulfide (2.65 g, 12.0 mmol, 1.2 equiv.). The crude product was 
purified by column chromatography on silica using dichloromethane (1st column) and hexane:diethyl 
ether (95:5; 2nd column) as an eluent to afford 111 as a colourless oil (73%, 2.25 g, 7.31 mmol, 
d.r.>99:1). 
 
1H-NMR (400 MHz, –5 °C, CDCl3, ppm, rotamers): δ = 7.52 – 7.45 (m, 2H), 7.32 – 7.22 (m, 3H), 
6.05 (d, J = 4.9 Hz, 0.3H), 5.79 (d, J = 5.1 Hz, 0.7H), 4.12 – 4.02 (m, 0.7H), 3.89 – 3.82 (m, 0.4H), 
3.40 – 3.27 (m, 1H), 2.04 – 1.88 (m, 2H), 1.74 – 1.63 (m, 1H), 1.56 – 1.44 (m, 2H), 1.26 (s, 2.9H), 1.08 
(s, 6.9H), 0.93 (d, J = 6.4 Hz, 1.6H), 0.91 (d, J = 6.5 Hz, 1.4H). 
13C-NMR (101 MHz, –5 °C, CDCl3, ppm rotamers): δ = 153.8 & 153.6, 135.2 & 134.0, 133.4 & 
133.0, 128.9 & 128.7, 128.2 & 127.6, 79.8 & 79.7, 63.9 & 61.6, 39.3 & 39.0, 38.3 & 37.7, 33.8 & 33.7, 
28.0 & 27.7, 26.2 & 26.0, 21.9 & 21.8. 
FT-IR (ATR, cm−1): �̃ = 2974, 2930, 2874, 1692, 1404, 1392, 1364, 1294, 1248, 1156, 1124, 1088, 
1066, 966, 858, 748, 734, 690, 656. 
MS (EI, 70 eV): m/z (%) = 142 (100), 141 (21), 126 (31), 110 (36), 98 (31), 82 (23). 
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HR-MS (EI, 70 eV): [C13H16ONS], calcd.: 234.0953; found: 234.0945 ([M−Ot-Bu]+). 
13.2 Thioether Exchange and Subsequent Trapping Reactions 
 
N-Boc piperidine 108a. Following TP11, thioether 106a (88 mg, 0.300 mmol, 1.0 equiv.) and 
TMEDA (134 µL, 0.900 mmol, 3.0 equiv.) were reacted with s-BuMgOCH2CH(Et)Bu· 
LiOCH2CH(Et)Bu (1.10 M, 0.82 mL, 0.900 mmol, 3.0 equiv.). After a reaction time of 6 h, the reaction 
mixture was quenched with saturated aqueous NH4Cl. The crude product was purified by column 
chromatography on silica using hexane:diethyl ether (9:1) as an eluent to afford 108a as a colourless 
oil (79%, 44 mg, 0.237 mmol). 
All analytical data can be accessed in section 13.1. 
 
N-Boc piperidine-2-d 110b. Following TP11, thioether 106a (88 mg, 0.300 mmol, 1.0 equiv.) and 
TMEDA (134 µL, 0.900 mmol, 3.0 equiv.) were reacted with s-BuMgOCH2CH(Et)Bu· 
LiOCH2CH(Et)Bu (1.30 M, 0.69 mL, 0.900 mmol, 3.0 equiv.). After a reaction time of 6 h, the reaction 
mixture was cooled to 0 °C and quenched with AcOD/D2O (0.10 mL each). The crude product was 
purified by column chromatography on silica using pentane:diethyl ether (9:1) as an eluent to afford 
110b as a colourless oil (70%, 39 mg, 0.209 mmol). The amount of the deuterated product in the isolated 
material is >97%. 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 3.42 – 3.28 (m, 3H), 1.63 – 1.53 (m, 2H), 1.53 – 1.46 (m, 4H), 
1.45 (s, 9H). 
D-NMR (61 MHz, CDCl3, ppm): δ = 3.4. 
13C-NMR (101 MHz, CDCl3, ppm): δ = 155.1, 79.2, 44.8, 44.5 (t, J = 21.1 Hz), 28.6, 25.9, 25.8, 24.6. 
FT-IR (ATR, cm−1): �̃ = 2976, 2934, 2856, 1688, 1476, 1444, 1414, 1392, 1364, 1336, 1314, 1300, 
1270, 1254, 1164, 1132, 1084, 1070, 1040, 890, 866, 846, 768. 
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MS (EI, 70 eV): m/z (%) = 131 (18), 130 (38), 129 (32), 128 (11), 85 (37), 84 (12), 57 (100), 41 (18). 
HR-MS (EI, 70 eV): [C10H18DO2N], calcd.: 186.1479; found: 186.1473 (M+). 
 
Thioether 106b. Following TP11, thioether 106a (88 mg, 0.300 mmol, 1.0 equiv.) and TMEDA 
(134 µL, 0.900 mmol, 3.0 equiv.) were reacted with s-BuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu 
(1.14 M, 0.79 mL, 0.900 mmol, 3.0 equiv.). After a reaction time of 6 h, the reaction mixture was cooled 
to 0 °C and quenched with S-methyl phenylthiosulfonate (565 mg, 3.00 mmol, 10 equiv.). The crude 
product was purified by column chromatography on silica using pentane:diethyl ether (9:1) as an eluent 
to afford 106b as a colourless oil (85%, 59 mg, 0.255 mmol). 
All analytical data can be accessed in section 13.1. 
 
Allyl piperidine 110c. Following TP11, thioether 106a (88 mg, 0.300 mmol, 1.0 equiv.) and TMEDA 
(134 µL, 0.900 mmol, 3.0 equiv.) were reacted with s-BuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu 
(1.30 M, 0.69 mL, 0.900 mmol, 3.0 equiv.). After a reaction time of 6 h, the reaction mixture was cooled 
to 0 °C and allyl bromide (259 µL, 3.00 mmol, 10 equiv.) was added. The reaction mixture was cooled 
to −40 °C and CuCN·2LiCl (1.0 M, 0.09 mL, 0.090 mmol, 0.3 equiv.) was added. The solution was 
slowly warmed to room temperature over 16 h. The crude product was purified by column 
chromatography on silica using pentane:diethyl ether (95:5) as an eluent to afford 110c as a colourless 
oil (52%, 35 mg, 0.155 mmol). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 5.74 (ddt, J = 17.2, 10.1, 7.2 Hz, 1H), 5.05 (dq, J = 17.0, 
1.5 Hz, 1H), 5.00 (ddt, J = 10.0, 2.0, 1.1 Hz, 1H), 4.27 (br s, 1H), 3.97 (d, J = 13.5 Hz, 1H), 2.76 (td, 
J = 13.2, 2.7 Hz, 1H), 2.39 (dddt, J = 13.8, 8.3, 7.1, 1.3 Hz, 1H), 2.29 – 2.14 (m, 1H), 1.66 – 1.53 (m, 
5H), 1.45 (s, 9H), 1.42 – 1.33 (m, 1H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 155.1, 135.6, 116.5, 79.0, 50.0, 38.8, 34.4, 28.4, 27.6, 25.4, 
18.8. 
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FT-IR (ATR, cm−1): �̃ = 2976, 2934, 2858, 1686, 1448, 1408, 1392, 1364, 1320, 1266, 1244, 1166, 
1144, 1094, 1078, 1068, 1032, 1008, 994, 912, 868, 766. 
MS (EI, 70 eV): m/z (%) = 184 (17), 128 (100), 127 (14), 110 (23), 84 (59), 57 (40). 
HR-MS (EI, 70 eV): [C10H18O2N], calcd.: 184.1338; found: 184.1338 ([M−allyl]+). 
 
N-Boc piperidine 110d. Following TP11, thioether 106a (88 mg, 0.300 mmol, 1.0 equiv.) and 
TMEDA (134 µL, 0.900 mmol, 3.0 equiv.) were reacted with s-BuMgOCH2CH(Et)Bu· 
LiOCH2CH(Et)Bu (1.00 M, 0.90 mL, 0.900 mmol, 3.0 equiv.). After a reaction time of 6 h, the reaction 
mixture was cooled to −40 °C and ZnCl2-solution (1.0 M in THF, 0.90 mL, 3.00 mmol, 10 equiv.) was 
added. After warming up to room temperature, the solution was recooled to –40 °C and SPhos (12 mg, 
0.030 mmol, 10 mol%), Pd(dba)2 (8.6 mg, 0.015 mmol, 5 mol%) and 4-iodoanisole (215 mg, 
0.900 mmol, 3.0 equiv.) were added. The reaction was stirred at 55 °C for 16 h. The crude product was 
purified by column chromatography on silica using hexane:diethyl ether (9:1) as an eluent to afford 
110d as a colourless oil (25%, 22 mg, 0.076 mmol). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.17 – 7.09 (m, 2H), 6.93 – 6.83 (m, 2H), 5.37 (d, J = 2.9 Hz, 
1H), 4.07 – 3.96 (m, 1H), 3.80 (s, 3H), 2.73 (ddd, J = 13.5, 11.5, 3.9 Hz, 1H), 2.32 – 2.21 (m, 1H), 
1.92 – 1.79 (m, 1H), 1.63 – 1.49 (m, 3H), 1.46 (s, 10H) 
13C-NMR (101 MHz, CDCl3, ppm): δ = 158.0, 155.5, 132.1, 127.6, 113.8, 79.4, 55.2, 52.5, 39.8, 28.4, 
27.9, 25.5, 19.3. 
FT-IR (ATR, cm−1): �̃ = 2974, 2936, 2864, 1684, 1610, 1512, 1456, 1410, 1392, 1364, 1288, 1270, 
1246, 1176, 1154, 1134, 1126, 1108, 1034, 872, 828. 
MS (EI, 70 eV): m/z (%) = 237 (55), 236 (18), 192 (17), 191 (92), 162 (15), 134 (21), 121 (27), 83 (16), 
82 (21), 57 (100), 55 (17), 44 (21), 43 (16), 41 (33). 
HR-MS (EI, 70 eV): [C17H25O3N], calcd.: 291.1834; found: 291.1822 (M+). 
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Allyl piperidine 112a. Following TP11, thioether 111 (92 mg, 0.300 mmol, 1.0 equiv.) and TMEDA 
(134 µL, 0.900 mmol, 3.0 equiv.) were reacted with s-BuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu 
(1.10 M, 0.82 mL, 0.900 mmol, 3.0 equiv.). After a reaction time of 4 h, the reaction mixture was cooled 
to 0 °C and allyl bromide (78 µL, 0.900 mmol, 3.0 equiv.) was added. The reaction mixture was cooled 
to −40 °C and CuCN·2LiCl (1.0 M, 0.09 mL, 0.090 mmol, 0.3 equiv.) was added. The solution was 
slowly warmed to room temperature over 16 h. The crude product was purified by column 
chromatography on silica using hexane:diethyl ether (95:5) as an eluent to afford 112a as a colourless 
oil (83%, 59 mg, 0.248 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 5.77 (ddt, J = 17.2, 10.2, 7.2 Hz, 1H), 5.08 – 4.97 (m, 2H), 
3.85 (tt, J = 8.3, 6.3 Hz, 1H), 3.73 (ddd, J = 13.9, 7.3, 3.2 Hz, 1H), 3.01 (ddd, J = 13.9, 10.3, 5.9 Hz, 
1H), 2.40 (dddt, J = 14.2, 7.1, 5.9, 1.4 Hz, 1H), 2.24 (dtt, J = 13.5, 7.6, 1.1 Hz, 1H), 1.87 (ddtd, 
J = 13.3, 10.3, 7.2, 1.2 Hz, 1H), 1.73 – 1.68 (m, 1H), 1.68 – 1.62 (m, 1H), 1.45 (s, 9H), 1.20 – 1.12 (m, 
1H), 1.12 – 1.06 (m, 1H), 0.98 (d, J = 6.8 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 155.4, 135.4, 116.7, 79.0, 53.0, 39.0, 37.4, 34.9, 31.1, 28.4, 
26.1, 21.5. 
FT-IR (ATR, cm−1): �̃ = 2976, 2928, 2872, 1688, 1642, 1478, 1456, 1408, 1392, 1364, 1350, 1332, 
1304, 1278, 1246, 1178, 1148, 1094, 1070, 992, 912, 866, 770. 
MS (EI, 70 eV): m/z (%) = 142 (100), 98 (46). 
HR-MS (EI, 70 eV): [C10H16ON], calcd.: 166.1232; found: 166.1225 ([M−Ot-Bu]+). 
 
Allyl piperidine 112b. Following TP11, thioether 111 (92 mg, 0.300 mmol, 1.0 equiv.) and TMEDA 
(134 µL, 0.900 mmol, 3.0 equiv.) were reacted with s-BuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu 
(1.10 M, 0.82 mL, 0.900 mmol, 3.0 equiv.). After a reaction time of 4 h, the reaction mixture was cooled 
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to 0 °C and 3-bromocyclohexene (145 mg, 0.900 mmol, 3.0 equiv.) was added. The reaction mixture 
was cooled to −40 °C and CuCN·2LiCl (1.0 M, 0.09 mL, 0.090 mmol, 0.3 equiv.) was added. The 
solution was slowly warmed to room temperature over 2.5 d. The crude product was purified by column 
chromatography on silica using hexane:diethyl ether (95:5) as an eluent to afford 112b as a colourless 
oil (78%, 65 mg, 0.233 mmol, d.r. = 74:26). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 5.80 (dtd, J = 9.8, 3.6, 2.1 Hz, 0.7H), 5.72 (dq, J = 9.9, 3.2 Hz, 
0.3H), 5.64 (dq, J = 10.2, 2.4 Hz, 0.7H), 5.60 – 5.52 (m, 0.3H), 3.92 – 3.71 (m, 2H), 3.02 – 2.89 (m, 
1H), 2.51 – 2.34 (m, 1H), 2.05 – 1.97 (m, 2H), 1.97 – 1.89 (m, 1H), 1.83 – 1.71 (m, 2H), 1.68 – 1.53 
(m, 2H), 1.53 – 1.42 (m, 10H), 1.31 – 1.18 (m, 1H), 1.13 – 1.04 (m, 1H), 1.00 (d, J = 6.8 Hz, 2H), 0.99 
(d, J = 6.8 Hz, 1H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = Major: 156.0, 129.1, 127.9, 79.0, 56.6, 39.1, 37.7, 33.0, 31.0, 
28.5, 26.0, 25.6, 25.4, 21.5, 20.9; Minor: 156.0, 128.9, 127.4, 79.0, 57.5, 38.8, 38.0, 32.8, 31.1, 28.4, 
26.1, 25.4, 25.2, 21.7, 20.9. 
FT-IR (ATR, cm−1): �̃ = 2948, 2928, 2870, 1688, 1450, 1408, 1392, 1364, 1322, 1280, 1244, 1176, 
1148, 1086, 1062, 770, 724. 
MS (EI, 70 eV): m/z (%) = 206 (11), 198 (16), 143 (18), 81 (10), 41 (21). 
HR-MS (EI, 70 eV): [C17H29O2N], calcd.: 279.2198; found: 279.2216 (M+). 
 
N-Boc piperidine 112c. Following TP11, thioether 111 (92 mg, 0.300 mmol, 1.0 equiv.) and TMEDA 
(134 µL, 0.900 mmol, 3.0 equiv.) were reacted with s-BuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu 
(1.10 M, 0.82 mL, 0.900 mmol, 3.0 equiv.). After a reaction time of 4 h, the reaction mixture was cooled 
to −40 °C and CuCN·2LiCl (1.0 M, 0.09 mL, 0.090 mmol, 0.3 equiv.) and 4-fluorobenzoyl chloride 
(109 µL, 0.900 mmol, 3.0 equiv.) were added. The solution was stirred at −20 °C for 5 h. The crude 
product was purified by column chromatography on silica using hexane:diethyl ether (9:1) as an eluent 
to afford 112c as a colourless solid (46%, 44 mg, 0.137 mmol, d.r.>99:1). Recrystallization of the 
product from hexane gave crystals suitable for single crystal X-ray diffraction analysis. 
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m.p.: 108.3 – 110.5 °C. 
1H-NMR (400 MHz, CDCl3, ppm): δ = 8.07 – 7.96 (m, 2H), 7.16 – 7.05 (m, 2H), 4.62 (br s, 1H), 3.86 
(d, J = 13.2 Hz, 1H), 3.32 (ddd, J = 13.4, 8.9, 4.3 Hz, 1H), 2.08 – 1.95 (m, 1H), 1.84 – 1.66 (m, 2H), 
1.52 – 1.41 (m, 1H), 1.38 – 1.15 (m, 10H), 0.96 (d, J = 6.5 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm): δ = 196.3, 165.3 (d, J = 254.4 Hz), 155.5, 132.3, 130.8 (d, 
J = 9.1 Hz), 115.4 (d, J = 21.7 Hz), 80.8, 60.3, 43.2, 34.3, 32.0, 28.7, 28.0, 21.1. 
FT-IR (ATR, cm−1): �̃ = 1676, 1598, 1420, 1368, 1322, 1268, 1244, 1224, 1178, 1162, 1152, 1088, 
994, 956, 842, 822, 772, 664. 
MS (EI, 70 eV): m/z (%) = 204 (24), 198 (58), 143 (35), 99 (18), 97 (16), 95 (79), 75 (14), 56 (40), 55 
(45), 41 (63). 
HR-MS (EI, 70 eV): [C18H24O3NF], calcd.: 321.1740; found: 321.1719 (M+). 
 
N-Boc piperidine 112d. Following TP11, thioether 111 (92 mg, 0.300 mmol, 1.0 equiv.) and TMEDA 
(134 µL, 0.900 mmol, 3.0 equiv.) were reacted with s-BuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu 
(1.10 M, 0.82 mL, 0.900 mmol, 3.0 equiv.). After a reaction time of 4 h, the reaction mixture was cooled 
to –40 °C and ZnCl2-solution (1.0 M in THF, 0.90 mL, 3.00 mmol, 10 equiv.) was added. After warming 
to room temperature, the solution was recooled to −40 °C and SPhos (12 mg, 0.030 mmol, 10 mol%), 
Pd(dba)2 (8.6 mg, 0.015 mmol, 5 mol%) and 4-iodoanisole (215 mg, 0.900 mmol, 3.0 equiv.) was 
added. The reaction was stirred at 55 °C for 2.5 d. The crude product was purified by column 
chromatography on silica using hexane:diethyl ether (9:1) as an eluent to afford 112d as a colourless 
oil (32%, 29 mg, 0.095 mmol, d.r.>99:1). 
 
1H-NMR (400 MHz, CDCl3, ppm): δ = 7.16 – 7.09 (m, 2H), 6.87 – 6.79 (m, 2H), 4.80 (dd, J = 9.8, 
6.3 Hz, 1H), 3.95 (ddd, J = 13.7, 7.0, 3.1 Hz, 1H), 3.79 (s, 3H), 3.25 (ddd, J = 13.8, 10.7, 5.6 Hz, 1H), 
2.04 – 1.89 (m, 2H), 1.84 – 1.75 (m, 1H), 1.55 (dt, J = 13.6, 10.2 Hz, 1H), 1.30 (s, 9H), 1.20 (dddd, 
J = 13.3, 7.6, 5.6, 3.0 Hz, 1H), 0.91 (d, J = 6.8 Hz, 3H). 
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13C-NMR (101 MHz, CDCl3, ppm): δ = 158.0, 155.9, 136.7, 126.3, 113.6, 79.3, 56.1, 55.2, 38.3, 38.2, 
31.1, 28.3, 26.4, 21.5. 
FT-IR (ATR, cm−1): �̃ = 2950, 2930, 2872, 1686, 1512, 1456, 1402, 1364, 1292, 1280, 1242, 1172, 
1148, 1126, 1112, 1090, 1034, 826, 774, 758. 
MS (EI, 70 eV): m/z (%) = 250 (12), 249 (78), 248 (28), 232 (12), 205 (16), 204 (100), 162 (14), 135 
(14), 134 (20), 121 (26), 97 (10), 96 (18), 57 (53), 41 (17). 
HR-MS (EI, 70 eV): [C18H27O3N], calcd.: 305.1991; found: 305.1992 (M+). 
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13.3 Single Crystal X-Ray Analysis 
Single crystals of the compounds, suitable for X-ray diffraction, were obtained by slow evaporation of 
solvents solutions. The crystals were introduced into perfluorinated oil and a suitable single crystal was 
carefully mounted on the top of a thin glass wire. Data collections were performed on an Oxford 
Xcalibur 3 diffractometer equipped with a Spellman generator (50 kV, 40 mA) and a Kappa CCD 
detector, operating with Mo-Kα radiation (Ȝ = 0.71071 Å). Data collection and data reduction were 
performed with the CrysAlisPro software.XXV Absorption correction using the multiscan 
methoda) was applied. The structures were solved with SHELXS-97, XXVI refined with 
SHELXL-97XXVII and finally checked using PLATON. XXVIII Details for data collection and structure 
refinement are summarized in the tables at the different sections. 
N-Boc piperidine 112c. 
 
Figure 12: Molecular structure of N-Boc piperidine 112c in the crystal, View of the two crystallographically independent 
molecules in the unit cell. DIAMONDXXIX representation; thermal ellipsoids are drawn at 50% probability level. 
 
                                                     
XXV Program package CrysAlisPro 1.171.38.46 (Rigaku OD, 2015). 
XXVI Sheldrick, G. M. (1997) SHELXS-97: Program for Crystal Structure Solution, University of Göttingen, 
Germany. 
XXVII Sheldrick, G. M. (1997) SHELXL-97: Program for the Refinement of Crystal Structures, University of 
Göttingen, Germany. 
XXVIII Spek, A. L. (1999) PLATON: A Multipurpose Crystallographic Tool, Utrecht University, Utrecht, The 
Netherlands. 
XXIX DIAMOND, Crystal Impact GbR., Version 3.2i. 
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Table 12: Details for X-ray data collection and structure refinement for N-Boc piperidine 112c. 
Empirical formula C18H24FNO3 
Formula mass 321.38 
T/ K 143(2) 
Crystal size [mm] 0.32 × 0.16 × 0.13 
Crystal description colorless block 
Crystal system triclinic 
Space group P-1 
a/ Å 10.4749(7) 
b/ Å 12.4545(8) 
c/ Å 13.7136(8) 
α/ ° 86.508(5) 
ȕ/ ° 74.026(5) 
Ȗ/ ° 88.935(5) 
V/ Å3 1716.79(19) 
Z 4 
ρcalcd./ g cm−3 1.243 
μ/ mm−1 0.091 
F(000) 688 
Θ range/ ° 4.14 – 25.68 
Index ranges −12 ≤ h ≤ 12 
 −15 ≤ k ≤ 15 
 −16 ≤ l ≤ 16 
Reflns. collected 12409 
Reflns. obsd. 3915 
Reflns. unique 6475  
(Rint = 0.0437) 
R1, wR2 (βσ data) 0.0514, 0.0986 
R1, wR2 (all data) 0.0989, 0.1209 
GOOF on F2 0.983 
Peak/hole/ e Å−3 C18H24FNO3 
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